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Organisms respond to genetic or environmental perturbations by modulating their 
cellular metabolism. Changes to these metabolic processes are orchestrated through the 
regulation of multiple biological processes, such as gene expression, protein synthesis or 
enzymatic reactions, among others. Metabolites that are intermediates or end-products of 
these regulatory processes, can be regarded as the ultimate biochemical phenotype of a 
cellular system. Traditionally, regulatory molecules and their mechanisms have been 
studied using a reductionist approach, targeting only the specific pathway and its 
intermediates. In order to understand the systems level regulatory interactions that 
determine the physiological state of a cell, statistical analysis of metabolomics data in 
combination with other omics data can be used. However, there are still large gaps in our 
understanding of how to systematically: (i) estimate and remove non-biological sources of 
variation in high-throughput datasets; (ii) characterize the influence of natural variation or 
genetic perturbation on the metabolome, and (iii) derive accurate and biologically informed 
identification of the regulatory control of metabolic networks of the cell.  
Motivated by these unresolved challenges, this thesis aims to understand how an 
organism’s metabolite profile is influenced by (i) unwanted non-biological artefacts; (ii) 
natural variation; (iii) induced genetic perturbation, with an aim to provide important 
insights on the regulatory and molecular mechanisms involved. By addressing these 
specific questions, the following knowledge was gained:  
 To derive biologically meaningful information from high-density datasets, the data 
should be free from unwanted variation such as batch effects. To this end, 




untargeted metabolome survey and a filtering procedure based on the singular 
value decomposition was developed to remove these batch effects. This technique 
removed unwanted variation while permitting recovery of signals of biological 
origin (Chapter 3).  
 To understand the influence of natural variation in the metabolic profiles, data 
generated from an untargeted metabolite survey of oleaginous algae-Chlorella 
species was used (Chapter 4). Statistical analysis of the metabolic profiles revealed 
(i) discordance between ribosomal-based phylogenetic classification and 
metabolic phenotypes; (ii) metabolic diversity between strains to be growth-stage 
dependent and influenced by habitat-specific variations; (ii) strain-specific 
associations with physicochemical traits. The top performing strains were enriched 
in metabolites belonging to isoprenoid and energy metabolism.  
 To understand the regulation of biochemical processes that generate metabolite 
diversity, genetic perturbation-based approaches were used in Arabidopsis 
(Chapter 5). Analysis of multi-omics datasets using an integrative omics approach 
revealed (i) shared regulatory mechanisms between glycosylation of primary and 
secondary metabolites; (ii) coordinated regulation of processes associated with 
metabolite glycosylation and phytohormone biosynthesis; (iii) dependence of plant 
defence strategies on mechanisms that increase metabolite diversity.  
Taken together, the approaches developed in this thesis, integrate environmental 
factors and metabolic network components with metabolomics data using statistical 
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“In God we trust; all others must bring data.” 
… W. Edwards Deming 
1.1. Era of big data and integrative omics 
Technological advances in the fields of physical sciences, computing and 
engineering have herald in drastic changes to the way data is generated, stored and 
analysed. Ease of data generation along with the availability of high computational 
power has led to increasing use of statistics in analysing networks, be it social or 
biological (such as transcriptional or metabolic networks). Biologists already familiar 
with handling big datasets from the time of microarray, have now embarked on 
designing larger experiments producing high density datasets.  
This confluence of statistics, computing and biology has created an 
environment conducive for mining and analysing large biological datasets (Marx, 
2013). In this study, we have focused on developing computational solutions for 
analysing metabolic phenotypes by integrating omics datasets to discover novel 
biological relationships.  
1.2. Metabolomics and transcriptomics 
Metabolites are substrates and end-products of enzymatic reactions regulated 
through dynamic biochemical and gene expression changes in the cell (Fiehn, 2002). 
Metabolomics attempts to study the role of metabolites in the physiological and 
developmental state of cells, tissues, organisms and their responses to perturbations. 
Measurement technologies such as mass spectrometry (MS) or nuclear magnetic 
resonance spectroscopy (NMR) (described in Section 2.1.5) are commonly used for 
profiling metabolite levels. Such measurements of metabolite concentrations, along 




interpretations. By providing a real-time measure of the metabolite signals in various 
metabolic pathways, metabolomics approaches provide an accurate snapshot of the 
specific biochemical phenotype (Katajamaa and Oresic, 2007; Raamsdonk et al., 2001). 
Metabolomics approaches can be used to provide a critical assessment of complex 
phenotypes, as well as identify biomarkers related to diseases sub-types, physiological 
responses and the like (Baker, 2011).  
The increasing availability of genome-wide datasets (Suhre et al., 2011; Wen 
et al., 2014), providing interactions between genes and metabolites (Hirai et al., 2005; 
Kresnowati et al., 2006) has now made it possible to establish that cellular metabolic 
phenotypes are directly affected by changes to gene expression levels. Cell growth and 
maintenance is orchestrated via enzyme mediated regulation of metabolite levels, that 
mostly occur via transcriptional and/or translational changes, post-translational 
modifications, binding of small molecules in response to genetic or environmental 
factors (Saito et al., 2010; Zelezniak et al., 2014). Knowledge of such regulatory 
mechanisms increasingly depend upon understanding the genetic structure and gene 
expression levels (Fiehn, 2002). In order to characterize the changes in the genome‐
wide RNA expression patterns, global transcriptome analysis is used.  
1.3. Coordination of metabolic networks – the key to an organism’s 
response to change 
Metabolic pathways are co-ordinately regulated at multiple levels and are 
organized in the form of metabolic networks in a cell. These networks are scale-free, 
contain metabolites as nodes and provide basic biochemical building blocks, enable 
growth and maintenance of biological systems. Metabolic networks allow organisms 
to respond to perturbation and environmental factors by modulating metabolic 
reactions in these networks. For example, plants being sessile, modulate biochemical 




biotic stresses such as pathogens, and herbivores among others (Obata and Fernie, 
2012).  
1.3.1. Regulation of metabolic networks 
Knowledge of regulatory mechanisms governing metabolic processes is 
essential for understanding the changes in the biochemistry and physiology of the 
system in response to perturbation. Variation in metabolite levels serve as functional 
indicators of regulatory processes influencing the physiological state of a system. 
Variation in the levels of metabolites can broadly be due to (i) non biological sources- 
such as instrument, sampling or experimental errors, (ii) natural variation or 
environmental factors, referring to macroscopic natural fluctuations such as changes to 
growth conditions, temperature etc., (iii) external perturbations, such as those that 
occur through the regulation of gene expression or that modify natural growth 
conditions.   
Furthermore, the intricate network of interactions between metabolites are 
likely to regulate a number of biological processes, rather than affecting only a specific 
pathway. However, the feedback mechanisms that regulate metabolite levels via 
translational control, signal transduction pathways, or allosteric regulation are poorly 
understood, while protein abundances or enzymatic activities are also difficult to 
measure. Therefore, in order to understand an organism’s response to perturbation, 
their genetic potential and genotype-phenotype relationships, a clear conceptual 
framework with multi-level measurements of biological entities is required.  
Integrating metabolomics and transcriptomics datasets can provide new 
insights into biochemical processes by linking lower level biological entities (such as 
DNA, RNA and metabolites) and higher organizational levels (such as physiological 




metabolite profiling can also be used to identify novel functions for genes and aid in 
genome annotation (Prosser et al., 2014).  
1.3.2. Metabolomic profiling- measuring metabolite levels 
Metabolites possess increasingly diverse physicochemical properties with 
varying concentration levels that typically range from picomolar to millimolar (Bedair 
and Sumner, 2008; Boccard and Rudaz, 2014). Thus, analytical tools, which can cover 
this vast chemical space and also provide unbiased and accurate quantitative 
measurements of the concentration levels are required. With these criteria, mass 
spectrometry-based metabolomics provide the best platform technology for obtaining 
non-targeted, high-throughput metabolite profiles of the complete metabolome (Bedair 
and Sumner, 2008; Lei et al., 2011; Werner et al., 2008b). The high accuracy of mass 
spectrometers enable the detection of exact masses of metabolites that can serve as 
putative indicators of molecular formula or structures.   
These non-targeted mass spectrometry-based metabolomics experiments 
which provide extended coverage of analytes along with measurements on interacting 
data layers, generate massive data structures. Furthermore, MS-based metabolomics 
experiments, being extremely sensitive to sample and analytical conditions, produce 
datasets wherein the actual biological variation is highly confounded with non-
biological sources of variation. Additionally, genetic or environmental perturbations 
also alter metabolite abundances by reprogramming metabolic pathways. Thus, 
appropriate statistical procedures for handling such datasets should factor in the 
different sources of variation affecting the metabolite profiles. 
Understanding and characterizing these complex datasets pose numerous 
analytical challenges at different stages of the experimental lifecycle, ranging from data 




techniques and tools have been designed to address these challenges, unique problems 
associated with the application of metabolite profiling remain.  
1.4. Motivation for current research 
The basic tenets of scientific research are directed towards increasing 
knowledge and providing key avenues for further research in any domain. Thus, being 
in the increasingly challenging and emerging field of metabolomics, identifying 
metabolic strategies and networks in various biological systems is a key objective. 
Understanding the properties of such biological networks, including their architecture, 
regulatory processes, and robustness to evolutionary, environmental and genetic 
changes is key to predicting and engineering desired responses. Progress in 
understanding such networks is predicated on generating accurate descriptions, 
typically by measuring qualitative and quantitative relationships among the biological 
entities in different layers (e.g., transcriptome, metabolome, proteome) in response to 
perturbations.  
Studies using metabolomics approaches have excellent capabilities to estimate 
the effect of different treatment conditions, and provide insights as to how genetic 
information and environmental factors can influence cellular metabolic responses and 
phenotypic characteristics (Hendriks et al., 2011). However, to fully exploit the wealth 
of information in such datasets, multivariate statistical approaches and integrative 
omics strategies that can elucidate complex biological interactions, taking into account 
the influence of other non-biological sources of variations, needs to be developed.  The 
work presented in this study specifically attempts to contribute to the understanding of 
the influence of natural variation or perturbation on the metabolic phenotype of a cell, 





1.4.1. Organization of the thesis 
A detailed review of the current state of metabolomics challenges, platform 
technologies, and data analysis techniques are provided in Chapter 2. Following are 
the specific questions addressed in the different results based Chapters of this study:  
Chapter 3: How does non-biological variation affect the metabolomics 
profile?  
Mass spectrometry-based metabolomics experiments are extremely sensitive 
to the non-biological sources of variation, such as sample extraction or analytical 
conditions. Furthermore, such experiments generate large and complex data that are 
confounded by multiple sources of technical and biological artefacts. Combining data 
from such experiments performed over long time periods of time (weeks/months) or 
assayed in different batches present numerous challenges. These are often overlooked 
in current pipelines, and may lead to systematic errors, such as batch effects, that could 
be misinterpreted as being of biological origin (Leek et al., 2010).  
We have developed approaches for identifying and removing sample and 
assay-related (batch) effects in untargeted metabolome data using multivariate 
statistical techniques. We demonstrate the use of a filtering procedure based on the 
singular value decomposition (SVD) on untargeted metabolite profile data from 
oleaginous algae- Chlorella, to remove structure in data related to day of sample assay. 
The batch effect corrected data is then analysed in an integrated manner to derive 
meaningful biological information in Chapter 4. 
Chapter 4: How do environmental and biochemical factors affect metabolic 
resource partitioning strategies? 
Cellular metabolism of organisms is tightly regulated in response to 
environmental pressures. Understanding the impact of habitat and biochemical factors 




biological systems, whose bio-products are extremely sensitive to such factors. 
Increasing energy demands has led to the search for alternative sources of energy, with 
biofuel from algae being one of the most promising (Brennan and Owende, 2010).  
The yield of bio-energy products in high cell densities depends on the 
metabolic resource partitioning strategies employed by the organism.  Therefore, in this 
study, we used untargeted high-resolution mass spectrometry along with biochemical 
profiling to understand the metabolic differences at exponential and stationary growth 
stages of 22 naturally varying Chlorella strains isolated in Malaysia by our 
collaborators from University of Malaya (UMA).  
Chapter 5: What is the impact of genetic perturbations on the metabolic 
network?  
Metabolites have important functional and ecological roles, such as regulating 
defence, growth, providing stress tolerance, and are highly valuable as 
pharmaceuticals. These diverse functions are orchestrated through intricate metabolic 
networks, for example in plants, these networks involve almost 200,000 secondary 
metabolites (Wink, 2010). The diversity of metabolites mainly arise through 
biochemical processes such as conjugation (e.g., glycosylation). While the individual 
enzymes and metabolites involved in these processes are known, there are large gaps 
in the field about (i) how the different molecular entities that are involved in 
conjugation processes, function in coordinated networks; and (ii) how metabolite 
conjugation is regulated in response to other processes, such as development and 
defence.  
We used a putative glycosylation regulatory mutant- tt8, in the model plant 
Arabidopsis thaliana, to understand the regulatory processes governing metabolite 




network. To discover novel glycosylation targets of TT8 and its regulatory network, 
we developed and used an integrative omics approach.  
Finally, Chapter 6, summarizes the key findings and contributions of the 
thesis, and provides recommendations for future work. An outline of the data analysis 
tools developed/implemented in two interdisciplinary collaborative projects during the 
present work is also provided in the Appendix. Important aspects of this study, along 
with the overall organization of the topics analysing perturbational effects on metabolic 
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2. Literature review 
“What was vital was overlaid and hidden by what was irrelevant.  
Of all the facts which were presented to us, we had to pick just those  
which we deemed to be essential” 
... Sherlock Homes in ‘The Adventure of the Naval Treaty’ 
 
The literature reviewed here has been organized into two parts. The first part of the 
review provides an overview of metabolome, metabolomics approaches and data 
analysis strategies. In the second part, metabolic networks, multi-omics approaches and 
challenges are discussed.  
2.1. Metabolome  
The term “metabolome” refers to the complete collection of metabolites 
synthesized by a biological system. Metabolites have important structural and 
functional roles, and are low molecular weight intermediates or end products of 
biochemical reactions occurring within cells (Bhalla et al., 2005; Fiehn, 2002). Real-
time measurement of metabolite levels through metabolite profiling techniques help 
determine the active biochemical processes in an biological system (at the time of 
measurement), and provide an accurate biochemical phenotype (Fiehn, 2002).  
Measuring metabolite level fluctuations provides important insights into the 
interactions between the genotype and the environment, and also the various sub-
cellular modifications that are a part of homeostasis. This information can be used to 
assess the cellular response to environmental changes (Bhalla et al., 2005) and in 




The metabolic profile of a biological system isolated from a specific location, 
developmental stage or environment represents a unique metabolite signature for that 
particular system observed at that instant of time and in that highly specific 
physiological state.   
2.1.1. Metabolite classes and diversity 
Metabolites possess an enormous range of physicochemical diversity, for 
example, in plant kingdom alone there are nearly 200,000 different types of metabolites 
(Wink, 2010). The activity and sub-cellular specificity of metabolites to organs, tissues 
and biochemical pathways arise mainly due this diversity. Metabolites are classified as 
either primary metabolites such as sugars, amino acids, and organic acids or secondary 
metabolites such as phenylpropanoids, terpenoids and alkaloids. This classification is 
based on their functional roles, with primary metabolites playing an active role during 
growth, development and central energy conversion cycles, while, secondary 
metabolites, are mostly involved in specialized functions, such as coordinating cellular 
response to environmental perturbations and in signalling (Hartmann, 2007). These 
functions of secondary metabolites, require them to be synthesized and localized in 
specialized cells, tissues, or organs. 
Secondary metabolism pathways are generally specialized to cell or tissue type 
during initial differentiation stages (Rhodes, 1994). Such specialization of metabolic 
pathways also exist between different compartments within the cell. For example, 
recent reports have emphasized on the dynamic and highly specific phyto-metabolome 
by  assessing the specificity of foliar metabolic responses in plants to fungus 
(Schweiger et al., 2014). 
The diversity in structures and functions of secondary metabolites arise mainly 
through biochemical processes, such as conjugation, that change the basic chemical 
properties of a small number of core metabolites (Hartmann, 1996).   Such changes to 
the chemical structure of the metabolites confer new functional properties such as 
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altered bioactivity, subcellular mobility, compartmentalization among others. For 
example, these processes help mediate inactivation of toxic forms of metabolites 
(Winkel-Shirley, 2001) and de novo biosynthesis of new compounds among others 
(Sakakibara, 2006).  
A number of conjugation processes such as glycosylation, sulfation, 
acetylation, methylation, amino acid conjugation, gluthatione conjugation  and 
lipophilic conjugation exist in nature (LeBlanc, 2007). Specialized enzymes such as 
carbohydrate active enzymes (CAZy) (Lombard et al., 2014) are involved in 
conjugation of metabolites and are responsible for generating the secondary metabolite 
diversity.  The importance of these processes in secondary metabolism can easily be 
judged by the fact that nearly 4% of the genome of higher plants encodes CAZy.  
Advances in metabolomics approaches have led to a better understanding of 
the classification and roles of primary and secondary metabolites. With many 
secondary metabolites also identified to have important roles in growth and 
development, most scientists now consider the differentiation between primary and 
secondary metabolites as obsolete.  
2.1.2. Metabolomics 
Metabolomics is the comprehensive analysis of the metabolome by profiling 
metabolite levels (Fiehn, 2002) using various measurement technologies (described in 
Section 2.4). The practice of using ‘metabolomics’ to describe analytical and 
quantitative measurement of metabolite began with Oliver et al (Oliver et al., 1998). 
However, it is only in the last decade where technological developments have provided 
a breakthrough to the increasing use of metabolomics in research, as witnessed in the 
exponential growth in the number of articles returned by PubMed search for the term 
‘metabolom*’ (* is a wild card, includes metabolome, metabolomic and metabolomics,  
accessed June 2014) (Figure 2.1).   
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Metabolomics complements other omics approaches and provides unique 
advantages that help understand the relationship between mechanistic biochemistry and 
cellular phenotype (Gary et al., 2012; Goodacre et al., 2004). 
 
Figure 2.1. Number of articles in PubMed  
Firstly, due to the complex regulatory mechanism in cells, changes to gene or 
protein expression levels might not directly result in a change in the morphological or 
biochemical phenotype. Unlike genes or proteins that might be subjected to post-
translational or epigenetic regulations, metabolites whose structures are determined via 
metabolite profiling techniques serve as direct signatures of biochemical activity, and 
can be used to detect unexpected pleiotropic effects. Thus, metabolomics approaches 
can be used to determine biochemical processes that are activated in a particular 
phenotype. Such analysis in combination with the transcriptomic information can be 
used to understand regulatory networks controlling these phenotypes, thereby 
providing important clues to understand the genotype-to-phenotype relationship. For 
example, comparing metabolite profiles using differential metabolite analysis helped 
uncover the effects of a silent mutation in yeast (Raamsdonk et al., 2001) and in potato 
(Weckwerth et al., 2004).   
Secondly, with advances in computational and analytical technologies, 
metabolomics has attained the technical robustness to provide alternate and 
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complementary measure of phenotypes. Using the concept of Metabolic Control 
Analysis (Kell and Mendes, 2000; Teusink et al., 1998) which states that metabolite 
levels serve as direct substitute for physiological measurements, metabolomics 
experiments  can be used to measure changes to biological parameters such as gene or 
protein expression levels, without knowing anything about an organisms genetic 
makeup or its regulatory networks. Multi-omics approaches provide quantitative 
descriptions of cellular regulation and identify early metabolic biomarkers in disease 
progression. For example, by analysing metabolite fluxes together with transcriptome 
profiles, metabolic reprogramming strategies leading to tumorigenesis have been 
identified (Sreekumar et al., 2009; Zhang et al., 2012). 
Systematic analyses of metabolic snapshots of environmental and microbiome 
samples offers great potential to identify hitherto unknown novel bio-active compounds 
and pathways (Medema et al., 2011; Steen et al., 2010). Understanding such novel 
biological designs will lead to better metabolic engineering strategies in synthetic 
biology applications, for example, to produce or consume key metabolites in response 
to environmental cues. Furthermore, with most natural products from secondary 
metabolism being induced under conditions associated with their habitat and lifestyle, 
exploring these natural variants can aid in the identification of natural products with 
important commercial and pharmaceutical values (Clardy and Walsh, 2004). This 
strategy has been used to understand the metabolic markers of biotechnological traits 
useful for biofuel production in Chapter 3.  
2.1.3. Analysing the metabolome 
At any given time, the metabolic state of a cell is maintained through the 
regulation of dynamic biochemical processes in response. By coordinating metabolite 
levels, these processes provide the basic building blocks of cell metabolism ensuring a 
thermodynamically favourable environment for growth and development. The 
regulation of metabolite levels and metabolite network connectivity can be studied 
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using metabolomics approaches. This provides a unique metabolic fingerprint for each 
system, where the specific metabolic response can be correlated to different sources of 
variation. Studying perturbations which alter gene and metabolite levels, and thereby 
regulating metabolic activity provide a mechanistic view of the regulatory networks 
(Jansen, 2003). In particular, it will be of interest to understand the degree to which 
gene expression changes affect metabolite concentration. There are two possible 
scenarios in which metabolomics approaches can provide valuable insights: 
2.1.3.1. Natural intrinsic variations 
This is an intriguing feature of cell metabolism, wherein genetic variation 
between organisms, or diverse environmental factors create distinct metabolic 
phenotypes. These metabolic signatures are indicative of the natural variation present 
in such organisms, and can be used to understand how an organism’s genetic makeup 
complement’s its environment and enable it to survive in a unique ecosystem. The 
advent of multi omics technologies has facilitated an ecosystems biology approach, 
wherein, genome wide association studies of an entire population are sampled and the 
inherent genetic and metabolic variation are analysed. These approaches are also used 
for identifying novel bio-products in their natural state and can provide the data for 
unravelling complex interplay between genes and environment. For example, 
understanding ecological principles governing growth and production of desired 
compounds in microbiomes, can help design efficient metabolic engineering strategies 
(Bouslimani et al., 2014; Nah et al., 2013; Yen et al., 2013). Environmental samples 
have higher levels of inherent variation and require robust experimental design 
[discussed in Section 2.5]. 
In this thesis, the variation in the metabolite profiles due to (i) non-biological 
sources (Chapter 3); (ii) natural variation (Chapter 4); and (iii) genetic perturbations 
(Chapter 5) are discussed.   
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2.1.3.2. Deliberate and controlled perturbations  
The genetic basis for metabolite regulation, diversity, concentration, and the 
interrelationships between metabolic pathways, regulatory networks can be studied 
using perturbation-based approaches. These studies are designed to link genotype with 
the corresponding phenotype. Such perturbational strategies can be: 
2.1.3.2.1. Localized 
The change in metabolite levels resulting from a localized intervention, such 
as targeting genes at specific steps in a pathway are used to understand the cause and 
effect relationship. Typically loss-of-function (gene silencing, mutagenesis), gain-of 
function (transgenesis), chemical elicitors or inhibitors, RNAi or amiRNA approaches 
are used in this functional genomics approach (Jansen, 2003). Furthermore the effect 
of the localized intervention can be used to estimate the causal relationships arising out 
of pleiotropic effects in the global metabolic network.  
2.1.3.2.2. Global 
Biological systems thrive even in harsh environmental conditions by 
reconfiguring their metabolic networks to ensure that metabolic homeostasis is 
maintained. Measuring metabolic responses during treatments applied to the entire 
system such as biotic or abiotic stressors, transient or diurnal time series in natural 
conditions, other environmental changes (stress, nutrients etc.) can provide clues to 
understand the changes to the organism’s biochemical processes as a response to 
perturbations. In this case, changes to the metabolic network might be induced at 
multiple branch points, thereby affecting a large number of metabolites simultaneously. 
These network-wide perturbations can also be used to guide a more localized analysis. 
For example, identifying that GLDC enzyme was correlated with tumorigenesis, led to 
a more targeted study using a perturbational models [described in Appendix 1] (Zhang 
et al., 2012).  
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2.1.4. Qualitative Vs Quantitative approaches in metabolomics 
Metabolomics approaches can be designed to provide either a qualitative 
description, such as nature, physicochemical properties of metabolites and/or 
quantitative analysis where metabolites and their levels are analysed. For example, to 
differentiate classes of metabolites selectively enriched between legumes grown in a 
fertile soil with those grown in drought conditions, qualitative analysis can be 
performed.  The results from such analysis can be used for identifying biomarkers 
indicating the physiological state of an organism in response to its environment, as well 
as to compare wild-type and genetically engineered systems (Alisdair et al., 2004).  
Accurate absolute or relative metabolite concentrations can be quantitatively 
measured to analyse flux changes, metabolic reprogramming strategies, differential 
activation of pathways when comparing different genotypes, treatment conditions, 
environmental perturbations etc. An unbiased approach to profile as many metabolite 
as possible is used. These analyses help derive specific biological question, wherein 
either a targeted approach or a non-targeted approach can be used. 
2.1.4.1. Targeted metabolomics 
This approach is generally used when testing a specific hypothesis, wherein 
the possible metabolic targets or pathways affected are known. For such approaches, 
good knowledge of the biological problem is desired as this will ensure that the 
sampling strategy captures the maximum change in metabolite levels. Furthermore, 
sound knowledge of extraction chemistry is also required to design the extraction and 
sample preparation steps for isolating specific classes of metabolites (Halabalaki et al., 
2014; Kim and Verpoorte, 2010; Parab et al., 2009). The extracted metabolites are then 
quantified using tandem MS or NMR spectroscopy-based approaches. Using such 
techniques, new classes of metabolites and novel connections in metabolic networks 
can be discovered. For example, these approaches can be effective in analysing the 
levels of desired compounds, such as in the field of nutritional metabolomics (Jones et 
17 
 
al., 2012), food safety/quality (Cevallos-Cevallos et al., 2009), environmental 
chemistry and toxicology (Viant and Sommer, 2013), identification of biomarkers of 
diseases (Kaddurah-Daouk et al., 2008), or effects of genetic modifications on a 
specific enzyme (Fiehn, 2002). 
2.1.4.2. Non-targeted metabolomics 
To obtain a comprehensive, unbiased coverage of the entire metabolome, a 
non-targeted metabolomics approach is used. The non-targeted nature of these 
approaches provide a methodological starting point generating data-driven hypotheses. 
These approaches can be used to identify novel bio-products (Bouslimani et al., 2014), 
new connections between metabolic pathways, and uncovering biochemical 
phenotypes of novel biological systems such as microbiomes (Segata et al., 2013). 
These new links between cellular pathways and biological mechanisms aid in a better 
understanding of cell biology, physiology and can be used to engineer novel products.  
A combination of first non-targeted, and then targeted approach is suggested 
to perform an unbiased characterization of the metabotype and to subsequently identify 
novel metabolites. For example, non-targeted approach can be used to identify the most 
affected pathway, then a targeted analysis can be performed to accurately obtain the 
concentration levels of metabolites from that pathway.  
2.1.5. Metabolomics platform technologies: Choice of metabolomics 
hardware based on experimental approach 
A number of technical and analytical challenges exist in performing 
metabolomics experiments. Firstly, there is wide physicochemical heterogeneity 
between metabolites and a broad dynamic range of abundance (Wink, 2010). These 
require multiple extraction strategies coupled with combination of analytical 
techniques to achieve adequate metabolite coverage (De Vos et al., 2007; Fernie, 2007; 
Patti, 2011). Secondly, analytical instruments with ultra-high resolution, high scan 
speeds are required to ensure that the chemical space of a broad range of metabolites is 
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covered thoroughly. These in turn produce large amounts of data, which needs 
advanced statistical analysis to obtain meaningful information (Werner et al., 2008a).  
Lastly, the biological question, sample type and experimental design should be the 
basis for choosing an analytical instrument. With the above criteria, MS and NMR 
instruments that facilitate metabolomics experiments to be performed with high 
specificity, reproducibility and in both qualitative and quantitative manner should be 
selected. A brief overview of the characteristics of these instruments is provided below.   
2.1.5.1. Nuclear magnetic resonance  
NMR provides the option to have a highly selective and non-destructive 
approach, thus, it is widely used for structure elucidation, confirmation and 
quantification of both known and novel metabolites (Kim et al., 2011; Wishart, 2008b). 
Unlike MS, NMR can be used to analyse samples existing in both solutions or as solid-
state samples. However, NMR has relatively low sensitivity, thus limiting the 
metabolic coverage. This makes NMR to be preferred mainly for targeted approaches, 
such as flux analysis using 1-D or 2-D NMR. Nevertheless, NMR has great potential 
in quality control measurements, and in chemotaxonomy to classify and characterize 
biological systems based on their distinct metabolic signatures.  (Wishart, 2008b) has 
discussed NMR-based metabolomics in depth. 
2.1.5.2. Mass spectrometry    
Mass spectrometry-based metabolomics is widely popular in both targeted and 
non-targeted approaches as it provides high resolution, sensitivity and coverage 
required for identification and quantification of metabolites. The ratio of mass-to-
charge observed of ions is measured in this technique.  These observations provide 
specific chemical information which can directly be related to the chemical structure 
and formula. For example, accurate mass, isotope distribution patterns and 
characteristic daughter ions are all produced using MS. These results are used for 
fragmentation-based structure elucidation or identification via spectral matching to 
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compound databases such as HMDB (Wishart et al., 2013), KEGG (Okuda et al., 2008) 
or MetaCyc (Zhang et al., 2005).  
The high sensitivity of MS is used to detect metabolites even at picomolar or 
femtomolar levels. High mass accuracy (detection differences less than 2ppm) and high 
resolution, make the next generation instruments, such as Fourier transform-ion 
cyclotron resonance MS (FT-ICR-MS) and Orbitrap MS to be used derive semi-
quantitative measurements of metabolite concentrations. For absolute quantitative 
measurements of metabolite levels, quadrupole ion trap mass spectrometers or triple 
quadrupole mass spectrometers (for tandem MS/MS) are used. The high sensitivity and 
resolution, comes with its caveats, requiring robust data analysis strategies for 
obtaining biological information. A detailed discussion on various stages of mass 
spectrometry-based metabolomics experiments is provided (Dettmer et al., 2007).  
2.1.5.2.1. Hyphenated mass spectrometry techniques 
The two most common approaches for MS-based metabolic profiling are either 
direct injection of the sample into MS or using chromatography techniques such as gas 
chromatography (GC), high-performance or ultra-performance liquid chromatography 
(LC) and capillary electrophoresis (CE) in conjunction with mass spectrometry 
(hyphenated mass spectrometry) to provide better separation and resolution of 
metabolite profiles.   
Direct injection-based approaches are faster compared to others as time spent 
in the chromatographic run is saved. Thus, for screening large number of samples, such 
as those from a population-based research or a large environmental study these 
approaches are used. However, direct injection of compounds are prone to matrix 
effects such as ion suppression or enhancement and lead to inaccurate quantification of 




MS with chromatography-based separation enables the separation of ions 
based on its physicochemical properties such as size and charge, and thus, avoid matrix 
effects. These advantages makes chromatography coupled MS to be one of the most 
widely used approach in analysing complex samples. Furthermore, additional 
information on metabolites detected, mainly in the form of retention times of those 
metabolites is obtained. Such information is especially useful while performing 
database-dependent metabolite identification. 
GC-MS-based approaches require the analytes (thermo-labile) to be in gas 
phase, and are suitable for both volatile and non-volatile compounds following 
derivatization. This approach is widely used in targeted metabolomics where the 
chemical properties of metabolites are known. For example, GC-MS is popular in plant 
metabolomics to detect volatile metabolite contributing to aroma (Shuman et al., 2011). 
Furthermore, GC-MS has comprehensive robust metabolite libraries that can be used 
for metabolite identification (Hummel et al., 2007). The major limitation of GC-MS is 
the extensive derivatization steps, and restrictions based on the chemical properties of 
metabolite classes. Thus, liquid phase-based methods such as LC-MS have found 
favour among metabolomics researchers.  
LC-MS is generally less restrictive than GC-MS. For example, in LC-MS, 
samples can be mildly heated during ionization. This property of LC-MS makes it ideal 
for non-targeted metabolomics approaches that are performed to detect both thermo-
labile and thermo-stable metabolites. An additional analysis strategy is the flexibility 
to use a number of columns based on reverse phase, ion exchange and hydrophobic 
interactions principles (Allwood and Goodacre, 2010). Ultra-high performance liquid 
chromatography (UHPLC) provides a fast and efficient way to increase 
chromatographic resolution and detection range, while decreasing the analysis time 
compared to HPLC. The major challenge in LC-MS-based approaches is the bottleneck 
in metabolite databases. With a number of variations in separation columns, a 
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comprehensive database facilitating cross-comparisons between different approaches 
has been difficult to construct. Thus, putative metabolites are usually validated via 
NMR or tandem MS/MS and MRM (Multiple Reaction Monitoring) methods. These 
methods provide a detailed description of the chemical structures and aid in validation 
of the metabolite detected. LC-MS-based metabolomics has been reviewed in this 
article (Bin et al., 2012).  
Separation of charged metabolites can be performed using CE-MS. However, 
its sensitivity is low, hence metabolites have to be enriched before being used in CE-
MS. Furthermore, it also lacks comprehensive reference libraries. Depending on the 
objectives of the experiment, nature and range of metabolites to be detected, a number 
of ionization techniques, such as, electron ionization (EI), electrospray ionization 
(ESI), atmospheric pressure chemical ionization (APCI), chemical ionization (CI), 
MALDI, desorption ESI (DESI) and extractive ESI (EESI) can be used. Detailed 
reviews (Ernst et al., 2014; Lei et al., 2011; Rai et al., 2013) discuss strategies used in 
analytical platforms to data acquisition techniques for mass spectrometry-based 
metabolomics. 
2.1.6. Design of Experiments 
It is important to note that metabolomics data can be observed at different 
scales, such as tissues, organs, organism or communities. Each of these systems have 
their own complexities that affect, the rate at which metabolite concentration changes, 
time delays between gene-metabolite responses among others. Therefore, it is 
important to develop an experimental design that can provide insights into biological 
responses without confounding effects (Leek et al., 2010). For example, pilot studies 
should be performed in order to optimize various extraction and analytical procedures. 
The nature and class of the metabolites specific to the experiment should be examined, 
before conducting a large-scale study.  
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The experimental design can be tuned to the biological question of interest, 
after primarily addressing the data acquisitions challenges. Robust study designs 
minimizing nuisance variations (sample handling and analytical) and maintaining 
sample integrity should be used (Hendriks et al., 2011; Leek et al., 2010). Furthermore, 
good experiment designs should not only aim to reduce analytical-measurement 
variations, but, should also ensure that the experiment has considerable statistical 
power to answer the biological question. For these reasons, a pilot study along with 
thorough literature survey should be performed. These results can then be used to 
ascertain the levels of biological and technical variation in the samples. Adequate 
number of biological and technical replicates should be selected after accounting for 
the predicted variation among replicates. Such careful analysis can ensure that the 
actual experiment meets the coverage, reliability and reproducibility criteria to provide 
sound biological information. To ensure minimal confounding effects due to 
instrument or analytical variations, factorial or randomized study designs can be 
considered. Minor influences due to non-biological sources of information can be 
detected by performing exploratory data analysis during data pre-processing.  
If careful statistical considerations are taken into account at the experimental 
design phase of a multi-omics project, then there is an opportunity to build rigorous 
systems-level statistical models that fully take advantage of the interdependent 
workings of biological molecules. A number of reviews (Fernie et al., 2011; Gibon and 
Rolin, 2012; Goodacre et al., 2007) have provided detailed recommendations for 
performing well-designed, robust metabolomics experiments.  
2.1.7. Data analysis strategies in metabolomics 
High-throughput metabolomics experiments enable the detection of large number 
of signals, such as, measuring 10,000 features (ions) across different conditions. These 
measurement technologies typically produce gigabytes of data having intricate patterns 
hidden in their data structures. Such datasets, require enhanced data standards and 
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strategies involving robust, high quality statistical procedures to obtain biological 
knowledge. The data analysis procedures depend on the (i) choice of analytical 
platform, (ii) experiment design and biological question, and (iii) inherent properties 
of the data (Boccard et al., 2010) 
 Data extraction, handling and treatment procedures which greatly influence the 
ability to identify and quantify metabolites of interest, have a direct role in the 
biological interpretation (Katajamaa and Oresic, 2007). Extracting the relevant 
information from the overwhelming amount of data generated by these high throughput 
techniques is an important objective for knowledge discovery in this field (Boccard et 
al., 2010; Goodacre et al., 2004). Development of bioinformatics techniques, 
specifically for data storage and management, raw data extraction, pre-processing and 
statistical analysis, integration with other omics datasets, metabolite identification and 
metabolic modelling is crucial for future progress of metabolomics and systems 
biology (Shulaev, 2006; Wishart, 2009). 
To extract valuable information, irrespective of the analytical technique used, 
metabolomics data is analysed in the following step-wise manner: pre-processing, pre-
treatment, data analysis, validation and interpretation (Eliasson et al., 2011; Goodacre 
et al., 2007; Hendriks et al., 2011; Katajamaa and Oresic, 2007). Pre-processing 
methods transform raw signals into a representation facilitating robust statistical 
comparisons. They typically include filtering, peak alignment, noise removal, baseline 
correction, normalization and scaling (Boccard et al., 2010; van den Berg et al., 2006). 
Pre-processing is usually followed by a quality control strategy, where exploratory data 
analysis is performed to check data quality and identify any issues in sample 
processing, analytical or technical errors, batch effects etc.  
Data analysis techniques try to reduce the multi-dimensional datasets into smaller 
components, thereby enabling the researchers to identify differential metabolites, 
interesting patterns in the data structure, and visualize the dynamic information using 
24 
 
both univariate and multivariate analyses (Saccenti et al., 2014). Most analysis 
strategies utilize both supervised methods (uses prior information to guide the 
classification) such as ANOVA, partial least squares (PLS) and discriminant function 
analysis (DFA), and unsupervised (to describe the overall pattern or data structure) 
methods such as hierarchical clustering, principal component analysis (PCA) and selF-
organizing maps (Broadhurst and Kell, 2006). To aid in biological interpretation the 
differential features identified using the above techniques are then mapped onto 
metabolic pathways. Robust data analysis strategies not only provide interesting 
biological interpretations, but also help design better experiments, optimize protocols 
and reduce experimental errors (Parab et al., 2009). 
In a typical metabolomics dataset, the biological differences between samples are 
hidden under intricate patterns in the data, confounded with obscuring sources of 
variability introduced at various stages of sample generation or analysis, such as 
systematic errors during experiments, misplaced samples or instrument errors. Thus, 
separating out the relatively small but important patterns in metabolite concentrations 
related to genetic variation or multitude of environmental changes is not 
straightforward. Naïve analysis of such datasets can lead to serious misinformation 
(Leek et al., 2010). Multivariate statistical techniques for identification and removal of 
non-biological sources of variation are discussed in depth in Chapter 3.  
The vast volume of data has facilitated the development of a number of application-
specific software pipelines and advanced statistical techniques for data handling, data 
processing and mining, and visualization aiming at disentangling the complex 
regulatory processes in biological systems (Biswas et al., 2010; Pluskal et al., 2010; 
Smith et al., 2006; Xia et al., 2012). (Sugimoto et al., 2012) provide a comprehensive 
review on the bioinformatics tools and techniques available for mass spectrometry-
based metabolomics data analysis.  
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The functional annotation along with data mining and extraction of knowledge 
from the wealth of information obtained is one of the grand challenges of 
metabolomics. The metabolomics research community, functioning under the umbrella 
of Metabolomics Society (http://metabolomicssociety.org/),  has developed a set of 
guidelines ensuring minimal reporting standards for experiments, thus, providing the 
much needed benchmarks for data analysis, exchange and comparison of metabolomics 
experiments (Fiehn et al., 2008; Goodacre et al., 2007; Members et al., 2007). These 
require researchers to diligently record metadata such as temperature, growth 
conditions (minimal set of data of reporting standards and general guidelines) that aid 
in biological interpretation and reduce experimental errors.  
2.2. Metabolic networks 
2.2.1. What are metabolic networks? 
Biological systems derive their important characteristics like adaptability, stability 
and resilience through the regulation of highly interconnected chains of metabolic 
pathways that encompass heterogeneous biological entities including DNA (genes), 
mRNA, proteins and metabolites. The complex interactions between various 
components in a biological system is best characterized as networks. A number of 
biological networks, each donning a different functional role such as protein-protein 
interaction (PPI) networks, metabolic networks, transcriptional regulation networks, 
signal transduction networks interact with each other. These biological networks being 
dynamic and selectable, respond to environmental pressures by regulating various 
biochemical processes in the cell. Thus, these networks are a reflection of biological 
processes such as metabolism, transcription and translation that take place in the cell, 
(Ideker et al., 2001), and, provide an overview of the regulation by proteins, activation 
or inactivation of enzymes by posttranslational processes and feedback loops 
The collection of metabolites, their pathways and their inter-relationships, 
holding information about a series of biochemical events constitute an organism’s 
26 
 
metabolic network. For example, using both computational predictions and 
experimental procedures, a metabolic pathway database, PlantCyc, containing more 
than 800 pathways from over 300 plant species has been developed (Zhang et al., 2005). 
These pathways are co-ordinately regulated at multiple levels, such as by feedback 
regulation of metabolic reactions and transcriptional regulation of sets of metabolic 
genes. Through metabolomics approaches it is now possible to sample thousands of 
unique ions, assign putative formula and structure, add new pathways, and even 
develop naïve metabolic networks (Dettmer et al., 2007). Metabolic networks act as 
scaffolds for metabolic models and can be used to predict cellular function and study 
of the role of individual reactions.  
Robustness and modularity of metabolic networks, are the two major 
properties that dictate how metabolic networks function and respond to external 
stimulus. Robustness is the property through which the cellular metabolism tries to 
maintain homeostasis on encountering genetic or environmental perturbations (Smart 
et al., 2008).  Robustness of metabolic networks is achieved mainly through the 
presence of multiple isozymes, therefore ensuring redundancy and a tight feedback 
control. Thus, the effect of blocking one enzyme or a pathway, often leads to the 
activation of an alternative route through its complementary isozymes. For example, 
the conversion of glucose-6-phosphate into glyceraldehyde-3-phosphate can be 
achieved using both glycolysis and pentose phosphate pathways. Such properties 
confer the ability to use multiple alternative pathways to synthesize the same 
metabolites, thus increasing the odds for an organism to survive in unfavourable 
conditions. Stable isotope-based metabolomics approaches wherein the movement of 
the targeted metabolite into different pathways or tissues is tracked, help in 
understanding the plasticity and the dynamic nature of metabolic networks.  
This observed robustness of metabolic networks, can be explained using the 
concept of modularity. Modularity describes the potential of independent and self-
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contained property of a system, i.e. the process through which a number of regulatory 
processes govern activation of specific modules to produce the desired metabolic 
response to perturbations. Modularity and plasticity of metabolic networks follow a 
power law distribution, with focus being on the few critical hub nodes, made of 
important genes and metabolites, in the dense highly interconnected community 
structure. These key genes or metabolites appear in many reactions, while most other 
genes or metabolites appear in only one or few reactions. Such key metabolites serve 
as common substrates at branch points of diverse metabolic pathways where a high 
level of coordinated gene expression exists (Huss and Holme, 2007). Identifying these 
critical branch point metabolites can provide insights into the master regulators and 
strategies for understanding metabolic response (Holme, 2011).  For example, in 
Arabidopsis, different branches of isoprenoid metabolic network such as carotenoids 
and brassinosteroids metabolic pathways exist independently and are activated based 
on subcellular localization of metabolic pathways (Vranova et al., 2012). The specific 
activation of metabolic modules occur based on compartmentalization and localization 
of metabolic response, thus, providing the mechanism for targeted production of 
metabolites in a tissue-dependent manner as a desired response to environmental 
factors (Brown et al., 2003).    
The analysis of these nonlinear, multivariate and multi-layered networks, 
identification of functional modules, along with the complexities in accurately 
detecting, quantifying and interpreting metabolomics datasets have led to the 
development of multiple techniques (Brohee et al., 2008; de Oliveira Dal'Molin et al., 
2010; Hamilton and Reed, 2014; Junker et al., 2006; Lewis et al., 2012; Mithani et al., 
2010; Ruppin et al., 2010; Yeang, 2009). The structure and properties of metabolic 
networks especially the topology and methods for the reconstruction of metabolic 
networks have been described in detail (Palsson, 2006).  The tight regulation of 
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metabolic networks and effects of genetic perturbations on metabolic networks are 
analysed in detail in Chapter 5.  
2.2.2. Integrative omics approaches 
Systems Biology seeks to "study the behavior of an in vivo biological process 
by systematically perturbing them and then monitoring the interactions between gene, 
protein, metabolite and informational pathways" (Ideker et al., 2001). Biological 
networks are complex systems which are highly inter-connected, non-linear, and 
dynamic with interactions at multiple levels. Traditionally, genes or proteins involved 
in different processes have been studied in a reductionist manner, for example 
characterizing genes only affected in specific metabolic pathways involved in human 
disease or plant defence response. However, coordination of cellular processes involves 
interconnectivity via networks of various biological pathways and their control by 
signalling and regulatory networks.  
Gene-regulatory motifs form the building blocks of functional modules by 
regulating the expression of genes and in turn metabolic pathways. These pathways 
then form functional modules which are highly interconnected and interact with 
different biological networks in the cell, thus forming a large-scale biological network 
requiring systems level approaches to understand biological processes in a holistic 
manner. Such integrative approaches to biological questions can yield important 
insights inaccessible to traditional reductionist methods. The main utility of systems 
approaches lies in the possibility to predict the results of experimental or natural 
perturbations. For example, Gal4p and Gcn4p lead to the breakthrough discovery 
showing how transcription factors work (Ptashne, 1988). However, to understand the 
transcriptional regulatory control orchestrated by these transcription factors, systematic 
analysis of data from different biological layers was needed.   
Technological developments in analytical platforms along with the rapidly 
decreasing cost of multiple omics measurements has caused an important paradigm 
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shift in the field of systems biology by facilitating integrative omics approaches (Cai, 
2012; Gary et al., 2012; Nielsen and Jewett, 2007; Segata et al., 2013; Wang et al., 
2013b).  By combining these heterogeneous biological information into a single 
systems level analysis, using techniques such as correlations, metabolic control 
analysis, information theories, and network/graph models, complex regulatory 
interactions can be better studied (Joyce and Palsson, 2006). Such analysis can reveal 
the dynamic interactions and connectivity in metabolic networks, permitting the 
discovery of new correlations and pathways among biological entities (Choi and 
Pavelka, 2012). However to connect these highly multivariate datasets in terms of 
biological networks, a clear conceptual framework with good experiment design, 
dedicated tools and statistically sound data analysis is required.  
Statistical techniques capable of handling heterogeneous datasets, which might 
contain of binary, categorical or continuous data, as well as being able to accommodate 
missing data, and remove artificially induced systematic biases should be developed 
(Wang et al., 2012). Furthermore, these techniques should be able to provide sound 
biological interpretation and visualization of multiple layers of data. The overall 
strategy in any multi-omics analysis is  
(i) identifying differential features for each dataset, such as genes, proteins or 
metabolites independently; 
 (ii) combining these results by mapping these features onto the biological 
networks using pathway information from databases such as KEGG (Kanehisa and 
Goto, 2000; Kanehisa et al., 2014), MetaCyc (Zhang et al., 2005), and Human 
Metabolome Database (Wishart et al., 2013) or by developing genome-scale metabolic 
models. This is then used for identifying patterns of correlation or co-regulation, For 
instance, transcriptomics and metabolomics data were integrated to identify clusters of 
genes and metabolites that were co-ordinately modulated in response to specific 
nutritional stresses in the model plant Arabidopsis thaliana (Hirai et al., 2004); 
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  (iii)  analyse network structure to identify enriched sub-networks, functional 
modules; and  
(iv) develop in silico cellular models using models such as Flux Balance 
Analysis (FBA) to predict reaction rates and network activities that give rise to cellular 
phenotypes (Wang et al., 2012). Bayesian methods, which are modelled to avoid over-
fitting datasets are also widely used. (Choi and Pavelka, 2012; Cline et al., 2007; Hirai 
et al., 2007; Kresnowati et al., 2006; Li et al., 2013; Segata et al., 2013; Takahashi et 
al., 2011) provide examples and detailed discussions on the integration of omics data.   
The two most commonly used approaches for data integration are correlation 
analysis, techniques such as PCA and PLS belonging to the unsupervised approaches 
and Genome-scale metabolic models (GEMs). In the first approach, normalized gene 
and metabolite datasets are analysed to identify significant gene-metabolite pairwise 
correlations (Allen et al., 2010; Hirai et al., 2005), this reveals the presence of co-
expressed connections. PLS can be used to model the metabolite abundances as a 
function of gene expression profiles (Pir et al., 2006). These are then visualized in the 
form of networks or used in enrichment analysis. Constraint-based approaches aim to 
develop a genome-scale metabolic model and incorporate the metabolic fluxes and 
reaction kinetics (Hamilton and Reed, 2014; Lewis et al., 2012; Price et al., 2003; 
Zelezniak et al., 2014). FBA uses GEMs to calculate how metabolites flow through the 
metabolic network. This enables researchers to predict the production rate of specific 
metabolites or the growth rate of an organism.  
These multi-omics approach are used in diverse areas ranging from studying 
ecological networks, where biotic interactions between species are of focus, to 
modelling biochemical networks within a cell and in diverse domains such as, 
toxicology, metabolism and pharmacokinetics. They have also been successfully 
applied to study regulatory interactions (Hirai et al., 2007), functional genomics 
(Raamsdonk et al., 2001; Tohge et al., 2005) and to identify genome wide quantitative 
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trait loci (Riedelsheimer et al., 2012; Saito et al., 2010). Analysing the associations 
between genotypic and phenotypic characteristics has important ramifications in 
pathological studies for explaining disease pathways and identifying biomarkers for 
prognosis and diagnosis (Kaddurah-Daouk et al., 2008; Sreekumar et al., 2009; Zhang 
et al., 2012). Such integrated analyses provide important clues that help understand 
how genetic blueprints combined with non-genetic, environmental factors influence a 
biological system.  
The challenges in integrating multiple datasets, such as lack of uniform and 
standardized databases, lab-to-lab variations, are expectedly the same as observed in 
metabolomics data analysis. MetaboLights (Haug et al., 2013; Salek et al., 2013b), a 
database for freely storing metabolomics data with detailed experimental protocols and 
meta information, is championed by the European Bioinformatics Institute, and 
promises to be an important tool to overcome these barriers. 
2.2.3. Challenges in metabolomics 
The last decade has witnessed great advances in statistical techniques and 
measurement technologies aiding in robust characterization of the complete 
metabolome of an organism. However, a number of challenges ranging from sample 
preparation to metabolite identification and biological interpretation hinder 
comprehensive utilization of metabolomics data (Hegeman, 2010; Vuckovic, 2012). 
The high chemical and structural diversity of metabolites require specialized 
extraction protocols, taking the spatio-temporal location, genotype and compound 
classes into account. A suitable extraction procedure that provides both comprehensive 
coverage and specificity should be developed before using any metabolomics platform. 
Furthermore, to obtain the metabolite levels at the exact moment defined in experiment 
design, conditions that can possibly affect degradation or inter-conversion of 
metabolites should be prevented. This is usually performed by quenching the 
metabolism of the targeted biological system (Álvarez-Sánchez et al., 2010). For 
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example, intermediate metabolites such as those from Calvin cycle and nucleotides 
have a very short turn-over time and require immediate quenching (Fernie et al., 2011). 
The physicochemical characteristics of the metabolites in the biological system under 
consideration, should be the basis for developing any extraction buffer/method. (Kim 
and Verpoorte, 2010; Parab et al., 2009; Vuckovic, 2012; Want et al., 2013) provide a 
detailed reviews and protocols on sample preparation for metabolomics experiments.  
The above articles describe a variety of protocols for targeting the metabolites 
of interest, and for optimizing instrument parameters. However, trying to identify novel 
metabolites or pathways where the nature of metabolites are largely unknown is 
extremely challenging. Furthermore, the variation in extraction protocols has made it 
difficult to have standardized metabolomics databases, especially for MS-based 
approaches. For example, different instruments have slightly varying fragmentation 
patterns for the same metabolite, thus, standardized libraries are very hard to develop. 
Data curation is also difficult as curators are having to comprehend the uncharacterized 
measurement noise associated with high-throughput measurements, and errors during 
metabolite identification (Salek et al., 2013a) . (Wishart, 2009) provides list of 
databases used for metabolite identification and pathway mapping. 
These issues have resulted in a number of molecules that are detected by the 
instrument, but are not assigned to any metabolite and thus not included in the 
metabolite databases or repositories (Kind et al., 2009).  A survey conducted by the 
American Society for Mass Spectrometry (ASMS) in 2009 revealed metabolite 
identification to the biggest bottleneck among users (Spectrometry, 2009). The current 
practices allow high confidence identification for only major primary metabolite such 
as sugars, sugar phosphates, amino acids, and organic acids and certain secondary 
metabolite classes such as phenylpropanoids, and alkaloids. This is because, in a typical 
mass spectrometry analysis, for a particular metabolite, number of features such as their 
isotopic forms, adducts and daughter ions are produced. These ambiguities further 
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complicate metabolite identification via direct matching of the m/z ratios to the 
databases. Therefore, to identify novel compounds with high confidence, researchers 
use the rather slow technique of structure elucidations using fragmentations patterns 
obtained using tandem MS and NMR approaches. NMR-based identification strategy 
relies on detecting and matching the characteristic and unique “chemical-shift” 
fingerprint for each metabolite (Moco et al., 2007). However, with the probable 
chemical space of around 600 million compounds- determined using the seven golden 
rules, and up to 8 billion chemical formulas (theoretically possible C, H, N, S, O, P-
formulas for compounds up to 2000 Da), it is an enormous challenge identify novel 
compounds when the closest reference compounds are not available in the databases. 
The time, effort and cost involved in experimentally determining characteristic 
properties for millions of molecules present in any given bio-system is a daunting 
challenge. Thus, a significant improvement in experiment design and data analysis 
tools is an urgent necessity to enhance systems biology-based knowledge discovery.  
2.2.4. Metabolomics as a tool in biological research 
The potential of metabolomics as a tool far outweighs the challenges, a 
delightful scenario to be in as it encourages and rewards technological advances. By 
providing the insights into biochemical regulations, metabolomics immediately adds a 
new dimension as an analytical technique. The areas in which metabolomics techniques 
have been applied are diverse, and new applications are continuously being explored, 
a selected few are discussed here.  
 Functional genomics, systems biology and biotechnology (Alisdair et al., 2004; 
Hamilton and Reed, 2014; Nielsen and Jewett, 2007; Saito and Matsuda, 
2010): Understanding regulatory networks in biological systems, developing 
genome-scale metabolic networks, studying cellular dynamics using 
mathematical modelling, effects of perturbations, metabolomics as a tool in 
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enhancing and developing compounds with useful traits in various biological 
systems. 
 Plant biology, plant-microbe and plant pathogen interactions, agriculture 
(Bhalla et al., 2005; Dixon et al., 2006; Hall, 2006; Lee et al., 2013; 
Narasimhan et al., 2003; Okazaki and Saito, 2012; Rasmussen et al., 2012): 
Characterizing biochemical and genotype-phenotype relationship, cellular 
responses to different environments, identifying novel plant products and 
developing metabolic engineering strategies for producing compounds with 
important pharmaceutical and commercial values. 
 Food science and nutrition (Dervilly-Pinel et al., 2012; Jones et al., 2012; 
Wishart, 2008a): For detecting contaminants, enhancing nutritional value of 
foods, optimizing fermentation and bioremediation processes, impact of 
fertilizers and pesticides on plants and environment, assessing substantial 
equivalence from genetically modified organisms compared to natural 
cultivars, among others. 
 Human health and disease (Aboud and Weiss, 2013; Kaddurah-Daouk et al., 
2008; Spratlin et al., 2009; Suhre et al., 2011; Wikoff et al., 2009): For 
identifying early biomarkers useful as disease and prognostic indicators, 
diagnosing pathologies, and in drug development and assessing therapeutic 
targets of disease, assessing associations between genetic variation and human 
disease phenotypes, to understand the complex interactions of host, diet and 
gut microflora in human health. 
 Environmental metabolomics and natural products research (Bundy et al., 
2009; Nguyen et al., 2012; Rochfort, 2005; Viant and Sommer, 2013; Zhang 
et al., 2010): Assessing ecotoxicology, microbiome structure and functions, 
components of ecosystems biology, interactions of organisms with 
environment, discovering natural products, studying evolutionary relationships 
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using phylogenomics and metabolic networks, designing new bio-parts using 
ecological principles in synthetic biology applications. 
 
The following chapters of this thesis systematically address different issues 
related to metabolomics data processing and integration of multiple biological data 
layers.    
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3. Statistical methods for identification and removal of non-
biological sources of variation 
 
 ‘Data does not equal information; information does not equal knowledge; 
and, most importantly of all, knowledge does not equal wisdom. We have oceans of 
data, rivers of information, small puddles of knowledge, and the odd drop of wisdom.’ 
… Henry Nix (1990) in ‘A National Geographic Information System – An 
Achievable Objective?’ 
 
3.1. Background and introduction 
Metabolomics technologies have now reached a stage of development where 
the primary concern is not about generating high quality data but rather about obtaining 
meaningful biological knowledge from gigabytes of information. This ability to 
generate large amounts of data will aid in the understanding of previously inaccessible 
domains of biology (Goodacre et al., 2004; Kell, 2004). Furthermore, robust data 
analysis of biochemical phenotypes can provide unique insights in the context of both 
hypothesis generating (exploratory) and hypothesis testing (confirmatory) phases of 
research (Jaeger and Halliday, 1998).  
Designing systematic experiments, analysis protocols and extracting relevant 
knowledge from the wealth of data is critical to all omics applications. MS-based 
metabolomics experiments are extremely sensitive and provide unparalleled detection 
and coverage of metabolites. As these technologies not only increase the quantity of 
data, but also affect its properties (Godzien et al., 2013), successful application of these 
experiments depend on both the analytical system and the data mining strategies.  
Typically, in a large dataset the true biological responses detected are hidden under that 
façade of data confounded with unwanted variation (Leek et al., 2010). Such 
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experiments demand advanced statistical procedures to identify and remove unwanted 
non-biological sources of variation (Eliasson et al., 2011; Hendriks et al., 2011). 
Metabolomics data processing typically includes exploratory data analysis to 
check the quality of data (such as presence of batch effects) before proceeding to pre-
treatment, pre-processing and statistical analysis for identifying differential metabolites 
(Katajamaa and Oresic, 2007).  Exploratory data analysis (EDA) should be conducted 
to identify any systematic errors before further experiments can be performed (Boccard 
et al., 2010).  
A description of the web-based exploratory data analysis application- datPAV 
(Biswas et al., 2011) developed during the initial part of this research is provided in 
Appendix 1. datPAV provides various statistical and visualization options for 
exploratory data analysis. To enable quick examination of high-throughput omics data 
and cater to the needs of the wide range of omics studies, datPAV has been designed 
as an web-based tool for performing multi-omics exploratory data analysis. 
3.1.1. The importance of batch effects in omics data 
Limited by sample processing time (each sample requiring on average 20 
minutes for LC MS-based analysis), large sample metabolomics experiments often 
need to be performed over weeks or in different batches. Even with robust protocols 
and optimization of sample preparation methods, each batch represents a unique 
analytical environment having its own time and place-dependent experimental nuances. 
For example, in a metabolomics experiment with two samples A and B, each with four 
biological replicates; there might be differences in the resultant outcome of one 
biological replicate, for example A1 due to batch, extraction or analytical errors. This 
difference can influence A1 to have a metabolite profile which is completely different 
from other replicates of A and might even influence A1 to be similar to B. If these 
errors and batch effects are not removed, then the statistical power to compare the 
variance between two groups in parametric (t-tests) or non-parametric tests is lost. This 
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is mainly due to the increased variation in group A as the result of the outlier replicates. 
In large blinded studies or for non-supervised analysis, A1 might also be grouped with 
B. If such systematic errors are not undetected, then they lead to confounding biological 
interpretation. A real example, where the outlier replicates of wild-type, were found to 
be similar to outlier replicates of mutant lines, is shown in Chapter 5. 
Careful experiment designs can minimize batch effects, however it can only be 
eliminated if the whole study is conducted in a single batch. Thus, batch effects are 
almost an inevitable consequence of large experiments. For example, human error 
(differences during sample preparation), different analytical platforms, instrument 
variations during long periods of operation such as temperature changes or ionization 
efficiency, changes in chromatography such as column conditions can introduce 
unwanted experimental sources of variations in the metabolite profiles (Leek et al., 
2010). There can also be differences due to unwanted biological variation such as 
differences in sample mass, concentration or cell number among others.  These 
systematic experimental or analytical influences lead to qualitative and quantitative 
differences in the relative peak intensities of the metabolites, that are unrelated to the 
biochemical phenotype-the main focus of the study. The resulting peak intensity of 
each metabolic feature (counts) is a combination of both the biological signal, as well 
as unwanted (non-biological) variation.  
Analysing data from such experiments presents numerous challenges due to 
the influence of these batch and sampling/measurement variables (Ernest et al., 2012). 
In order to distinguish biologically relevant signals from experiment noise, robust 
normalization procedures are required. Batch effects can affect subsets of metabolite 
features in different ways (Redestig et al., 2009). The standard pre-processing steps 
such as binning, alignments,  normalization and scaling procedures can be used for 
adjusting technical variation due to abundances (van den Berg et al., 2006). These pre-
processing steps assume general invariability for all metabolite features and do not 
include corrections for systematic variations due to batch effects (Leek et al., 2010). 
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Thus, potentially misinterpreting signals arising out of experimental artefacts as being 
of biological origin. This can lead to major problems and incorrect biological 
conclusions when such spurious differences due to batch effects are completely 
correlated with the biological question (outcome of interest). Furthermore, ignoring 
batch effects during data analysis can increase confidence intervals, therefore affecting 
robust identification of differential metabolites (Ernest et al., 2012).  
3.1.2. Existing solutions for removing batch effects 
For microarray-based expression profiling, sophisticated normalization 
methods that directly incorporate batch adjustments in statistical models such as 
ComBat (Johnson et al., 2007), Surrogate Variable Analysis (Leek and Storey, 2007),  
and Remove Unwanted Variation (Gagnon-Bartsch and Speed, 2012) have been 
developed. A thorough review on batch effects and their removal methods for 
microarray-based expression studies is provided in (Lazar et al., 2013). For 
metabolomics experiments, which are susceptible to an even higher amount of 
unwanted variation than microarray studies, the development of batch effect correction 
procedures have been relatively minimal (De Livera et al., 2012; Ernest et al., 2012; 
Wang et al., 2013a). However, batch effect removal procedures using these 
applications require a specific experimental design. Thus, these applications could not 
provide a ready solution for experiments having customized sampling strategies. The 
specific details pertaining to each statistical application mentioned above is discussed 
later in this Chapter. 
Unsupervised methods such as PCA have been successfully used for capturing 
systematic variation due to latent variables (such as batch effects) in a large datasets 
(Alter et al., 2000; Leek et al., 2010; Leek and Storey, 2007). After normalization and 
scaling, PCA makes use of co-variances or correlations among the metabolite features 
to decompose the original data matrix onto a lower dimensional space. The reduction 
of the variation across thousands of features resulting from biological differences and 
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confounded with the influence of nuisance latent variables into orthogonal PCs, 
provides a robust statistical measure to quantitatively characterize the metabolite data 
structure. The PCs are actually linear combinations of the original data variables. 
Maximum variation and the most interesting phenomena is typically observed in the 
first few PC loadings, with subsequent components explaining decreasing amounts of 
variation (Ivosev et al., 2008; Liland, 2011). Visualization of the PCs that describe the 
maximum variation in the data structure can reveal the underlying relationships 
between the metabolite features as a manifestation of biological differences or batch 
effects. PCA shares a close mathematical relationship with singular value 
decomposition (SVD) (Alter et al., 2000; Shlens, 2014). Typically, SVD-based 
calculations are carried out within PCA. 
In this Chapter, I developed a statistical approach for removing batch effects 
in the large-scale untargeted metabolomics data using SVD. I developed this approach 
using data obtained from a survey of natural variation in oleaginous algal species. 
Specifically, metabolite measurements were obtained from 22 Chlorella strains, 
compared over two growth phases and run in four batches, to remove structure in data 
related to day of sample assay (268 samples being run in 4 batches spread over a 
month). Here, the term batch refers to a collection of samples processed at a particular 
instance using the same instrument under identical conditions. In this study, batch 
refers to the day on which the samples were processed in the mass spectrometer 
(abbreviated as RunDay). Furthermore, batch is an all-encompassing term for both 
observed and unobserved variation affecting the samples processed in a particular day.  
3.2. Materials and methods 
3.2.1. Experimental design 
In order to survey the natural variation in oleaginous microalgae and identify 
strains for efficient biofuel production, 22 algal strains were isolated by colleagues at 
the University of Malaya (Vello et al., 2014) from 7 different locations and a total of 
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16 different habitats in Malaysia (refer to Chapter 4 for detailed sampling strategy). 
These strains were then isolated and cultured in laboratory conditions (as described in 
Vello et al., 2014). We then performed untargeted metabolite profiling for these 22 
strains at 2 growth phases, namely, exponential (between day 4 to 6) and stationary (at 
day 12). A total of 264 samples (262 samples, as some strains did not have all the 
replicates), 22 Strains X 2 Growth Stages X 3 Biological replicates X 2 Technical 
replicates, apart from blanks (for determining instrument or analytical noise/errors) and 
matrices (sample extraction matrix) were profiled. Blanks undergo the entire extraction 
process, but without the sample material. They were run after each set of 6 samples (3 
biological replicates and 2 technical replicates from one strain). The large number of 
samples required metabolite profiling to be carried out over 4 different batches spread 
over 2 weeks (May 15 to May 23, 2013) (Figure 3.1).  
Such experimental designs are prone to batch effects, as over long periods of 
time, instrument characteristics might change. Furthermore, samples that are collected 
at the same time but profiled in batches might also face issues with sample degradation. 
This can be minimized by storing the samples at -80°C without any freeze/thaw cycles. 
In cases where the sample numbers are large, experiments can only be run in batches. 
Such experiments should be carefully designed with adequate randomization 
procedures used both during extraction and MS analysis stage. Furthermore, to utilize 
statistical techniques that can handle and correct for batch effects, multiple internal 
standards, along with pooled biological samples should be run in a randomized order 
in each batch. The experimental design used in this study did not use (i) randomized 
extraction or MS run order and (ii) did not have pooled biological samples or internal 
standards, thus, the metabolite profiles were influenced by batch-specific non-
biological sources of variation.  
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3.2.2. Metabolome profiling  
3.2.2.1. Metabolite extraction  
Cell disruption was achieved using bead beating of the cell pellets, specifically 
a Tomy micro smash MS 100 bead beater (Tomy Seiko Co., Tokyo, Japan) along with 
lysing matrix Y from MP Biomedical lysing kit (MP Biomedicals, Solon, OH). The 
screw-top micro centrifuge tubes containing Lysing matrix constituted 0.5 mm 
diameter Yttria-Stabilized Zirconium oxide beads. Lyophilized algae cells weighing 50 
mg were added to lysing matrix along with 1 ml pre cooled 80% methanol.  The sample 
was subjected to bead beating at 4000 rpm for 20 s and then thawed in ice for a minute. 
This procedure was repeated five times, the extract was then centrifuged twice at 
11,000 x g for 10 min at 4°C. The supernatant was pipetted out and filtered through 0.2 
µm syringe filters (Sartorius Stedim Biotech). The final extract was kept in -80°C 
refrigerator till the analysis. Metabolite extraction was performed by Ms. Vejeysri 
Vello (University of Malaya). 
 
3.2.2.2. LC-MS analysis 
Chromatography separations were carried out using a Zorbax Eclipse Plus-C18 
(2.1x50 mm, 1.8-µ) reverse phase column on an Agilent Infinite 1290 UPLC system. 
The temperatures for column and auto sampler were 50°C and 7°C, respectively. The 
mobile phase consisted of de-ionized water with 0.1% formic acid (solvent A) and 
LCMS grade acetonitrile (ACN) with 0.1% formic acid (solvent B). A gradient elution 
was conducted for separations using the following method: isocratic elution with 5% 
B for 0.5 min, followed by a 10 min gradient to 98% B, which was kept for 2 min, then 
re-equilibrated at 5% B for 2.5 min. The flow rate was 0.3 mL/min and injection 
volume was 3 µL. The samples were subjected to an Agilent Q-TOF 6540 mass 
spectrometer after separation through liquid chromatography. The analysis was carried 
out in positive mode with ESI as source for ions with a mass range between 50 to 1200 
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m/z. The nebulizer pressure (psi), source gas temperature (°C), dry and sheet gas flow 
(L/hour), capillary voltage (V) and sheet gas temperatures (°C) were 40, 250, 12, 12, 
4000 and 350, respectively. LC-MS profiling was performed by Dr. Peter Benke and 
Mr. Vinay Kumar from (Metabolites Biology Lab, NUS). 
For the data-dependent MS/MS, UHPLC system with column was setup in-
line with mass spectrometer, with a 14 min long separation method same as described 
above for untargeted metabolic profiling. Parameters used were: drying gas 
temperature at 250ºC with 12L/min (nitrogen) flow rate, nebulizer gas at 40 psi, sheath 
gas temperature at 350ºC with 12L/min (nitrogen) flow rate, capillary voltage at 
4000V, nozzle voltage 1500V, skimmer voltage 65.0V, fragmentor voltage 100V and 
octopole RFPeak voltage 750V. Parameters for precursor selections were: fixed 
collision energy at 20eV and 40eV, max precursors per cycle at 10, threshold (absolute) 
at 100cps, active exclusion enabled with exclusion after 2 occurrences and release of 
active exclusion after 30 s. Data acquisition was performed in centroid mode at the 
resolution of 30,000 with MS scan rate set at 8 spectra/s and MS/MS scan rate set at 4 
spectra/s. Metabolite identification for MS/MS data is ongoing, the results presented in 
this chapter use the MS1 data extracted from the MS/MS dataset for validating SVD-
based approach. 
3.2.3. Metabolomics data analysis 
3.2.3.1. Data processing and analysis 
Raw data files from Q-TOF (.d files) were converted into mzXML format using 
msconvert of the ProteoWizard suite (Chambers et al., 2012; Kessner et al., 2008). The 
parameters defined for Q-TOF were optimized for this dataset (method = ‘centWave’, 
ppm = 30, peakwidth = c(5,60), prefilter = c(0,0), snthresh=6, peak grouping: bw = 5, 
minsamp = 1, mzwid = 0.015; retention time correction algorithm: ‘obiwarp’) (Patti et 
al., 2012), a total of 67,467 features were extracted using XCMS package (version 1.38) 
(Smith et al., 2006) in statistical programming language R (version 3.01) (R Core 
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Team, 2014). This produces a data matrix where samples are represented in columns 
and the metabolite features in rows. In the resulting data matrix, each row (mass 
features) is characterized by a unique mass-by-charge ratio (m/z) and a retention time 
(rt; or the time taken for an ion to elute through the chromatography column). The 
columns of this data matrix provide the abundance or the counts (number representing 
concentration of that particular mass feature in the sample).  
All statistical analysis were performed using R version 3.01. Exploratory data 
analysis was performed using R and datPAV. Version control has been implemented 
using Git in RStudio™. All the scripts will be uploaded onto GitHub upon publication.  
Log transformation followed by centering and scaling was performed on the 
dataset during the data pre-processing stages. Raw Total Ion Chromatograms (TIC) 
were developed to obtain a visual representation of the reproducibility of metabolic 
profiles between biological and technical replicates. TICs plot the retention time on the 
x-axis, and the total ion current detected for all features/ions at that particular instance 
on the y-axis. The similarity between the TICs for the replicates indicate the similarity 
or differences in the metabolite profiles (including the abundance of each metabolite) 
between the replicates. Thus, visualizing TICs provides a quick measure of the 
relationship between the metabolite profiles of samples. Variation in the TIC profiles 
between replicates can indicate whether certain replicates of strains are potential 
outliers. An example is shown in Figure 3.2A, where the technical replicate-
D4_104_b3_r002 (here D4 indicates growth stage, 104 is the strain number, b1 is 
biological replicate 1 and r002 is the second technical replicate of that biological 
replicate) shown as a pink line clearly has a different profile. The coefficient of 
variation (CV) was calculated for each replicate of a strain. Specifically, the CV of the 
abundances of all features in a particular replicate was calculated, and this was done 
for each replicate of a strain. In an ideal scenario, the replicates will have similar CVs 
as the metabolite abundances should be similar. However, replicates that had different 
TIC profiles had a markedly different coefficient of variation. For example, the 
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coefficients of variation for the replicates of strain D4_104, were 43.62, 41.49, 43.44, 
42.61, 41.31 and 75.72 for D4_104_b1_r001, D4_104_b1_r002, D4_104_b2_r001, 
D4_104_b2_r002, D4_104_b3_r001 and D4_104_b3_r002, respectively. Based on the 
CVs, we can conclude that the variation in the abundances of features in 
D4_104_b3_r002, and therefore the metabolite profile, is different compared to the 
other replicates of strain D4_104_b3_r002.  
Figure 3.2B shows the distribution of the abundances for all the features in 
each replicate as a boxplot. Furthermore, to investigate the cause of variation in the 
CVs and distribution in the abundances of features between replicates, the number of 
missing values (zeroes) in each replicate were analysed. Interestingly, the outlier 
replicate that showed a different profile had a 20% increase in the number of features 
whose abundances were zero (Figure 3.2C). We can conclude that TICs, CV and the 
number of zeroes are inherently related to each other for each replicate. This 
observation was as expected as data points analysed here are abundances of features, 
thus are non-negative in nature and have a minimum value of zero. Therefore, the 
abundances are likely to follow a mixture of Poisson-distribution (for non-negative 
abundance) and normal-distribution (for zeroes). This observation suggested a heuristic 
strategy for identifying and removing outliers.  
To identify outliers among the CVs of replicates of a strain, boxplot statistics 
was used. Specifically, the CVs of replicates that were 1.5 times the interquartile range, 
above the upper quartile and below the lower quartile were deemed as outliers. Using 
this strategy, we identified the following strains to contain outliers (the number of 
outlier replicates in each strain is indicated in the brackets): D12_001 (1), D12_006 
(1), D12_014 (1), D12_051 (1), D12_177 (1), D12_187 (1), D12_207 (2), D12_252 
(2), D12_255 (1), D12_258 (1), D4_014 (1),  D4_094 (1), D4_104 (1), D4_245 (1), 
D4_254 (1), D4_268 (1) and D4_325 (1). Thus, after removing 19 outlier samples, the 
final data matrix used for analysis contained a total of 243 samples (125 from day 4 
and 118 from day 12). 
Figure 3.1. Sample (Strain) allocation to different batches. The rows indicate the 
strain and columns indicate the batch in which they were processed. Each batch 























































































Figure 3.2. Identification of outliers within replicates (A) TICs of the biological and 
technical replicates of a strain; (B) Boxplot showing the distribution of metabolite 
abundances in each replicate; (C) For each sample, the percentage of features whose 
abundances were zero is indicated in green shade. Red shade indicates the number of 
features whose metabolite abundances were detected.
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3.2.3.2. Missing values 
Missing values arise when a feature is identified in some samples but is not 
detected in others. For the sample in which the feature is not detected, the abundances 
are marked as zeroes or ‘NA’ in the metabolite data matrix. Thus, due to biological or 
technical variation between replicates of a sample, some replicates might contain a high 
number of missing values. For example, the feature might be present but not be detected 
in a sample if the concentration is below instrument limits or if there were analytical 
errors (Karpievitch et al., 2012). These missing values are a key challenge in 
quantitative analysis as they influence the distribution and variance of the metabolite 
profiles. Furthermore, the reason behind the missing-ness often cannot be easily 
determined, and a number of approaches have been developed for imputation of 
missing values (Gromski et al., 2014). 
In this study, to ensure that absence of certain features were not a result of 
software limitation, the actual chromatograms in the form of raw TICs were 
investigated to determine whether features really had missing values. These raw TIC 
plots were analysed for all the samples before initiating xcms-based data processing. 
Finally, in xcms, 𝑓𝑖𝑙𝑙𝑝𝑒𝑎𝑘𝑠 function that identifies peak groups where the sample is 
not represented and then integrates the signal in the region of that peak from the raw 
data, was used as a data imputation step.  
In typical metabolomics experiments, filters are set to select ions whose 
abundances are above a certain threshold such as 500 or 1000 counts. However, for our 
analysis, to obtain raw unfiltered dataset, no such filter was applied. Features that had 
missing values even after the imputation step were removed. Features present across 
all samples were selected mainly to avoid scenarios wherein the features not detected 
by the instrument, have their values artificially imputed during SVD filtering approach. 
Thus, for this study, we used a Filter by Flag (Flagged for presence or absence of a 
metabolite) approach, wherein metabolite  features detected and having an abundance 
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(intensity) value among all the samples at either exponential phase (day 4) or stationary 
phase (day 12) were used. This greatly reduced the data matrix from 67,467 features to 
13, 443 features in exponential phase (day 4) and 10,687 in stationary phase (day 12). 
Figure 3.3 shows the number of zeroes (missing values) in the replicates before the 
Filter by Flag approach. As expected in Figure 3.3A the blanks towards the left 
(indicated by the red box) and the matrix towards the right (indicated by the green box) 
had the maximum number of missing values. This plot also provides an indication of 
the outliers, i.e. replicates of strains having an unusually high number of zeroes. Figures 
3.3B and 3.3C provide a comparison of number of zeroes in each strain (sum of zeroes 
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Figure 3.3. Identification of missing values (A) the number of zeroes in each sample 
is shown here. The red and green boxes indicate samples from blanks and matrix 
respectively. As blanks are without the biological sample and matrix is the sample 
buffer, the number of metabolites in each of these samples are very low compared to 
the metabolite profiles of the biological samples (strains). Thus, blanks and matrix 
contain a higher number of zeroes. (B) heatmap showing the number of zeroes for 




3.3. Results and discussion 
3.3.1. Identification of batch effects 
“In high dimensional data, with far more measured  variables than 
observations, it is almost always possible to find a satisfactory separation between two 
or more classes” (Saccenti et al., 2014). 
The mass spectrometry-based metabolite profiling was performed in 4 batches. 
This could induce potential batch-specific variations in the metabolic profiles. An 
initial screening of the TICs of the blanks and matrix indicated that batch effects might 
influence the variation in metabolite profiles. Figure 3.4 shows the TICs of the blanks 
and matrix. Clearly there is a shift in the metabolic profiles in both blanks and matrix 
datasets. Furthermore, after pre-processing the data matrix, we used Bray-Curtis 
measure to create a dissimilarity matrix and visualize the separation using ordination 
plots (Figure 3.5). The points in the plots represent each blank or matrix sample. The 
points are coloured according to the RunDay. In experiments where batch effects do 
not influence the metabolic profiles, there would be no clear trends observed within 
either of the two subsets of control samples (blanks or matrix, respectively). However 
in this case, we observe RunDay to be a distinguishing factor between samples in both  
blank and matrix. This separation is indicative of instrument variations as the same 
sample preparation strategy was applied for all samples and in all batches.  
We then attempted to study how the RunDay differences affected the samples. 
Exponential and stationary phase data sets were treated as two separate datasets mainly 
for the following reasons:  
(i) Growth stage differences are themselves confounded within batches: 
From Figure 3.1, we observe that batch 4 did not have any samples from stationary 
phase. However, 14 out of 22 strains from the exponential phase were run in batch 4. 
Similarly 12 strains from stationary phase were processed in batch 2, while only 3 
strains from the exponential phase were processed in the same batch. This experimental 
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design resulted in unequal number of samples in each batch, and batch differences were 
confounded with growth stage-specific differences, thus requiring complex modelling 
approaches. Furthermore, any modelling solution used here, not only had to factor in 
the nesting of strain within batch, but also the unequal distribution of samples from the 
two growth stages into different batches. Therefore, attributing the differences in the 
metabolite profiles to strain-specific, and growth stage-specific effects from the 
combined dataset would be complicated due to this experimental design.  
(ii) Loss of information in the combined dataset: The main criterion for 
selecting mass features from the raw dataset for statistical analysis, was that a mass 
feature should be detected across all samples. When the datasets were treated 
separately, exponential phase had 13,443 features and stationary phase had 10,687 
features that passed the above criterion. However in the combined dataset, only 9,421 
features could be selected based on the above criterion. Thus, exponential phase and 
stationary phase when treated separately, had 4,021 (42%) and 1,266 (13%) features 
more, respectively. These differences could be attributed to the substantial and 
expected differences in the metabolic profiles of the strain during exponential and 
stationary growth stage. Therefore, treating the growth stages as a single experimental 
dataset would result in loss of growth stage-specific information, which were mainly 
determined from the features that were unique to each growth phase.  
For these reasons, we decided to treat the metabolite profiles of exponential 




































15th ACN Blank01 .mzXML
15th ACN Blank02 .mzXML
15th ACN Blank03 .mzXML
15th ACN Blank04 .mzXML
15th ACN Blank05 .mzXML
15th ACN Blank06 .mzXML
15th ACN Blank07 .mzXML
15th ACN Blank08 .mzXML
15th ACN Blank09 .mzXML
15th ACN Blank10 .mzXML
15th ACN Blank11 .mzXML
15th ACN Blank12 .mzXML
15th ACN Blank13 .mzXML
15th ACN Blank14 .mzXML
17th ACN Blank01 .mzXML
17th ACN Blank02 .mzXML
17th ACN Blank03 .mzXML
17th ACN Blank04 .mzXML
17th ACN Blank05 .mzXML
17th ACN Blank06 .mzXML
17th ACN Blank07 .mzXML
17th ACN Blank08 .mzXML
17th ACN Blank09 .mzXML
17th ACN Blank10 .mzXML
17th ACN Blank11 .mzXML
17th ACN Blank13 .mzXML
17th ACN Blank14 .mzXML
17th ACN Blank15 .mzXML
17th ACN Blank16 .mzXML
17th ACN Blank17 .mzXML
17th ACN Blank18 .mzXML
17th ACN Blank19 .mzXML
17th ACN Blank20 .mzXML
17th ACN Blank21 .mzXML
17th ACN Blank22 .mzXML
17th ACN Blank23 .mzXML
21st ACN Blank01 .mzXML
21st ACN Blank02 .mzXML
21st ACN Blank03 .mzXML
21st ACN Blank04 .mzXML
21st ACN Blank05 .mzXML
21st ACN Blank06 .mzXML
21st ACN Blank07 .mzXML
21st ACN Blank08 .mzXML
21st ACN Blank09 .mzXML




























































































Figure 3.4. Total Ion Chromatograms of (A) Blanks and (B) Matrix. These TICs 
clearly indicate a shift in the metabolite profiles. In ideal conditions all the TICs 
should overlap with each other.
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Figure 3.5. Principal coordinates analysis of (A) Blanks and (B) Matrix. Both the 
ordination plots show that blanks or matrix run in different batches- indicated by run 
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● Batch 1 (15 May) Color Key Sample assay day
(RunDay)
Batch 2 (17 May) 
Batch 3 (21 May) Batch 4 (23 May) 
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Using the same Bray-Curtis-based ordination analysis, we visualized the 
separation between strains at both exponential and stationary growth phases (Figure 
3.6). As expected, we observed clear separation between the strains based on RunDay. 
Analysis of distance using the adonis function from ‘vegan’ package (Jari Oksanen, 
2013) in R, was computed between the metabolite distance matrix and Strain or 
RunDay. We note that replicates cluster strongly within strains (for samples from 
exponential growth phase (day 4), the analysis of distance results using Bray-Curtis 
measure for calculating dissimilarities, indicated the R2 values to be 0.564, p-values 
<0.001 and for stationary growth phase (day 12), R2=0.634, p-values <0.001. 
Comparable results when Euclidean distance was used to define inter-sample 
distances). This rules out the possibility of the influence of carry over effects (in cases 
where the sample is not eluted completely during the run) or labelling errors (as the 
replicates within a strain clustered together). The points in the plots represent samples 
and are coloured based on RunDay to help visualize the relationships between strain-
specific differences and batch effects. We also observed small but significant 
associations using Bray-Curtis measure with RunDay, with the coefficient of 
determination (R2) values for day 4 being 0.190 and for day 12 it was 0.205, with p-
values less than 0.001.  Similarly results were observed when Euclidean distance was 
used. All calculations were performed with 999 permutations. 
To quantitatively assess the associations between priori factors (RunDay and 
strain) and variation in the metabolite data structure, we used a linear regression model. 
First the feature level data matrix was decomposed into orthogonal PCs using princomp 
function from the ‘stats’ package in R. The covariance matrix was used for generating 
the eigen values and eigen vectors. To interpret the variation captured in each 
component in terms of strain-specific and RunDay effects, we calculated R2 between 
the PC loadings and RunDay or strain as dependent factors. The significance of such 
correlations were tested using ANOVA. 
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Figure 3.6. Principal coordinates analysis (plotted using PRIMER6) of strains 
(A) exponential phase-Day 4 and (B) stationary phase-Day 12. The run day (batch) in 
which the samples were run clearly influences the variation in both PC1 and PC2 for 
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It is important to note that both RunDay and strain-specific (biological) 
variation influences metabolic differences. The R2 statistic and its associated p-values 
for both day 4 and day 12 are plotted in Figure 3.7 against their corresponding PC. We 
observe that both strain-specific association and RunDay effects are significantly 
associated with the leading PCs (blue box in Figure 3.7). Furthermore, strain-specific 
association survives on higher PCs but RunDay variation tends to disappear after the 
initial PC. This is shown in Figure 3.7 wherein the R2 and p-values for RunDay (shaded 
green) become insignificant (R2 < 0.1, p-values >0.1) after the top few PCs. Now that 
we have clearly established RunDay to be a significant batch effect, it is of critical 
importance to isolate and remove the effect of RunDay to observe natural variation or 
genotypic differences between the strains.  
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Figure 3.7. Associations between principal component loadings of 
metabolomics data with RunDay and strain at exponential-day 4 and stationary-day 12 
phase. The blue boxes highlight the confounding effects between the batches- RunDay 
(shaded green) and biological differences (shaded red) on higher PCs. R2 values 
describing degree of association between each PC eigenvector and either RunDay or 
strain identity. Associations that are statistically significant are shown in closed 
symbols.  
 
3.3.2. Current methods for removing unwanted variation 
The current solutions for quantifying batch effects are based on (i) data 
normalization using internal standards or pooled quality controls, (ii) linear regression 
models, and (iii) advanced statistical techniques. We briefly discuss each of these 
approaches and why they were not suitable for this study.  
3.3.2.1. Internal standard and quality control-based approaches 
Internal standards (IS) are compounds or commercial standards that can be 
used to assess the reproducibility of the instrument. These compounds have chemical 
properties that enable them to be clearly distinguishable from the samples under 
investigation. For example, IS might contain unique peaks or elute at different retention 
times, thus making it easier to identify them from the peaks generated from the sample. 
Quality control (QC) samples on the other hand are pooled mixtures of the biological 
samples under investigation (Naz et al., 2014). In this approach, the idea is to capture 
all metabolites which have the potential to be detected by the instrument. In this 
manner, the instrument can sufficiently capture the entire spectrum of the metabolome 
under investigation. Dunn et al., 2012 provides an excellent review on the importance 
of QC’s in metabolomics analysis(Dunn et al., 2012)(Dunn et al., 2012)(Dunn et al., 
2012). Studies have shown that using quality control samples help mitigate batch 
effects better than using internal standards (Van Der Kloet et al., 2009).   
On detecting batch effects, existing methods normalize the feature intensity to 
that of an internal standard. For example, the normalized log abundances for each non-
IS or QC feature in each sample is obtained by subtracting from the log abundance of 
the IS or QC. This will introduce an additional bias if the features are not correlated 
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with the IS or QC samples. The other major drawback of using single internal standards 
is the assumption that unwanted variation occurs only after sample preparation and that 
every metabolite in a sample undergoes the same type of unwanted variation. This 
might not be true as the influence of batch effects might vary based on the chemical 
properties of the metabolite. Furthermore, selection of an appropriate IS also depends 
on knowing the chemical background of the samples under investigation. This is not 
possible for untargeted studies where the analytical properties of the samples are not 
known beforehand.  
The unwanted variation detected using the IS might also be influenced by 
cross-contamination effects of the other metabolites. This has led to the development 
of methods such as cross-contribution compensating multiple standard normalization 
(CCMN) to identify and remove batch effects influenced by run order in GC-MS 
(Redestig et al., 2009). Such approaches provide an excellent solution for removing run 
order, provided adequate internal standards were chosen. If the unwanted variation was 
not due to the instrument, but resulted during sample extraction or collection periods, 
then using IS or QC will not remove these confounding factors. There are very limited 
strategies that can be used when even the QC samples or internal standards are affected 
by batch. 
In this study, there were no dedicated QC or IS samples. Even then, as 
witnessed in Figure 3.5, the blanks and the matrix themselves showed significant batch 
effects. Thus, for such large-scale studies, multiple IS or advanced statistical techniques 
need to be utilized. For a smaller study, randomized sample and extraction order might 
have been feasible, however in this study it was not possible to partially extract samples 
from strains for each batch as it was not designed to facilitate a random order. In 
specific, in the absence of randomized design, retroactive randomization wherein 
samples are aliquoted each time from the same sample solution, in order to analyse the 
samples in different batches will lead to active degradation of the samples during the 
freeze and thaw cycles. Therefore, for experiments with large number of samples, a 
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clear randomized pattern for sample storage, extraction and MS analysis, with multiple 
pooled biological quality controls and internal standards should be included in the 
experimental design. 
3.3.2.2. Linear regression 
Confounding effects can be modelled as either fixed or random effects in a 
mixed linear model. If the latent variable (batch effect) is modelled as a fixed-effect 
then the resulting treatment groups means will include the latent variable. Thus, 
limiting the variance and confidence interval to be modelled only on the remaining 
residual errors and sample sizes. Furthermore, model inferences can only be estimated 
based on the latent variable. However, if the latent variable is modelled as a random 
effect, then this factor becomes a source of random variation and the experiment results 
will cover all probable scenarios under the influence of the latent variable. This 
approach is used in programs such as MetabR that implement linear mixed models to 
normalize metabolomics data based on fixed effect confounding variables (Ernest et 
al., 2012). MetabR requires the metabolite features to have a normal distribution, which 
is not feasible, as it is challenging to ensure normal distribution for environmental 
samples collected in an untargeted approach. 
3.3.2.2.1. Linear model 
We performed a naïve removal to RunDay effect and subtracted the influence 
of RunDay, by using the residuals from the above model to perform linear regression 
using strain as a factor. Our analysis showed that though batch effects were reduced, 
RunDay still had a significant association with metabolite features (Figure 3.8A). 
Using adjusted p-values, calculated using mt.maxT function from the multtest package 
in R, the number of significant features in exponential phase were determined to be 
3,208 and stationary phase had 2,555 significant features (p-value < 0.05). Figure 3.8B 
shows the number of significant features associated with RunDay, strain, and common 
to both RunDay and strain.   
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Figure 3.8. Naïve removal of RunDay effect using linear model. The left column shows 
the results obtained at exponential phase, whereas the right column shows the 
stationary phase. (A)The p-values are plotted as a histogram, with the x axis splitting 
the range of FDR adjusted p-values in bins of 0.05 and the y axis the corresponding 
number of features in that range. The dotted line indicates the number of significant 
features that are purely by chance alone (p < 0.05). The first row shows the distribution 
of p-values that associated with strain, whereas the second row shows the p-values 
associated with RunDay; (B) Significant features that are common between RunDay 
and strain, and unique to each RunDay or strain. 
 
3.3.2.2.2. Nested linear model 
A nested linear model was then used to test whether this approach can mitigate 
the batch effects and identify strain-specific significant features. The nested model, 
shown below, was used for each of exponential and stationary growth phase. 
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𝑙𝑚(𝑥~ 𝑎𝑠. 𝑓𝑎𝑐𝑡𝑜𝑟(𝑅𝑢𝑛𝐷𝑎𝑦𝐼𝑑)  +  𝑎𝑠. 𝑓𝑎𝑐𝑡𝑜𝑟(𝑅𝑢𝑛𝐷𝑎𝑦𝐼𝑑)/𝑎𝑠. 𝑓𝑎𝑐𝑡𝑜𝑟(𝑆𝑡𝑟𝑎𝑖𝑛𝐼𝑑)) 
Strain and RunDay (batch) are treated as fixed effects as we are interested in 
differences in these specific days and strains.  Furthermore, as strain is completely 
nested within each batch, it is fit within RunDay in a nested model. Residuals from the 
above model were calculated, and the residuals for each feature were tested against 
each of strain and RunDay (as factors). This analysis effectively tested for the presence 
of any feature in the residual for significant association to strain or RunDay, once the 
nested nature of these factors had been taken into account. The results from the above 
analysis did not detect any significant association of feature against either RunDay or 
strain, as the p-values of all such features from the residual dataset were above 0.1. 
These results were as expected, as the main factors influencing variation in the 
metabolite profiles were strain-specific differences and batch effects. Therefore, 
modelling strain and RunDay as fixed effects showed that the residuals did not contain 
signal associated with strain or RunDay. The above model further supports the 
observation that strain-specific and RunDay-specific differences were the major factors 
that were driving the variation in the metabolite profiles. 
Nested model does not reduce the influence of batch effects: The ideal scenario is, after 
fitting the nested model, we would want to detect a higher number of features that are 
associated with strain alone and minimum number of features associated with RunDay. 
We then estimated the number of significant features associated with (i) RunDay, and 
(ii) strain (Figure 3.9).  We observed that the number of significant features associated 
with RunDay were 11,736 at exponential and 9,600 at stationary. Furthermore, 12,405 
and 9,479 features were also significantly associated with strain. The distribution of p-







Figure 3.9. Significant features detected using a nested linear model. The first row 
shows the distribution of p-values that associated with strain, whereas the second row 
shows the p-values associated with RunDay. The dotted line indicates the number of 
significant features that are purely by chance alone (p-value < 0.05). 
 
As we observed that the number of significant features that were associated with both 
RunDay and strain were quite similar, we then calculated the number of significant 
features that were (i) common to both (overlapping features of RunDay and strain), (ii) 
significant in RunDay only, (iii) significant in strain only. The results shown in Figure 
3.10 indicate that a high number of features, that were detected as significant, were 
common to both RunDay and strain. Furthermore, the number of features that were 
detected as significant only in RunDay or strain is less than the number that are 
common to both RunDay and strain (Figure 3.10). These results further strengthen the 
observation, that for this experimental design, a nested linear model is unable to 
separate out the influence of batch effects from strain-specific differences. 
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Figure 3.10. Overlaps between significant features detected using a nested linear 
model. 
3.3.2.3. Advanced statistical models 
These models have been designed to identify surrogate variables manifested in 
the form of batch effects. They identify specific parts of the data matrix that are affected 
by batch effects, and perform targeted removal of unwanted variation. ComBat 
(Johnson et al., 2007), uses an empirical Bayes framework to fit a linear model 
including both biological factors and batch covariates. ComBat works exceptionally 
well for small datasets when the latent variables are known (Chen et al., 2011). For 
large datasets, with potential unknown non-biological sources of variation factor 
analysis, methods such as surrogate variable analysis (SVA) (Leek et al., 2012; Leek 
and Storey, 2007) can be used. SVA combines SVD and linear model analysis to 
capture the unwanted variation due to multiple factors.  
65 
A number of approaches for removing unwanted variations or batch effects, 
use factor analysis. For example, Remove Unwanted Variation (RUV) (Gagnon-
Bartsch and Speed, 2012) and for metabolomics RUV-2 (De Livera et al., 2012) use 
negative controls to detect the presence of unwanted variation and subsequently 
remove them using linear regression models. These negative controls are features that 
are not affected based on biological factors or experiment design. RUV and CCMN 
rely on the identification of specific compounds as negative controls. If these 
compounds are provided then it can identify compounds that are not affected by batch 
effects. Furthermore, in the absence of any non-changing features, RUV-2 can utilize 
internal standards or blanks as negative controls. The hypothesis is that any variation 
in the negative control set is only due to the influence of unwanted variation. 
A recent report evaluating six batch effects correction methods for expression 
microarray data suggested ComBat to be the most effective (Chen et al., 2011). In the 
same review, the researchers mention that for cases when genuine biological variations 
are completely confounded with batch effects, none of the methods could effectively 
reduce batch effects.  
In this study, RUV-2 and CCMN could not be applied as we did not have non-
changing features in our dataset. Different strains being run on different days (Figure 
3.1), led to strain being completely nested within RunDay and resulted in a singular 
design model matrix in ComBat.  ComBat cannot invert design matrixes in a singular 
system. Using such an experimental design in ComBat, resulted in the following error: 
Error in solve.default(t(design) %*% design) : #  Lapack routine dgesv: system is 
exactly singular: U[24,24] = 0 
SVA has been used for identifying surrogate variables, however, for this 
experiment, when SVA was used, the confounding effects of RunDay with strain-
specific differences resulted in no surrogates being identified. A possible cause for this 
outcome is that the strains were completely nested within batches, therefore limiting 
the ability of SVA to detect surrogate variables. It will be an interesting future exercise 
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to test the exact reason that led SVA not to detect any surrogate variables. This can be 
tested by permuting the sample observations between strains and batches. 
Motivation for an SVD-based approach: 
From the Figures 3.6, 3.7, a clear progressive effect of batch differences could 
be detected. Figure 3.7 also showed that batch effect was associated with the leading 
PCs. These results suggested that a PCA-based approach could provide a solution to 
reduce the influence of batch effects. PCA-based approaches have been shown to 
effectively correct widespread batch effects (Leek and Storey, 2007; Pickrell et al., 
2010). In a recent report by Goldinger et al, the authors compare the effectiveness of 
using PC-filtering approaches with approaches that use linear models. They put 
forward a caution that, PC-filtering might remove biologically relevant data. They state 
that the approach is suitable when linear models are not effective in removing batch 
effects. As shown above, for the experimental design used in this study, regression-
based methods were ineffective in removing batch effects, and existing tools such as 
ComBat or SVA could not reconcile the confounding factors in the experimental 
design. 
Confounding variation due to batch effects have been effectively mitigated by 
filtering out multiple PCs (Fehrmann et al., 2011; Goldinger et al., 2013; Price et al., 
2006; Stranger et al., 2012). These reports highlighted the use of SVD-based filtering 
for mitigating batch effects. It is important to note that in an SVD-based approach when 
PC filtering is applied, there is a tendency to lose some information that is not 
associated with non-biological sources of variation. One of the arguments put forward 
by Goldinger et al as the limitation of PCA for mitigating batch effects is that the 
components of variation that contribute to each principal component are often 
unknown. However, in this study, we first computed the association between and the 
factors of interest, namely strain and RunDay (described in Section 3.3.1 and Figure 
3.7). With this motivation, we attempted to investigate the effectiveness of using SVD-
based filtering for mitigating batch effects from untargeted metabolomics data. 
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3.3.3. Removal of batch effects: Solution based on SVD 
In this study, we utilize the data decomposition technique of SVD to develop 
a novel statistical framework for removing batch effects.  Upon identifying PCs that 
are significantly associated with RunDay and strain, we employ a filtering procedure 
using SVD to minimize or remove batch effects.  
This approach consists of 3 steps (Figure 3.11). The first step is to quantify the 
association between PC and the priori factors, in this case strains and RunDay (Figure 
3.7) using analysis of variance models. This resulted in the identification of PCs that 
were most correlated with the surrogate and with the outcome. In the second step, the 
proposed algorithm decomposes the metabolite matrix into 𝑈𝐷𝑉T components using 
SVD. Lastly, it nullifies a small number of singular values of the diagonal matrix 𝐷, 
based on their association with RunDay and finally re-computes the metabolite matrix 
preserving the overall strain-specific biological variation and removing confounding 
batch effects. The procedure below explains these steps in detail.  
Figure 3.11. Procedure for batch effect removal using SVD 
3.3.3.1. Approach to perform batch effect removal using SVD:  
1. For a 𝑚 × 𝑛 scaled metabolite feature matrix 𝑌, with 𝑚 metabolite features 
observed over 𝑛 samples and 𝑚 > 𝑛, the variation in 𝑌 results from strain-
specific metabolic differences confounded with systematic variation caused by 
RunDay effect. The RunDay effect is depicted here as a function of latent 
variable 𝐿.  
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2. To identify the influence of RunDay on the metabolite matrix, PCs of 𝑌, which 
form the linear transformations of the original variables, are calculated using 
the princomp function on the covariance matrix in R.  
3. Associations between PC (using loadings) of 𝑌 and influence of the RunDay 
latent variable 𝐿 is calculated using the below given linear regression model  
Run day:lm(x~ as. factor(RunDay)) and Strain:lm(x~ as. factor(Strain)) 
4. A filtering procedure using SVD (svd function in R) is then performed on the 
scaled original metabolite matrix, yielding 𝑌 = 𝑈𝐷𝑉T. Here 𝑈 is an 𝑚 × 𝑛 
orthonormal matrix, 𝐷 is a 𝑛 × 𝑛 diagonal matrix containing positive singular 
values, and 𝑉 is an 𝑛 × 𝑛 orthonormal matrix. PCs are then rows of 𝐷𝑉T, where 
the 𝑖th PC is found in the 𝑖th row of 𝐷𝑉T. The columns of 𝑈 are the loadings of 
their respective PCs. The above description is for cases when m > n. It should 
be noted that for real-valued data, U can be an  𝑚 × 𝑛 orthogonal matrix and 
D an 𝑚 × 𝑛 rectangular diagonal matrix.  
5. The SVD algorithm was run on all components in the decomposed matrix. For 
each PCi which was significantly associated (p-values <0.05) with run day 
(determined from the linear model), we replaced the same 𝑖th singular values 
present in the diagonal matrix 𝐷 with zero ‘0’. The diagonal matrix 𝐷 with the 
replaced value was then used for recomputing the metabolite matrix, resulting 
in 𝑌*= 𝑈𝐷*𝑉T. 
6. By nullifying the 𝑖th values of PCs that were significantly associated with 
RunDay and re-computing the new matrix, we effectively filtered out the 
variation influenced by RunDay. These steps are illustrated in Figure 3.12.  
7. Furthermore, the re-computed matrixes were confirmed for efficient removal 
of RunDay effect by testing the number of differential metabolite features 
associated with RunDay and strain using permutation-based F-statistics. Each 
feature in the recomputed metabolite matrices was tested using the mt.maxT 
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function from the multtest package (Pollard et al., 2005) in R. This function 
provides permutation adjusted p-values for step-down multiple testing 
procedures. The null hypothesis corresponds to no differential metabolite 
features across samples when RunDay or strain was used as a factor. We 
performed 1000 permutations for each feature and iteratively tested the 
recomputed metabolite matrices to arrive at the stage where we could observe 
no significant features based on RunDay, whereas strain still had a significant 
effect. Due to the multiple testing, false discovery rate (FDR) adjusted p-values 
were generated using Benjamini-Hochberg procedure.  
Test of effect size and inflation statistics: We tested for (i) effect size using correlation 
as function of test statistic, and (ii) inflation effects by observing the distribution of 
numerator and denominator of F-statistics. 
 Correlation as function of test statistic:  Correlation as a function of test 
statistic was used as function to calculate the R2 value associated with an F-statistic. 
The correlation coefficient can be used to measure of the strength of the effect rather 
than to test the significance of the effect (Rodgers and Nicewander, 1988). In the 
presence of multiple groups, Rodgers et al provided a measure to determine the 
relationship between the coefficient of determination R2 and F-statistic through the 
formula 𝑅2 =  𝐹(𝑘 −  1)/[𝐹(𝑘 − 1)  + (𝑁 − 𝑘)] 
 In the above formula, F is the F-statistic, k is the number of groups (strain or 
RunDay), and N is the total number of samples. The R2 value was calculated for each 
feature. Using the above relationship, the correlation statistic [effect] is computed for 
the F-statistics for each of batch and strain-specific effects. This relationship is plotted 
in the in the third rows of Figures 3.12 A, B and C. The features deemed as significant 
(FDR adjusted p-value < 0.05) after permutation-based tests are coloured in red. The 
significant features have a high R2 and F-statistic, indicating that the model describes 
the variation well, and, the variation between group means are high. Expectedly, 
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features which did not have a significant FDR adjusted p-values, also had a low F-
statistic value and low coefficient of determination.  
 We then tested for inflation of the F-statistics, related to the choice of whether 
shrinkage estimators are required. The numerator and the denominator of the F-
statistics were obtained using the 𝑚𝑡. 𝑡𝑒𝑠𝑡𝑠𝑡𝑎𝑡. 𝑛𝑢𝑚. 𝑑𝑒𝑛𝑢𝑚 from the multtest 
package in R. The numerator assesses the variation of the means between groups. The 
denominator is an average of the sample variance estimated for each group. Artefactual 
inflation of test statistics may occur in cases of small differences (numerator) amplified 
by small within group variances, and a simple analysis was undertaken to explore this 
issue. In this analysis, the ratio of denominator to numerator is plotted in the last rows 
of Figure 3.12 A, B and C. These plots indicate the number features (in y axis) and 
ratio of the test statistic (in log scale in the x axis). In an ideal scenario the features that 
are deemed as significant should have low denominator to numerator ratio. Such ratios 
indicate that the between group means are largely different, and thus, the numerator 
has a high degree of variation. In Figures 3.12 A, B, C, the number of strain-specific 
significant features that have low denominator to numerator ratio is higher than those 
affected by batch effects (on the bottom left panel). As the PCs are removed, this trend 
increases for the strain-specific features, while decreasing for batch affected features. 
Taken together, these results help conclude that the SVD-based filtering is effectively 
removing only the variation associated with batch effects, as the strain-specific 
variation still exhibit significant ratios (with low values) between denominator-to-
numerator of the F-statistic. 
 
AFigure 3.12. Illustration of batch effect removal using SVD. (A) The uncorrected data 
matrix is shown. The first row show displays the metabolite matrix in a mass-by-
charge retention time plane. The grey shaded points represent the full data matrix. 
Points shaded in blue, red and black represent the significant features associated with 
strain, RunDay and those which are common, respectively. The second row shows 
the number of significant differential features (p-value < 0.05) associated with strain 
and RunDay. The left column shows the results obtained with strain as a factor, 
whereas the right column shows results with RunDay. The third row plots the 
relationship between R2 and F-statistic for each feature.  The last row plots the distri-
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BFigure 3.12B. The significant features associated with RunDay has reduced.
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Removing top 5 PCs
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CFigure 3.12C. The significant features associated with RunDay are negligible and 
batch effects are significantly reduced.
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3.3.3.2. Results from the application of the batch effect removal algorithm  
To test whether the proposed algorithm works well for removing unwanted 
variation, we would have to understand that the differences between strains are 
correlated with the unwanted variation as a result of batch differences. Thus, an 
effective solution will (i) reduce the number of features which are influenced by 
RunDay, (ii) identify features which are influenced only by strain-specific variation, 
and (iii) remove the influence of RunDay and preserve only the effect due to strains for 
features which are confounded with both RunDay and strain effects (Figure 3.12A, B, 
C).  
The above approach was used for removing batch effects from metabolite 
matrices of strains profiled at both exponential (day 4) and stationary phase (day 12). 
For both data matrices, significant association with RunDay was observed with mainly 
the top few PCs. Thus, the top PCs captured the systematic variation due to batch 
effects. Before batch correction, at exponential stage, there were 10,664 differential 
features between strains and 5,165 features showing significant differences based on 
RunDay (Table 3.1). Similarly for the day 12 matrix, we observed 9,044 and 5,116 
features due to strain and RunDay differences, respectively.  Using the above approach, 
batch effects were substantially minimized by nullifying the singular values of the first 
4 PCs for stationary and first 7 PCs of exponential phase. For example, Figure 3.13 
shows groupings of strains before and after batch correction. This illustration shows an 
increasing or decreasing trend in the raw (scaled) data due to RunDay in loadings of 
PCs 1, 2 and 3. The removal of RunDay associated variance resulted in the strains to 
cluster based on their biological differences.  For stationary phase, we retained 18.99% 
of the residual variance of the original matrix containing 10,687 features. Out of this 
set, 5,878 features were significant due to strain-specific differences and 6 features 
significant due to RunDay effect. However the features affected by RunDay were 
different from those affect due to strain, hence were ignored during metabolite 
identification. For exponential phase, there were multiple sources influencing the 
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metabolite matrix, such as differences in growth rate between strains which were 
further confounded with batch effects. Thus for exponential phase, after batch effect 
correction, we retained 13.31% of the residual variance from the metabolite matrix 
encompassing 13,444 features. The batch correction resulted in identification of 3,979 
features showing significant strain-specific variation and 138 features which were 
significantly affected by RunDay. Over all, the batch effect removal procedure greatly 
reduced the variation in metabolite profiles attributed to run day to almost 0% for 
stationary (day 12) and around 1% for exponential (day 4) phase. The features that were 
still associated with RunDay were artefacts or adducts and hence did not map onto any 
metabolite from with METLIN (Sana et al., 2008) or MetaCyc- constrained to the 
Chlorella metabolome (Zhang et al., 2005)  databases. 
Table 3.1. Significant metabolite features before and after batch effect removal 
 Exponential phase Stationary phase 
 Raw data 
Features detected 67,468 67,468 
Complete features 13,444 10,687 
Residual variance 100% 100% 
Strain-specific features 13,012 10,309 
RunDay-specific features 10,537 8,910 
 Batch effect removed 
Residual variance  (PCs 
removed) 
13.31% (7 PCs) 18.99% (4 PCs) 
Metabolites identified 1,102 996 




RunDay-specific features 138 6 

































































































































































































































































































































































































































Figure 3.13. The plots depict the first two PC loadings of PCA performed on strains 
before and after batch correction for (A) exponential phase- day 4, uncorrected data; 
(B) exponential phase- day 4, after batch effect correction; (C) stationary phase- day12, 
uncorrected data; (D) stationary phase- day12, after batch effect correction. The y axis 
in first, second and third row show PC 1, 2 and 3, respectively. The x-axis represent 
RunDay time stamps. The absence of within batch grouping based on run order indicate 
that there was no within batch variation and that only RunDay difference (between 
batches) was the major confounding factor.  Interestingly, the strains achieve a better 
(random) spread after removing the batch effect from the data structure.  
 
To assess the feasibility of using SVD filtering in the present case, the following 
analyses have been undertaken to show that SVD-based filtering approach used in this 
study retains some strain-specific biological information:  
Case study 1: Strains that were run within a single batch in each growth stage: We 
designed an analysis to investigate the validity of the SVD procedure by only 
examining inter-strain differences within a given RunDay batch. Specifically, to 
estimate the percentage of variation explained by strain-specific differences before and 
after the application of the SVD batch effect correction on all samples, but only 
comparing samples within the same batch to their uncorrected counterparts. This was 
tested using analysis of distance measure (𝑎𝑑𝑜𝑛𝑖𝑠 in vegan package) on 14 strains 
which were run in batch 4 from exponential phase and 12 strains from stationary phase 
run in batch 2 (Figure 3.1). Table 3.2 describes the results from 𝑎𝑑𝑜𝑛𝑖𝑠 which shows 
that the within batch strain-specific differences are preserved following the application 
of the SVD procedure. Interestingly, the variation explained (R2) by strains, seems to 
increase by 6% for exponential phase while decreasing by 3% for stationary phase after 
batch effect correction procedure. 
From the same analysis the distribution of F-statistics for the strain-specific 
differences (based on 999 permutations) (Figure 3.14A) also indicate an overlap in the 
magnitude of the F-statistics between the uncorrected and batch effect corrected data. 
The y axis in the plot shows the density of F-statistics values. The topological ordering 
between the strains is represented by plotting the first two axes of the double centered 
distance matrix obtained from 𝑐𝑚𝑑𝑠𝑐𝑎𝑙𝑒 in Figure 3.14B. .
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Table 3.2. Analysis of distance results for within batch comparison
Growth 
stage 





Strain 13 61300 4715.4 2.4771 0.32792 0.001 *** 




Strain 13 56657 4358.2 3.2337 0.3891 0.001 *** 





Strain 11 77775 7070.4 4.719 0.49013 0.001 *** 




Strain 11 60677 5516.1 4.2697 0.46517 0.001 *** 











































































































































































































Figure 3.14. Analysing relationship between strains 
before and after batch correction. (A) Density plot that 
shows the overlap in the distribution of F-statistics 
between the uncorrected and batch corrected data; (B) 
Relationship between strains plotted using the first 2 




These plots indicate that though the variation between strains seems to have 
decreased, the topological ordering of strains such as, (i) D4_001 and D4_006 at 
exponential stage, and (ii) D12_006 and D12_014 at stationary stage, appear to be 
preserved before and after batch effect correction. 
By definition, the issue of whether it is appropriate to use SVD across batches 
cannot be assessed using this analysis, but these results clearly indicate there is 
preservation of biological signal following application of the SVD procedure. The issue 
of across-batch correction is addressed in the following sections. 
Case study 2: Validation of biological interpretations and strain relationship using 
independent data 
The biological relationships between strains used in this study, were tested 
using an independent experiment performed in August 2014. This experiment was a 
targeted tandem MS/MS analysis that was performed for validating the putative 
metabolites predicted from this study. We extracted MS1 data from this datset to 
compare the relationship between strains. 
Targeted metabolomics was performed using tandem MS/MS on 6 strains that 
were shown to have the most diverging physicochemical traits. They were 
UMACC001, UMACC187, UMACC253, UMACC254, UMACC322, and 
UMACC051 profiled at both exponential and stationary phase. The MS1 spectrum was 
extracted from the tandem MS/MS data and processed using the same methods as 
described in the thesis. Importantly, these new data on selected strains were run in the 
one batch. Thus, they provide an ideal test case to understand whether batch effect 
correction procedure preserves the biological relationship between strains. For 
comparative analysis, the same 6 strains were selected from the original dataset and the 
batch corrected dataset, in both exponential and stationary phase. Analysis of distance 
measure was used to determine the variation explained by the strains (Table 3.3) and 
distribution of F-statistics were assessed. 
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Table 3.3. Analysis of distance comparing relationship among 6 strains 
 
 




Strain 5 33367 6673.5 3.8113 0.39654 0.001 *** 
Residual 29 50779 1751 NA 0.60346   
Corrected 
data 
Strain 5 21817 4363.4 3.2625 0.36 0.001 *** 
Residual 29 38785 1337.4 NA 0.64   
MS/MS 
data 
Strain 5 5531.9 1106.38 3.9194 0.62022 0.001 *** 




Strain 5 39261 7852.2 4.4525 0.47104 0.001 *** 
Residual 25 44088 1763.5 NA 0.52896   
Corrected 
data 
Strain 5 38042 7608.5 6.5802 0.56823 0.001 *** 
Residual 25  28907 1156.3 NA 0.43177   
 MS/MS 
data 
Strain 5 6821.8 1364.36 5.6202 0.70076 0.001 *** 




Figure 3.15. Density plots that depict the distribution of F values obtained from the 
permutation test for the raw, batch corrected and independent MS/MS data  
 
The results again reflect the earlier trend, with a minor change, in this case, 
batch effect correction in stationary phase seems to explain 5% more variation than the 
uncorrected data. However for exponential phase, there seems to be a 3% decrease. The 
distribution of F-statistics show an overlap between the raw data, corrected data and 
MS/MS data from the new experiment (Figure 3.15). Furthermore the topological 
ordering of strains remains similar in all 3 datasets (Figure 3.16). From these results, 
we can conclude that relationship between strains is preserved. Importantly, it also 
supports the claim that SVD-based filtering effectively removes batch effects while 
still retaining strain-specific differences. 
 
Figure 3.16. Relationship 
between 6 strains  in the 
raw data, batch corrected 
data and in the new 
MS/MS dataset, plotted 



































































































































































































































SVD-based approach preserves biological interpretation 
Figure 3.17 shows the effect of SVD-based filtering of PC components. The y 
axis indicates the number of significant features (determined using permutation-based 
F-statistics) that were associated with Strain (coloured red) and RunDay (coloured 
green). The x axis indicates the number of PCs that have been removed.  
As witnessed in the Figure 3.17, the number of significant features that are 
associated with RunDay drops of rapidly after removal of the top few PCs in both 
exponential (Day4) and stationary (Day12) phase. Furthermore, while RunDay 
associated features are removed after the top few PCs, there still seems to be a 
significant number of features that are associated with strain differences. Unlike, the 
nested linear model, these are strain-specific features alone and are not significant when 
RunDay is used as a factor.  
A detailed representation of the effect size, inflation statistic and the 
relationship between strain-specific and run-day specific features are provided in 
Supplementary Figures 1 and 2 for exponential and stationary phase, respectively. 
Furthermore, as observed in Figure 3.14, the overall relationship between strains 
analysed in the same batch, before and after batch correction procedure, is similar. 
Therefore, SVD-based correction seems to effectively reduce non-biological sources 
of variation. 
Metabolites in batch effect corrected data show significant associations with PC 
A recent method ‘Jackstraw’ that computes the association between 
metabolites and principal components was tested on the raw and batch corrected data. 
It uses a resampling method to produce accurate significant measures of associations 






Figure 3.17. Number of significant features that are associated with RunDay and strain 
after removing each PC. The x axis indicates the PCs and the y axis indicates the 
number of significant features. 
The over-fitting characteristics that result from computation of principal 
components from the same set of variables are also taken into account (Chung and 
Storey, 2014). The 𝑝𝑒𝑟𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛𝑃𝐴 function from the jackstraw package was used to 
estimate the number of significant principal components from both raw and batch 
corrected data at each growth stage. Interestingly, the test did not detect any significant 
principal components in the raw data. However, when the 𝑝𝑒𝑟𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛𝑃𝐴 function 
was used on the batch effects corrected dataset, it determined the first 26 components 
of exponential phase and first 22 components of stationary phase to have significant 
associations with metabolites (Figure 3.18). The x axis in Figure 3.18 represents the 
PCs and the y axis shows the percentage variation explained by each PC. 
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Figure 3.18. Significant associations between principal components and metabolites. 
The y axis indicates the percentage variation and the x axis indicates PCs. 
These results suggest that the variation in the uncorrected dataset might be 
masked due to batch effects, thus, the metabolites did not show any significant 
association with the principal components. Furthermore, the above results further 
support the assumption that SVD-based filtering retained significant variation due to 
strain-specific effects. This observation is based on the detection of significant 
association between metabolites and principal components of the batch effects 






Comparison of SVD-based approaches with standard batch effect removal approaches 
The effectiveness of using PCA-based approaches in this fashion has been 
subject to some debate, and in particular, the generality of this procedure is unclear, 
hinging on the fact that the influences of non-biological, batch-related variables are 
thought to manifest themselves in the first few principal components. In practice, this 
is probably extremely difficult to establish in general terms, due to the context-specific 
and diverse nature of such non-biological influences in large sample series. Goldinger 
et al. argue that such PCA filtering is less effective than linear modelling, and 
demonstrate the even principal components with small variance contributions can be 
associated with batch related variables (Goldinger et al., 2013) 
Recently, Leek et al compared the effectiveness of using PCA (using SVD) 
and SVA for identifying and mitigating batch effects (Leek, 2014). In this study, using 
three published datasets and one simulated dataset, the author compared supervised 
SVA and svaseq for count data (similar in nature to metabolite abundances in the 
metabolomics data matrix), with standard methods for removing batch effects. The 
author uses SVD to perform PCA-based batch effect removal. For the simulated 
dataset, when batch effects had low correlation with group effect, SVA and RUV-based 
approaches performed better than PCA-based approach. However, the author shows 
that in datasets where there is moderate or high correlation between batch and group 
effects, then unsupervised SVA and PCA-based approaches perform better than RUV-
based approaches.  
In the present case, we have analysed the association between biological and 
non-biological variables, and eigenvector composition, and at least here, PCA 
effectively decouples the influence of these factors, despite their highly confounded 
nature. But the generality of this procedure is unclear and we emphasize, in common 
with others, that the influence of batch effects needs to be carefully investigated on a 
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case-by-case basis, and undue reliance should not be placed on prescriptive solutions. 
The extent to which PCA filtering should be used a general strategy for removing batch 
effects, potentially even in situations when these factors are either not available or not 
recorded, is unclear and more work is needed in this area. 
 
3.4. Conclusions 
We used significance tests and analysis of variance measures to evaluate the 
impact of batch effects on the metabolite features when both batch and biological 
differences were confounded. Given a set of linear combination of PCs estimated from 
the metabolomics data, we developed a (i) filtering procedure that minimizes such 
unwanted variations resulting in preservation of biological signals (ii) and does not 
require negative controls, QCs or standards for removing unwanted variation. We use 
the non-targeted algal metabolomics data to show that the proposed filtering procedure 
can be used to effectively remove nuisance variation caused by batch effects, while 
preserving the biological source of variation to serve as a direct indicator of 
biochemical phenotype. The analysis of this dataset is further examined in the next 
Chapter (discussed in Chapter 4).  
We have demonstrated the need for incorporating batch effect correction 
methods as a standard protocol especially for high throughput datasets. This can largely 
simplify complex methods and provide meaningful biological interpretations. 
Furthermore, with increased sharing of metabolomics datasets among the scientific 
community through initiatives such as MetaboLights and COSMOS (Salek et al., 
2013b), it is imperative that comprehensive meta information is recorded for removing 
batch differences. Similar to the case of expression microarrays, these data standards 
will facilitate increased meta-analysis and large-scale data mining providing further 
justification for implementing robust experimental design and data analysis strategies 
(Gibon and Rolin, 2012; Rai et al., 2013). It is also important to note that experimental 
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designs should incorporate the use of multiple internal standards and pooled standards. 
The samples should be extracted and processed in a randomized order. These steps are 
provide vital information that can be used to identify and mitigate batch effects. 
The SVD-based approach described in this study, provides a suitable 
alternative for mitigating batch effects, when the experimental design issues render 
regression-based methods as ineffective. The methods described in this Chapter may 
also have a role to play in identifying and removing batch effects in any large-scale 
experiments such as Next Generation Sequencing (NGS) studies. Taken together, 
implementation of these techniques will lead to improved experimental designs and 




4. Environmental and biochemical determinants of 
metabolic resource partitioning in naturally varying 
microalgae- Chlorella  
“This preservation of favorable variations and 
 the rejection of injurious variations,  
I call Natural Selection.” 
… Charles Darwin (1859) in ‘Origin of Species’ 
4.1. Background and Introduction 
The increasing energy demands along with the depleting fossil fuels has 
resulted in finding alternative sources of energy critical for sustaining modern life 
(Georgianna and Mayfield, 2012).  Biofuel production using microalgae has clear 
advantages over other renewable sources of energy due to the following characteristics:  
(i) Microalgae produce and accumulate oil as nonpolar lipids, such as 
triglycerides (TAGs), from sunlight and carbon dioxide (Wijffels and Barbosa, 
2010). These rich sources of TAGs can be converted to high quality biofuels.  
(ii) Compared to other alternatives such as crop biomass, microalgae grow 
relatively rapidly (Wijffels and Barbosa, 2010) and are easy to metabolically 
engineer for producing the desired bio-products.  
(iii) Microalgae can be farmed on non-arable land (Chisti, 2007) and using non-
potable water (Phang, 1990), thus, minimizing wasteful diversion of resources 
that can be better utilized and crucial for growing food crops. 
The vast natural diversity of algae along with their enormous chemical and 
physiological variability provides an environment conducive for identifying efficient 
strains for biofuel production (Stengel et al., 2011). Such diversity also highlights the 
ability of microalgae to thrive in diverse ecosystems (Radakovits et al., 2010). 
Unbiased high-throughput screening of the biochemical profiles of such populations, 
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especially inter-species comparisons, can provide insights into the genetic and  
environmental factors influencing production of valuable commercial products from 
oleaginous microalgae (Stengel et al., 2011). Furthermore, such studies can also 
provide insights into the factors that shaped evolutionary diversity in these species i.e. 
the role of environment in shaping evolutionary and regulatory divergence between 
species.  
Microalgae exhibit enormous diversity in their lipid profiles, ability to 
synthesize energy, growth rates and biomass productivity, all of which determine the 
yield (Stengel et al., 2011). Thus, bioprospecting natural variants with the desired traits 
such as strains that can grow quickly having high biomass and lipid content, can 
drastically reduce the time required to optimize metabolic engineering strategies for 
large-scale production of biofuels, and have high economic benefits (Georgianna and 
Mayfield, 2012).  
In this study, we focus on the green oleaginous microalgae- Chlorella, which 
are widely distributed in fresh water environments (Eckardt, 2010). Initially, a number 
of algal isolates were assigned to the genus Chlorella. However, this taxonomy 
classification was not reliable because of the lack of distinct morphological 
characteristics. With further molecular analysis, these isolates were then separated into 
two classes of chlorophytes, namely the Trebouxiophyceae (true Chlorella), and the 
Chlorophyceae (Blanc et al., 2010). Similar to other microalgae, Chlorella, has been 
the focus of interest mainly for (i) producing biofuels and high-value bioactives, (ii) 
sequestering carbon dioxide from the environment, (iii) and as biofertilizers or for 
bioremediation (Arbib et al., 2014). Furthermore, Chlorella has an inherent capacity to 
produce high amounts of  lipids (Pribyl et al., 2012) and biomass (Doan et al., 2011). 
Chlorella has been studied for a number of years starting from 1969 (Fott and 
Nováková, 1969), with most of the efforts initially focusing on identifying and 
screening for specific bioactive algal compounds (Onofrejova et al., 2010; Schumacher 
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et al., 2011), with later emphasis on analysing the effect of nutrients, growth conditions 
(Xin et al., 2010) and determination of optimal conditions for producing high quality 
biofuel (Rodolfi et al., 2009).  
However, the untapped potential of naturally varying microalgae as efficient 
producers of biofuel has never been comprehensively studied using non-targeted 
metabolomics approaches (Stengel et al., 2011). Previous efforts in screening tropical 
microalgae were largely focused on their use as food supplements or as fertilizers 
(briefly reviewed by (Vello et al., 2014)). Furthermore, there is growing evidence 
indicating that organisms vary in their ability to regulate both the levels and 
configurations of a given set of metabolic enzymes (Rhee et al., 2011), related to both 
variation in genetic and environmental factors. (Breunig et al., 2014; Chan et al., 2010; 
Wen et al., 2014). The development of advanced analytical measurement technologies 
(discussed in Chapter 2) combined with multivariate statistical techniques, have now 
provided opportunity to profile the diverse chemical space and richness of algal 
compounds. This approach also provides an unbiased characterization of the 
biochemical phenotype facilitating the characterization of effect of genetic and 
environmental (habitat) niche on the metabolic diversity.  
A major challenge is to understand the complex factors influencing the 
allocation of cellular resources to various processes such as growth, lipid productivity 
and biomass in oleaginous algae. Understanding how microalgae can convert the single 
carbon compounds into bio-products of interest can be studied using metabolomics. 
For example, comparing naturally varying strains using non-targeted metabolomics 
profiling can generate accurate quantitative biochemical phenotypes that help 
understand the preferential utilization of metabolic pathways in the cellular resource 
partitioning strategies. Knowledge of such processes can help in strain prioritization 
(Krug and Muller, 2014) whereby efficient strains that facilitate easy manipulation of 
metabolic pathways can be identified. This approach can also aid in removing 
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bottlenecks such as cell-density limits during synthetically re-engineered microbial 
biofuel production. Additionally, mass spectrometry-based metabolomics can reveal 
the genomic potential and characterize the metabolite concentration changes influenced 
by environmental factors.  
As inter-species comparison of strains isolated from different habitats are 
analogous to studying the environmental effects on metabolic phenotypes of oleaginous 
algae, we examined the natural variation of 22 Chlorella strains isolated from 7 
different geographic locations in Malaysia. To characterize the metabolic diversity of 
these strains, non-targeted metabolic profiling was performed. In this Chapter, I have 
undertaken a systematic analysis of these to analyse the metabolic diversity between 
22 Chlorella strains, with the specific aim of (i) understanding metabolic changes 
during growth; and (ii) identifying habitat-induced variation and biochemical 
determinants of metabolic phenotypes. 
This study is the first report to profile natural variation in oleaginous 
microalgae using a combination of non-targeted metabolomics, phylogenetic analysis 
and physicochemical profiling. We assess the strain-specific metabolic reprogramming 
strategies and analyse associations between physicochemical and metabolic profiles to 
identify key metabolic correlates of biotechnology related traits. The overall objective 
of this study is to identify algal strains that have biochemical and metabolic 
characteristics suitable for biofuel production. 
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4.2. Materials and methods 
4.2.1. Sampling strategy 
To survey the natural variation in oleaginous microalgae, untargeted 
metabolomics profiling was performed on 22 strains of Chlorella obtained from 
University of Malaya Algae Culture Collection (UMACC). These 22 strains were 
isolated from 7 different geographic locations (Figure 4.1), comprising of 16 diverse 
habitats (Table 4.1) in Malaysia (Courtesy: Ms. Vejeysri Vello and Prof. Siew-Moi 
Phang, UMA). Colleagues from UMA had previously characterized the lipid 
productivity and the fatty acid composition of these strains to identify promising strains 
for biofuel production. For detailed procedures on collection, culturing and storage of 
samples, kindly refer to (Vello et al., 2014).  
              Figure 4.1. Sampling locations in Malaysia 
Phylogenetic analysis of these 22 strains based on partial 18S rRNA sequences 
revealed that 15 strains belonged to the true Chlorella clade (within the class 
98 
 
Trebouxiophyceae) and 6 strains were from the Parachlorella clade, while 1 strain 
(UMACC 184)  was not sequenced (Table 4.1)(Vello et al., 2014).                     
Table 4.1. Species and sampling site description of 22 Chlorella strains (adapted from 
(Vello et al., 2014)) 
Strain Species Origin 
UMACC 001 Chlorella Pond at IPSP Farm, University of Malaya 
UMACC 006 Chlorella Fish tank containing chicken manure, IPSP Farm, 
University of Malaya 
UMACC 014 Chlorella IPSP Farm, University of Malaya 
UMACC 051 Chlorella Aerobic pond for POME treatment, Tenamaran 
Palm Oil Mill, Selangor 
UMACC 084 Chlorella Digested POME, enriched with goat dung, IPSP 
Farm, University of Malaya 
UMACC 087 Chlorella Digested POME, enriched with goat dung, IPSP 
Farm, University of Malaya 
UMACC 094 Chlorella Tenamaran Palm Oil Factory, Selangor 
UMACC 104 Chlorella Muddy water of Sementa Mangrove, Selangor 
UMACC 177 Chlorella Plastic container, Kuantan Pahang 
UMACC 184 Unidentified NA 
UMACC 187 Chlorella Tin, Chinese graveyard, Kuantan Pahang 
UMACC 207 Chlorella Concrete tank, shop houses, Kedah 
UMACC 268 Chlorella Raw palm oil effluent pond, Labu Palm Oil Mill, 
Negeri Sembilan 
UMACC 283 Chlorella Anaerobic pond 3, Labu Palm Oil Mill, Negeri 
Sembilan 
UMACC 322 Chlorella Wastewater treatment pond at oil refinery, Negeri 
Sembilan 
UMACC 325 Chlorella Wastewater treatment pond at oil refinery, Negeri 
Sembilan 
UMACC 245 Parachlorella Seawater from Terengganu 
UMACC 252 Parachlorella Sea Bass Pond at Sepang, Selangor 
UMACC 253 Parachlorella Sea Bass Pond at Sepang, Selangor 
UMACC 254 Parachlorella Sea Bass Pond at Sepang, Selangor 
UMACC 255 Parachlorella Sea Bass Pond at Sepang, Selangor 
UMACC 258 Parachlorella Sea Bass Pond at Sepang, Selangor 
It is important to note that though the strains are similar to those used in (Vello 
et al., 2014), the data for this study comes from a different batch. This study was 
specifically conducted to identify the differences in metabolic strategies during growth 




4.2.2. Experimental design 
Experiments were designed to assess the influence of habitat and genotype on 
the metabolic phenotypes. Metabolite profiles of 22 strains at two growth phases- 
exponential (day 4) and stationary phase (day 12) (Figure 4.2) were obtained using 
Liquid Chromatography Mass Spectrometry (LC-MS) (described in Chapter 3). 
Biological replicates of each of these strains were developed in a manner permitting 
assessments of metabolic variation. Specifically, for each strain, we profiled 3 
biological replicates and for each biological replicate 2 analytical replicates were used 
at each growth phase. 
Figure 4.2. Experimental design for generating metabolome and biochemical profiles. 
The physicochemical measurements were collected for 3 biological replicates. 
The physicochemical measurements collected by Ms. Vejeysri Vello (UMA) are: 
 
 Specific growth rates: monitored based on OD620nm and chlorophyll a (Chla) 
concentration. Figure 4.3 provides an illustration of the growth rate 
measurements for these 22 strains. There is no growth rate associated with 
strains at stationary phase. 
 Biomass (g/L) 
 Biomass productivity (g/L/day): expressed as the dry biomass produced (in g 
L−1 day−1), at the end of exponential growth phase, specifically it is biomass 
density (g L−1)×specific growth rate (day−1) 
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 Lipid productivity (mg/L/day) 
 Total lipid content (% dry weight) 
 Total protein content (% dry weight) 
 Total carbohydrate content (% dry weight) 
Figure 4.3. Representative growth rates for (A) Chlorella and (B) Parachlorella strains 
4.2.3. Metabolite identification 
We used the metabolomics datasets that were corrected for batch effects in this 
study. CAMERA package (Kuhl et al., 2012) in R (R Core Team, 2014) was used with 
the default parameters to remove isotopes and adducts before metabolite identification. 
Figure 4.4 shows the distribution of standard deviation of the abundance (in the y axis) 
for each m/z feature (in the x axis).  As there was higher variation in the larger 
metabolite masses, a 10 ppm mass and retention time window of 5 s was set after 
manually inspecting the peak width in the extracted ion chromatograms. After 
deionization, metabolite features which elute within 5 s of each other and having m/z 
within 10 ppm were grouped and the median m/z for this was calculated. The m/z was 
then used in database search for predicting putative metabolite identifications. The m/z 
and retention time for all the features detected in each dataset is provided in a 
Supplementary dataset (Dataset 1).  
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Figure 4.4. Standard deviation of metabolite abundances at exponential (day 4) and 
stationary (day 12) growth stage. The standard deviation increases linearly with 
increase in mass, indicating that higher masses are more variable, possibly due to the 
analytical limitations. 
 
We then used the binned m/z feature list to predict putative metabolites by 
matching them against MetaCyc- constrained to the Chlorella metabolome (Zhang et 
al., 2005) and METLIN (Tautenhahn et al., 2012) databases using the PCDL manager 
(Agilent) with a search window set to 10 ppm in positive mode. Specifically, the 
database was first searched for exact matches to the given m/z, if there were no exact 
matches, then the search extends to 1pp window, then 2 and so on till 10 ppm. The best 
match is the one which has the minimum difference in ppm from the given m/z value. 
All the metabolites described in this Chapter were putative identifications based on 
database matches. Supplementary Dataset 1 lists all predicted metabolites with their 
ppm differences (within 10 ppm). The predicted metabolites can provide valuable clues 
to possible metabolites and their pathways, however, these need to be validated using 
standards and tandem MS/MS techniques for absolute confirmation. The total number 
of putative metabolites, at (i) exponential phase -1,102 were detected in the batch 
corrected dataset, while 466 metabolites were differential, and at (ii) stationary phase - 




All statistical analyses in this study were performed using R and on batch effect 
corrected data. In figures, strain labels starting with UMACC are replaced by ‘DX_’ 
for clarity. Here X refers to the growth stage, thus X is 4 for exponential phase (D4_) 
and 12 for stationary phase (D12_). However, when the strains are referred to in the 
context of their genetic sequences or genomes, UMACC label is still used as there are 
no differences in these labels based on growth stages. Using this dataset, we identified 
significantly different (FDR adjusted p-values < .05) features between the 22 strains, 
amounting to 5,878 features at stationary phase, and 3,979 features at exponential 
phase.  
As a follow up to these initial surveys, data-dependent MS/MS is currently 
being performed using Agilent quadrupole time of flight mass spectrometry (Agilent 
Q-ToF 6540) with ESI probe in positive mode of ionization. The resulting fragments 
will be used to identify metabolites based on chemical structure similarity with 
standards or/and matching with MassBank database (Horai et al., 2010).  
 
4.3. Results and discussion 
4.3.1. Genetic divergence between algal strains 
rRNAs being key elements of the translation mechanism in cells are extremely 
conservative and are not structurally affected by artefacts produced due to lateral 
transfers (Pace et al., 1986). Furthermore, the length of the SSU-18S rRNA sequences 
are adequate to provide statistically robust comparisons between species. These 
characteristics make them ideal entities to be used for deriving phylogenetic 
relationship between organisms. For this study, phylogenetic analysis using the 18S 
rRNA sequences (courtesy Ms. Vejeysri Vello, Prof. Phang Siew Moi, UMA) provided 
a measure of the algal diversity sampled, especially given that these were 
uncharacterized microbes assayed over diverse geographical locations and habitats.  
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With the phylogenetic relationships already mapped out by Vello et al., 2014, 
we set out to derive a measure for calculating the genetic distance among the 21 strains. 
While the phylogenetic relationship was analysed by Vello et al, the work in Figure 
4.5A was mainly performed to assess genetic divergence within 21 strains that had 
metabolomics data. The phylogenetic analysis from Vello et al could not be used for 
the same purpose as (i) it used 29 strains, and (ii) Vello et al compared these 29 strains 
with 83 other taxa, mainly related to other Chlorella (from the GenBank database). In 
this Chapter, genetic differences were analysed between 21 strains (UMACC 184 did 
not have 18S data) in order to provide a measure of comparison between the metabolic 
distances for the same set. Specifically, it was used to analyse whether strain-specific 
metabolic traits could be related (at both growth stages) to the genetic differences 
between the strains. The genetic distance between the 21 strains was calculated using 
the 𝑠𝑡𝑟𝑖𝑛𝑔𝐷𝑖𝑠𝑡 function (Levenshtein distance) from the ‘Biostrings’ package (Pages 
et al.) in R. Hierarchical clustering based on average linkage method was then used to 
visualize this distance matrix (Figure 4.5A).   
From Figure 4.5A, we observed a clear separation between strains isolated 
from Seawater or Sea Bass Pond, namely UMACC 252, UMACC 245, UMACC 258, 
UMACC 253 and UMACC 254 and others. Interestingly, the above five strains are 
from the Parachlorella clade, thus exerting an influence on the genetic distance. The 
tight clustering within this group also suggest that these strains might have a similar 
genetic background. Furthermore, Strain UMACC 255 isolated from Sea Bass Pond 
and belonging to Parachlorella, formed a separate cluster with UMACC 322 which 
was isolated from a waste water treatment plant and belonged to the Chlorella clade. 
Surprisingly, the above two strains formed a unique subclade separate from the 
remaining 19 strains. This could possibly be due to the unexpectedly high similarity in 
the 18S rRNA sequences between these two strains. It will be interesting to perform 
complete sequencing of these strains to analyse their evolutionary and regulatory 
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relationships.  These observations from genetic distance-based clustering led us to 
further characterize the metabolic relationships between strains.   
4.3.2. Metabolic divergence between algal strains 
Metabolites identified from exponential phase-1,102 (full data), 466 
(differential) metabolites and from stationary phase we had 996 (full data), 655 
(differential) metabolites were used for calculating the metabolic divergence among 
the 21 strains using 𝑣𝑒𝑔𝑑𝑖𝑠𝑡 function (Euclidean distance) of ‘vegan’ (Jari Oksanen, 
2013) package in R. In the above description, full data refers to all the metabolites 
which were detected in the metabolomics profile for that growth stage, whereas 
differential refers to all the metabolites which were significantly varying in abundance 
between the strains. The distance matrix produced was visualized using hierarchical 
clustering based on average linkage method (Figure 4.5 Exponential phase: B, 
Stationary phase: C).  
There appeared to be substantial differences in the clustering patterns between 
genetic and metabolic distance matrices and even between growth stages in the 
metabolic profiles. For example, the clusters formed based on habitat or genotype in 
the genetic distance-based tree (Figure 4.5A) were conspicuous because of their 
absence in the metabolic distance trees. Furthermore, strains D4_322 (Figure 4.5B) 
(which had also shown significant genetic divergence, Figure 4.5A), and D12_001 
(Figure 4.5C), showed the maximum metabolic divergence at exponential and 
stationary phase, respectively. These large metabolic profile based divergence indicate 
that these strains have a markedly different metabolome compared to the others. 
UMACC 001 and UMACC 014 which formed a cluster based on genetic distance, were 
also clustered together based on metabolic profiles at exponential phase. However, this 
trend was not repeated in the metabolite profiles at stationary phase.  We observed that 
strains that were genetically divergent, were converging in the same cluster based on 
metabolic distances at exponential (D4_051 and D4_087, Figure 4.5B) and stationary 
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phase (D12_014 and D12_255, Figure 4.5C). Apart from these obvious groupings, 
there were no clear clustering patterns in the metabolic distance trees at both 
exponential and stationary phase.  
We then performed a Mantel test (𝑚𝑎𝑛𝑡𝑒𝑙 function in ‘vegan’ package, with 
999 permutations) computing Spearman’s correlation coefficient to analyse the trends 
between metabolic and genetic distance matrices. Mantel test, a non-parametric 
statistical method, that tests the significance of correlations between two distance 
matrices using permutations of rows and columns. In this implementation of Mantel 
test, the Spearman’s correlation coefficient ‘r’ will fall in the range of -1 to +1 
depending on the correlation between the elemental (strain) distributions in both the 
genetic and metabolic matrices. A strong negative correlation brings ‘r’ closer to -1, 
whereas in case of positive correlation the correlation coefficient value ‘r’ will be closer 
to +1.  An ‘r’ value of ‘0’ indicates no correlation between the two matrices. We did 
not observe any significant correlations between the genetic and metabolic distances at 
both growth stages (Table 4.2). This result is in accordance with previous studies on 
closely related genotypes, where studies conducted on Arabidopsis thaliana analysed 
the natural variation in different accessions and also showed that there was only a minor 
or no correlation between its genetic and metabolic diversity (Chan et al., 2010; 
Houshyani et al., 2012). Furthermore, they observed that metabolite levels were largely 
influenced by environment. The absence of genotype-metabotype correlation indicates 
that there is no one-to-one relationship between the genome and the metabolome of an 
organism. Thus, an unbiased metabolomics survey might be a better analytical 
technique to capture novel metabolites or understand the genomic potential of 
uncharacterized strains. Furthermore, there was no correlation (based on Mantel test) 
between the metabolic profiles of exponential and stationary phase, either using full 
data (r = 0.079, p-value = 0.297) or differential metabolites (r = 0.021, p-value = 0.43). 
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The above results indicate that the metabolite strategies in strains differ between growth 
stages. 
Table 4.2. Mantel test statistic (Spearman’s correlation coefficient r) between genetic 
and metabolic distances 
 
4.3.2.1. Metabolic diversity between algal strains 
To obtain a more intuitive feel for the growth stage-specific differences at 
metabolites, we generated a presence/absence matrix of the metabolites detected in 
each growth stage. The batch corrected dataset is used for putative identification of 
metabolites using a database search (described in Section 4.2.3). The metabolites 
identified in different growth stages number 1,102 in exponential and 996 at stationary 
phase. This number represents the total number of metabolites that were predicted 
based on mass similarity (within the given 10 ppm threshold) to existing metabolites. 
Using the m/z features that were differential between strains, we obtained 466 
metabolites at exponential and 655 metabolites at stationary phase. A matrix 
representing all the detected metabolites in this experiment was created. This 
presence/absence matrix had 4 different columns, wherein the presence of a metabolite 
in that column category is scored as ‘1’ and absence as ‘0’.  
This is visualized as a heatmap (Figure 4.6), wherein the detection of the 
metabolite in that set is indicated by a grey shade. The majority of metabolites detected 
seems to be common between exponential (day 4) and stationary phase (day 12), when 
the complete profile is used. However the differential metabolites, i.e. metabolites that 
vary in their abundance among the 22 strains were mostly unique to either exponential 
or stationary phase. 
Growth stage Dataset Vs Genetic distance 
Exponential  
phase 
Full data  0.108 (p-value = 0.22) 
Differential metabolites  0.180 (p-value  = 0.10) 
Stationary 
 phase 
Full data -0.076 (p-value = 0.74) 
Differential metabolites -0.112 (p-value = 0.81) 
107 
 
The Venn diagram in Figure 4.7 reveals that out of 655 differential metabolites 
at stationary phase, 311 were unique to the stationary phase alone. In other words, the 
metabolic differences between strains at stationary phase were due to significant 
changes to the abundance levels in 311 metabolites. The concentration levels for these 
metabolites did not significantly change or were not detected at exponential phase. A 
similar analysis shows that 56 metabolites were varying in their concentration only at 
exponential phase and not stationary phase. Taken together, a total of 655 unique 
metabolites are accountable for the strain-specific metabolic differences among the 22 
strains at exponential and stationary phases. Analysis of these metabolites will help 
understand the metabolic individuality of algal strains.






























































UMACC 104 UMACC 104
Figure 4.5. Distances between 21 strains (A) Genetic distance (Levenshtein distance), Metabolic distance (Euclidean distance using full dataset) at 
exponential phase (B) and stationary phase (C)  
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Figure 4.6. Heatmap (presence of a metabolite indicated in grey shade) showing 
differences in metabolites detected between growth stages. The rows represent 
metabolites, and columns are different datasets. 
Figure 4.7. Venn diagram highlights the differences between the metabolites detected 
in each growth stage. Abbreviations: Day12_all- Total metabolites detected in 
stationary phase, Day12_difF- Differential metabolites in stationary phase, Day4_all- 
Total metabolites detected in exponential phase, and Day4_difF- Differential 
metabolites detected in exponential phase.  
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Strain-specific metabolic phenotypes arise from both regulatory 
(concentration) and structural (chemical structure) differences in metabolites. Strains 
of the sub cluster of Parachlorella strains D4_255, D4_258, D4_252 and D4_254 at 
the exponential phase (Figure 4.8A) were all isolated from the same location in 
Selangor. It is interesting to observe the similarity between the metabolic profiles of 
these strains and raises the hypothesis that habitat might have an influence on the 
metabolic processes at early growth phases (No such clustering was observed during 
the stationary phase (Figure 4.8B)). However, the above hypothesis, though interesting, 
is purely speculative and warrants more experimentation and increased sample size to 
achieve statistically robust results.  
Interestingly, there were no differential metabolite features i.e. features with 
significant variation in their abundance when the strains were grouped according to 
their genotype (Chlorella Vs Parachlorella), at both exponential and stationary phase. 
Therefore, the major source of differences in the metabolite levels of these strains are 
due to strain-specific regulatory variations and/or environmental factors (such as 
habitat) influencing the biochemical phenotype.  
This analysis, highlights the fact that the time at which the metabolome is 
profiled is indicative of the metabolic state of a system. This should especially be taken 
note of when trying to understand an uncharacterized organism’s metabolic potential. 
In ideal scenarios metabolic profiling should be performed mostly over a time series.  
To identify metabolic pathways that were detected in both growth stages, these 
metabolites were mapped on Chlorella-specific metabolic pathways in KEGG (Table 
4.3 and Figure 4.9). Typically pathway or function enrichments in omics analysis are 
calculated by performing overrepresentation analysis using methods such as 
hypergeometric tests or Fisher’s exact test. This produces in an enrichment score, 
typically in the form of p-values as an indicative measure of pathway enrichment. Such 
an analysis was also performed for this study, specifically 𝑓𝑖𝑠ℎ𝑒𝑟. 𝑡𝑒𝑠𝑡 was used to test 
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for overrepresentation of these pathways in the total dataset and in the features that 
were differential between strains at each growth stage. It should be noted that this test 
was performed by treating the number of metabolites detected at each stage in the full 
dataset as the total population size for that stage. In typical experiments, such analysis 
is performed by treating the total number of entities in the pathway as the population 
size for that pathways, and the total number of entities in all metabolic pathways as the 
total population size. However, in metabolomics experiments, it should be noted that 
the maximum number of entities in a metabolic pathway for an experiment, is limited 
by the detection method (extraction protocols and capacity of mass spectrometers) used 
and the database. Therefore, in order to apply a uniform and unbiased measure of 
enrichment, the total population size for each stage was calculated using the total 
number of metabolites detected in that stage. The resulting p-values from this analysis 
are shown within brackets for each pathway in Table 4.3. Only 2-Oxocarboxylic acid 
metabolism in stationary phase had a significant enrichment score.  
The objective of this experiment was to observe the differences in the type of 
metabolites and their associated pathways. In order to capture differential enrichment 
of metabolic pathways, a targeted study with an extraction protocol optimized for such 
analysis and using instrumentation (for example tandem MS/MS) that can facilitate 
such comparisons is required. In scenarios where such experimentation is not possible, 
alternate complementary levels of information such as those measuring the 
transcriptome levels should be used to strengthen the statistical and biological 
interpretation (an example for such an application is described in Section 5.3.1).  
However, biological interpretation based on the (i) presence and absence of 
metabolites, and (ii) overall coverage of the untargeted metabolic profiles when 
overlaid on the canonical Chlorella-specific pathways, can still be derived from the 
metabolomics analysis (without MS/MS data) conducted in this study. As the same 
technique was used for profiling strains in both growth stages, it is assumed that the 
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detection limits for metabolites in both growth stages will be similar. With this 
hypothesis, the presence or absence of metabolites clearly relates to the differences in 
the type of metabolites and their associated processes that are active in metabolic 
pathways. These shifts in metabolic strategies during growth stages as shown in Figure 
4.9, can provide valuable clues to understand metabolic diversity of the 22 strains. In 
Figure 4.9, the total number of metabolites are represented as 100 percentage in the 
columns. The corresponding percentage of a pathway in the full data is shaded dark 
grey, whereas the number of differential metabolites identified onto that pathway is 
coloured orange (the percentage is calculated based on the total number of metabolites 
for that pathway).  
A 
B 
Figure 4.8. Hierarchical clustering of differential metabolites using Euclidean distance 
and average linkage method at (A) Exponential phase, (B) Stationary phase. 
 113 
 
Expectedly, the top pathways are associated with secondary metabolism or 
energy (Table 4.3). The maximum number of differential metabolites between the 
strains at both exponential and stationary phase belonged to secondary metabolism 
pathways such as (i) Carotenoids, ubiquinone and other terpenoids biosynthesis; (ii) 
lipid metabolism; Interestingly for the above two pathway classes, the number of 
differential metabolites in stationary phase is almost double the number found in 
exponential phase. These numbers indicate that the diversity in lipid production 
between the 22 strains arise mainly during the stationary growth phase; (iii) alpha-
linolenic acid (jasmonic acid) metabolism and (iv) phenylpropanoid metabolism. 
Similarly, differential metabolites were greater in stationary phase than in exponential 
phase for the above metabolic pathways. Linolenic acid is one of the major 
determinants of fatty acid content in algae, thus the differences in numbers indicate that 
the strains have the diverse metabolic strategies in alpha-linolenic acid metabolism that 
eventually result in varying fatty acid levels among these strains. It will also be 
interesting to perform a targeted analysis of the jasmonic acid pathway (discussed in 
Chapter 5) to determine whether these algal strains also have rudimentary mechanisms 
for phytohormone biosynthesis (Blanc et al., 2010). Phenylpropanoids include a large 
class of metabolites (discussed inn Chapter 5), with diverse functional roles, thus 
targeted analysis using MS/MS can further elucidate the implications of differences in 
this metabolite class.  
Finally, differential metabolites which mapped onto pathways related to energy 
generation were mainly associated with (i) amino acid metabolism, (ii) 2-
Oxocarboxylic acid metabolism and (iii) Aminoacyl-tRNA biosynthesis. The trends 
between the number of differential metabolites in stationary and exponential phase 
were mixed and require confirmation using MS/MS data to understand the differences 
in metabolic strategies (Table 4.3). This is also illustrated in Figure 4.9.  Supplementary 
Dataset 2 provides metabolites identified in each pathway as separate lists. 
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Table 4.3. Number of metabolites detected in each pathway for each growth stage. Enrichment values are shown within the brackets. 










cvr00906 Carotenoid biosynthesis   115 19 16 (0.17) 24 13 (0.19) 
cvr01210 2-Oxocarboxylic acid metabolism   NA 13 12 (0.08) 13 8 (0.14) 
cvr00260 Glycine, serine and threonine metabolism   51 13 10 (0.49) 13 5 (0.74) 
cvr00564 Glycerophospholipid metabolism   52 10 10 (0.04) 11 7 (0.14)  
cvr00592 alpha-Linolenic acid metabolism   40 11 10 (0.14) 11 6 (0.32) 
cvr00130 Ubiquinone and other terpenoid-quinone biosynthesis   80 13 9 (0.72) 14 5 (0.81) 
cvr02010 ABC transporters   122 14 9 (0.84) 15 7 (0.5) 
cvr00330 Arginine and proline metabolism   90 10 8 (0.44) 9 5 (0.34) 
cvr00970 Aminoacyl-tRNA biosynthesis   52 9 8 (0.23) 10 4 (0.7) 
cvr00270 Cysteine and methionine metabolism   57 9 7 (0.52) 8 2 (0.93) 
cvr00940 Phenylpropanoid biosynthesis   65 7 7 (0.1) 7 3 (0.66) 
cvr00960 Tropane, piperidine and pyridine alkaloid biosynthesis   68 11 7 (0.84) 12 5 (0.66) 
cvr00460 Cyanoamino acid metabolism   46 8 6 (0.61) 9 2 (0.96) 
cvr00590 Arachidonic acid metabolism   75 6 6 (0.14) 6 5 (0.06) 
cvr00860 Porphyrin and chlorophyll metabolism   124 10 6 (0.89) 11 4 (0.78) 
cvr00950 Isoquinoline alkaloid biosynthesis   93 6 6 (0.14) 7 2 (0.89) 
cvr01220 Degradation of aromatic compounds   NA 9 6 (0.78) 9 3 (0.83) 
cvr00240 Pyrimidine metabolism   66 5 4 (0.57) 6 3 (0.53) 
cvr00360 Phenylalanine metabolism   72 7 4 (0.9) 7 3 (0.66) 
cvr00380 Tryptophan metabolism   82 8 4 (0.96) 9 3 (0.83) 
cvr00591 Linoleic acid metabolism   28 4 4 (0.27) 3 3 (0.08) 
cvr00600 Sphingolipid metabolism   25 4 4 (0.27) 4 3 (0.22) 
cvr01040 Biosynthesis of unsaturated fatty acids   54 5 4 (0.57) 4 3 (0.22) 
cvr00230 Purine metabolism   92 5 3 (0.87) 5 3 (0.38) 
cvr00250 Alanine, aspartate and glutamate metabolism   24 4 3 (0.69) 4 3 (0.22) 
cvr00310 Lysine degradation   52 5 3 (0.87) 6 2 (0.82) 
cvr00400 Phenylalanine, tyrosine and tryptophan biosynthesis   35 5 3 (0.87) 5 0 (1) 
cvr00760 Nicotinate and nicotinamide metabolism   47 4 3 (0.69) 4 2 (0.58) 
cvr00770 Pantothenate and CoA biosynthesis   55 4 3 (0.69) 4 1 (0.9) 





Figure 4.9A. Differential presence of metabolites in metabolic pathways at Exponential phase. Abbreviations: Day4.FullData- Total metabolites 




Figure 4.9B. Differential presence of metabolites in metabolic pathways at Stationary phase. Abbreviations: Day12.FullData- Total metabolites 
detected in stationary phase, Day12.Differntial- Differential metabolites in stationary phase. 
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4.3.3. Physicochemical profiles 
The physicochemical profiles, totalling 7 different measurements (see 
Materials and methods) were characterized for the 22 strains. With the observation of 
strain-specific and growth stage-specific differences in the metabolic profiles, we 
analysed the physicochemical data to identify whether they exhibited a pattern similar 
to the metabolic profiles. We performed PCA on the centered and scaled 
physicochemical data using the 𝑝𝑟𝑐𝑜𝑚𝑝 function from the ‘stats’ package in R. The 
separation between strains at exponential and stationary growth stage was observed in 
the second PC axis which explained around 35% variation in the data. Interestingly, 
the variation in the first PC was largely associated to the influence of lipid or protein 
content in strains.   
Figure 4.10. PCA of physicochemical profiles of 22 strains. Strains in exponential 
phase are coloured blue, whereas stationary phase is coloured red. 
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We observed that the total protein and lipid productivity were inversely related 
to each other. To analyse this relationship further, we performed Kendall tau-based 
correlation (Figure 4.11). 
Figure 4.11. Correlation between physiochemical measures of 22 strains at (A) 
Exponential phase, (B) Stationary phase. P-values were adjusted using Bonferronni 
corrections. Abbreviations: totalCarbCon- Total Carbohydrate Content, 
totalProteinCon- Total Protein Content, totalLipidCon- Total Lipid Content, 
lipidProduc- Lipid Productivity, biomassProduc- Biomass Productivity, biomass- 
Biomass, growthRate- Growth Rate. 
 
From Figure 4.11, we observed that total lipid concentration was negatively 
correlated with total protein at both exponential and stationary phase. At exponential 
phase, both biomass productivity and lipid productivity were significantly correlated. 
The lack of correlation between biomass and lipids during stationary phase is not 
surprising as the lipid accumulation is commonly observed at the start of stationary 
phase when nutrients become limited. As lipid productivity is often used as an indicator 
for biofuel production efficiency, its correlation with biomass productivity, 
substantiates its usefulness as a suitable physicochemical-biomarker (Huerlimann et 
al., 2010). 
The significant negative correlation between total lipid and total protein 
indicates that likelihood of inherent lipogenic and proteogenic strains. Understanding 
the differences in molecular mechanisms between such strains can provide valuable 
insights into their resource partitioning strategies. Expectedly as the biochemical 
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profiles significantly vary between growth stages, the biochemical distance matrix of 
both exponential and stationary phase calculated using 𝑣𝑒𝑔𝑑𝑖𝑠𝑡 function (Euclidean 
distance) in ‘vegan, showed no correlation (r = -0.004, p-value = 0.48, calculated using 
Mantel test, 𝑚𝑎𝑛𝑡𝑒𝑙 function using Spearman’s correlation coefficient in ‘vegan’ 
package, 999 permutations). We then used the Mantel test to analyse pattern similarity 
between biochemical profiles and metabolite distances at exponential and stationary 
phase (Table 4.4).   
Table 4.4. Mantel test statistic (Spearman’s correlation coefficient r) between 
biochemical and metabolic distances. 
Growth stage Dataset Vs Biochemical profiles 
Exponential  
phase 
Full data -0.011 (p-value = 0.55) 
Differential metabolites  0.024 (p-value  = 0.39) 
Stationary 
 phase 
Full data 0.263 (p-value = 0.013) 
Differential metabolites 0.248 (p-value = 0.016) 
From the above table, we observe that there were small but significant 
correlations between the metabolic profiles of strains in the stationary phase and their 
biochemical profiles. Interestingly, there was no correlation between strains at 
exponential phase and their physiochemical profiles. The lack of a significant 
correlation between biochemical traits and metabolic profiles at exponential phase 
indicate that microbes decide their metabolic resource partitioning strategy late during 
their growth phase. 
To analyse if there were significant associations between any biochemical trait 
of the strains and the observed metabolic variation, we performed PERMANOVA 
(Permutational Multivariate Analysis of Variance Using Distance Matrices) with 999 
permutations using the 𝑎𝑑𝑜𝑛𝑖𝑠 function in ‘vegan’ package in R. Only biomass had a 
significant association with the metabolite profiles, both with differential metabolites 
(R2 = 0.084, p-value = 0.015) and full data set (R2 = 0.079, p-value = 0.019) at 
stationary phase. With biomass explaining around 8% of the variation in metabolite 
profiles, the results hint that the resource partitioning strategy of strains is reflected in 
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its end phenotype, thus, stressing the importance of analysing cellular metabolism in 
order to understand the molecular mechanisms that determine the efficiency of biofuel 
production. None of the other biochemical traits were significantly associated with 
metabolic profiles at stationary phases, whereas there were no correlation between any 
biochemical trait and the metabolic profiles at exponential phase. 
4.3.3.1. Biochemical determinants of resource partitioning 
The success of large-scale microalgae-based biofuel production depends on 
growth rate and oil content in strains. The high- and low-yielding groups are interesting 
candidates for the identification of naturally varying species-specific metabolic traits. 
Thus, we set out to determine if the best strains in each of the biochemical traits have 
markedly different metabolite profiles when compared to the worst strains (lowest 
producers, growers etc.) in each trait. Centered and scaled data were used to determine 
the best and worst strains. For each trait, strains in the top and bottom 10% of the range 
(values measured for each trait) were extracted (Figure 4.12) using the 𝑞𝑢𝑎𝑛𝑡𝑖𝑙𝑒 
function in R.  
Figure 4.12. Classification of strains based on their biochemical profiles. 
Strains which are consistently best performers are coloured dark blue; worst performers 
are coloured red; and strains which switched between lipid and protein productivity are 
coloured green. Abbreviations: growthRate- Growth Rate, biomass- Biomass, 
biomassProd- Biomass Productivity, lipidProduc- Lipid Productivity, totalLipidCon- 
Total Lipid Content, totalProteinCon- Total Protein Content, totalCarbCon- Total 
Carbohydrate Content. 
From the above figure, we observe that strain UMACC 322 which had the 
maximum metabolic divergence at exponential phase (D4_322, Figure 4.5B) is the top 
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strain in among three different biochemical traits (Biomass, Biomass productivity and 
Total Carbohydrate Content) at exponential phase. Similarly, UMACC 001 which had 
the maximum divergence based on metabolic distance at stationary phase (D12_001, 
Figure 4.5C), is the worst performer in three different traits (Biomass, Biomass 
productivity and Lipid productivity).  
We had earlier observed that D4_252 and D4_254 formed a separate sub 
cluster at exponential phase (Figure 4.5B). The possible divergence of their metabolic 
profiles emerges when comparing their biochemical traits. From Figure 4.12, we 
observe that strains UMAC 254 and UMACC 252 are one of the top lipid producers. 
However at stationary phase, UMAC 254 (D12_254) has switched to become a strain 
having one of the highest total protein content, thus, suggesting that early markers  of 
resource partitioning strategy can be identified using an organism’s metabolic profile. 
Similarly UMACC 187 (D12_187) which is not one the top strains at exponential 
phase, but has high biomass and biomass productivity and lipid productivity formed a 
separate sub cluster based on the metabolic profiles at stationary phase (Figure 4.5C).  
To analyse whether the differences in the biochemical traits reflect in 
quantitative differences in their metabolic profiles, F-tests were performed on 
metabolite matrices using the 𝑚𝑡. 𝑚𝑎𝑥𝑇 function (with 1000 permutations) from the 
‘multtest’ package (Pollard et al., 2005) in R. In this test, the top 3 strains in each 
category were grouped into one category and their metabolite profiles were compared 
against the bottom 3 for the categories given below (Table 4.5). Importantly, we did 
not observe influence of growth media on the metabolic profile differences, thus ruling 
out batch affects during culture preparation. 
Biomass which had a significant association with metabolite profiles at 
stationary phase seems to elicit the maximum difference (showing 795 features) 
between the metabolite profiles of strains at stationary phase. In other words, strains 
which differ based on biomass had divergent metabolite profiles. At exponential phase 
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biomass and lipid productivity (showing 196 and 116 features, respectively) which are 
dependent on the growth rate, along with lipid content (104 features) seem to elicit the 
maximum difference in metabolite profiles. The metabolic and biochemical 
relationships between strains are vastly different between growth stages. Strains having 
extreme biochemical profiles also have relatively divergent metabolic profiles 
compared to the others. 
Table 4.5. Biochemical determinants of metabolic diversity among 22 Chlorella 
strains. The numbers represent the number of significant differential features for each 
comparison. 
Comparisons Day 4 Day 12 








Chlorella Vs Parachlorella 0 0 
Prov-Seawater media and 
other media 
0 0 
Growth rate 8 0 
Biomass 55 795 
Biomass productivity 196 795 
Total carbon content 25 265 
Lipid productivity 116 128 
Total lipid content 104 173 
Total protein content 39 190 
Thus, in order to explore the behaviour of strain-specific metabolite 
associations in determining resource partitioning strategies, we used Haygood’s 
measure (Haygood et al., 2007). Haygood et al. described an approach for identifying 
tissue-specific gene expression patterns using maximal expression criteria: since few 
genes are expressed in a completely tissue-specific manner, even if that gene shows 
maximum expression in one tissue, there is a high probability that this expression level 
might also be witnessed in other tissues. This problem was recast into linear algebra by 
Haygood et al. Specifically, each gene is treated as a “vector” in the “tissue expression” 
space", thus, multiple tissues are treated as separate dimensions. In this approach, 
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tissue-specific measures are described by computing the square of the cosine angle 
between gene-vector and each of the tissue axes. However, this is equal to computing 









In the above expression 𝐸𝑔𝑡 is measured as the expression level of gene g in 
tissue t. This equates to simply normalizing the expression of a gene to the total 
expression measured across all included tissues. The advantage of such an approach is 
that the sum of 𝜎𝑔𝑡 is always going to be unity across all tissues. Furthermore, for any 
gene, the average of 𝜎 will always be 1/T. Thus, deviations from this value can be used 
to explore tissue-specificity. Furthermore, Haygood measure is independent of the 
overall expression level (application for metabolomics developed in discussion with 
Dr. Rohan Williams). In this study, the above concept had been modified to reflect 
strains as equivalent to tissues and metabolites abundance levels measured in the place 
of genes. This concept is particularly suited for metabolomics, as a higher or lower 
abundance of a metabolite in a particular strain hints at the possibility that the specific 
metabolite might play a critical role in determining the activation of its associated 
metabolite pathway. In our dataset, this translates into normalizing the abundance of 
each metabolite to the total abundance of the metabolite detected across all strains. 
Thus, the Haygood measure for a metabolite which does not have any specific 
abundance trend will be around 0.0454 (1/22 strains=0.0454). The above calculation 
assumes that a metabolite, which is within the normal abundance levels has an equal 
association with all the strains. Thus if the total abundance level is 1, this is split equally 
among all the strains resulting in 0.0454 being the Haygood measure for a non-strain-
specific metabolite. This analysis was performed on the 466 differential metabolites 
from exponential phase and 655 differential metabolites from stationary phase (Figure 
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4.13). It is important to note that while the heatmap in Figure 4.6 shows the 
presence/absence of a list of metabolites across growth stages, the values represented 
for each metabolite in Figure 4.13 is the Haygood measure for that metabolite in that 
particular strain. 
Figure 4.13. Heatmap showing the normalized values based on Haygood measure for 
(A) Exponential phase, (B) Stationary phase. The columns represent individual 
metabolites and the rows represent strains. Heatmap is plotted with Euclidean distance 
with average linkage clustering using the 𝑝ℎ𝑒𝑎𝑡𝑚𝑎𝑝 function in ‘pheatmap’ package 
in R. High metabolite association values are indicated in red shades in the plot. 
In (Figure 4.13), strains which previously showed high metabolite divergence 
or were categorized as the best or worst performers based on biochemical straits had 
distinct metabolite association patterns. For example D4_322 at exponential phase 
(Figure 4.13A) and D12_001 or D12_187 at stationary phase (Figure 4.13B) has a high 
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number of metabolites showing significant associations (increasing metabolite 
association is shaded from blue to red). 
Expectedly the metabolic pathways which were linked to these strain-specific 
metabolite associations were mainly related to energy, lipid or fatty acid biosynthesis 
(Table 4.3). Taken together, our results suggest that strains UMACC 187, UMACC 
254 and UMACC 322 to be the most efficient strains which can be targeted for further 
analysis for determining efficiency of large-scale biofuel production. Furthermore, 
UMACC 001 has a radically different metabolic and biochemical profile, and requires 
further analysis to determine the reprogramming strategies that allow it to have one of 
the highest total protein contents. 
4.4. Conclusions 
This survey of naturally varying strains measuring genetic diversity, 
biochemical characteristics and metabolic profiles allowed us to perform robust 
multivariate statistics to analyse the metabolic potential 22 Chlorella strains. We 
compared the metabolic divergence, genotype-metabotype associations and identified 
metabolic correlates of biotechnology related traits. This integrative analysis resulted 
in the identification of strain-specific metabolic biomarkers that can be developed for 
chemotaxonomic classification of oleaginous algae.   
Our results suggest that the metabolic differences among the strains might be 
due to differences in gene expression levels or variation in genome sequences not 
covered by the 18S rRNA sampling. In this study, the strains were isolated and had 
been grown in lab conditions. However, they still exhibit significant metabolic and 
biochemical differences. Furthermore, the metabolic and biochemical profiles were 
largely invariant based on ribosomal sequence-based genetic distances, thus, 
suggesting that the strain might have undergone habitat-influenced genetic adaptions. 
Such adaptions result in changes to gene function and expression levels which can 
affect the gene product and therefore its phenotypic evolution (Whittkopp, 2013).  
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Furthermore, the regulatory mechanisms involved in modulating metabolic 
functions remain incompletely defined. Thus, while biochemical methods provide a 
glimpse into an organism’s metabolic potential, the underlying mechanisms linking the 
genotype to its metabolic phenotype remain largely understudied. These require 
targeted transcriptomics and genomic analysis to narrow down the traits to specific 
genes. Such complementary information on gene expression levels can help build 
metabolic models and aid metabolic engineering techniques to probe symbiotic 
associations between genotype-metabotype (discussed using a model system in 
Chapter 5), their biochemical traits and influence of environmental factors.  
Overall, the results from this study provide insights on the effect of genotypic 
differences and habitat-specific factors that produce large metabolic diversity between 
phylogentically similar strains. It is interesting to note that the variation in metabolic 
phenotypes is due to specific metabolites, thus indicating a highly selective metabolic 
strategy. These results also highlight the importance of untargeted analysis to identify 
natural variants. Such untargeted metabolomics approach in a diversity-oriented study 
provides a conceptual framework for effectively screening and classifying algal species 
without relying on genome information. The identification of naturally efficient strains 
provides the opportunity to selectively mine and isolate species of interest containing 
the desired biochemical and metabolic traits from known locations. As these strains 
have a natural tendency for producing desired compounds, they provide a favourable 
starting position for metabolic engineering strategies. Taken together, the approaches 
described in this study can help understand the effects of genetic or environmental 
perturbations on the metabolic diversity of biological systems. 
Additionally, next generation sequencing techniques can be used to identify 
genomic potential and expression level variation for elucidating ‘hotspots’ based on 
gene-metabolic QTLs (Wen et al., 2014). These hotspots can be used for estimating the 
evolutionary divergence and can provide insights into to phenotypic buffering (Fu et 
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al., 2009) among the 22 strains. Such analysis will be useful for transforming systems 
level information info a functional large-scale production setup. 
  
 
 Part of the results presented in this Chapter have been submitted for 
publication, Amit Rai*, Shivshankar Umashankar*, Megha, Lim Boon Kiat, and Sanjay 
Swarup, “TT8 affects innate immunity in Arabidopsis by reprogramming hormone 
biosynthesis and glycosylation of metabolites”. Results from this Chapter are included 
as a part of a patent.  128 
5. Data-dependent multi-omics approach to uncover effects 
of genetic perturbation on metabolic network 
“Nothing unconnected ever occurs,  
and anything unconnected  
would instantly perish” 
… Emanuel Swedenborg, 18th century Swedish scientist and philosopher 
5.1. Introduction 
Organisms being complex systems, regulate their physiological responses 
through inter-connected, non-linear, and dynamic interactions between multiple 
biological layers such as DNA, RNA, proteins and metabolites. Elucidation of such 
molecular mechanisms orchestrated via regulatory changes to gene expression and 
gene products can provide important clues in assessing cellular responses. With the 
metabolome representing the closest biochemical phenotype of an organism, analysing 
gene-metabolite relationships using an integrative omics approach can provide a 
systems level understanding of these cellular processes (Joyce and Palsson, 2006). 
From the previous study, we determined that there is enormous metabolic 
diversity in naturally varying organisms. For example, in the plant kingdom, estimates 
indicate the presence of nearly 200,000 different types of metabolites with diverse 
physical and chemical properties (Fiehn, 2002). This diversity is generated via 
biochemical processes such as conjugations, hydroxylations, methylations, 
decarboxylations, oxidation/reduction and acyltransfer reactions. Among various 
conjugation processes, glycosylation which results in addition of sugar moieties to 




In plants, glycosylation or deglycosylation processes provide crucial 
modifications to the physicochemical properties of metabolites required for growth, 
development and stress response (Vaistij et al., 2009). This regio- and stereo- selective 
modification of aglycone molecules produce glycosides with diverse chemical 
structures and properties. Flavonoids consisting of almost 5,000 different structures, 
have important ecological, economic and pharmaceutical properties (Wink, 2010) and 
are one of the major classes of secondary metabolites to be influenced by glycosylation 
process. For example, glycosylation of a single flavonol metabolite, quercetin results 
in over 300 glycoside forms (Harborne and Baxter, 1999).  
Glycosylation and deglycosylation processes are regulated by a specialized set 
of enzymes known as carbohydrate active enzymes (CAZy) (Lombard et al., 2014). 
CAZy comprises of five enzyme classes. For deglycosylation processes, they are 
glycoside hydrolases (GHs), polysaccharide lyases (PLs) and carbohydrate esterases 
(CEs) and while glycosylation is mediated via glycosyltransferases (GTs) and auxiliary 
activity enzymes (AAs). Though, glycosylated forms of metabolites and their 
aglycones along with the enzymes mediating such processes have been studied, there 
are still gaps in understanding how (i) the coordination between different molecular 
entities such as genes and metabolites occur during sugar conjugation (glycosylated) 
processes, and (ii) processes such as plant innate immunity, stress response and growth 
are related to glycosylation of metabolites (Wink, 2010).  
In order to gain a holistic understanding of the molecular mechanisms co-
ordinately regulated during glycosylation, we systematically perturbed a basic helix-
loop-helix transcription factor, TRANSPARENT TESTA 8 (TT8) (Nesi et al., 2000) , 
in the model plant Arabidopsis thaliana.  Using a model plant in a laboratory setup 
provided us with a robust experimental strategy devoid of unwanted variation due to 
environmental factors.  
TT8 forms a ternary complex with two other proteins, TT2 and TTG1. This 




phenylpropanoid metabolic network (Baudry et al., 2004), thereby, co-ordinately 
controlling flavonoid biosynthesis. Recent reports (Xu et al., 2013) suggested that TT8 
might be involved in regulating the expression of genes in flavonoid biosynthesis. 
Interestingly, TT8, was also shown to alter the chromatographic profiles of both the 
aglycone (Pelletier et al., 1999) and glycosylated  (Narasimhan et al., 2003) forms of 
kaempferol and quercetin. However, it is not yet known whether TT8 directly regulates 
glycosylation of flavonoids and/or other metabolites (glycosylated and/or aglycone 
forms). These results indicate that TT8 might be a putative flavonoid glycosylation 
regulator and would be a suitable model to investigate: (i) glycosylation of flavonoids, 
(ii) the coordinated regulation of sugar conjugation, and, (iii) other processes that might 
be co-regulated with sugar conjugation. Furthermore, with glycosylation of flavonoids 
and other secondary metabolites regulated by CAZy genes, we hypothesize that TT8 
affects glycosylation of flavonoids by regulating CAZy.  
To discover novel glycosylation targets of TT8 and its regulatory network, we 
measured the effect of TT8 loss on the Arabidopsis metabolic network by performing 
non-targeted metabolomics profiling. Furthermore, to identify coordinated changes in 
the gene expression levels, we measured RNA levels using microarray-based 
expression profiling. To utilize the systems-level information from these high 
throughput datasets, I developed a novel integrative omics strategy that combines the 
genomic relationships with gene expression and metabolite abundances. In this study, 
I used multivariate statistical methods to analyse promoter sequences and performed 
enrichment analysis by integrating both genomics and metabolomics datasets. 
To the best of our knowledge, this study represents the first approach to utilize 
orthogonal and complementary levels of biological information provided via genomics 
(analysis of shared promoter motifs), transcriptomics and non-targeted metabolomics 




5.2. Materials and methods 
5.2.1. Plant materials and growth conditions 
 Arabidopsis thaliana plants of ecotype Wassilewskija (Ws-2) and tt8-3 
(deb122) were obtained from Versailles (INRA, France), while tt8-2 and Ler-0 were 
obtained from the Arabidopsis seed stock center (ABRC, USA). Dexamethasone (dex) 
inducible TT8:GR overexpression lines were created by transforming 2x35S:TT8:GR 
promoter in Wt-Col (CS60000) background.  
To generate 2x35S:TT8-GR construct, we amplified TT8 cDNA from 
PGWB20-TT8 clone using primers TT8-cla1(5’-
AACTCGAGATGGATGAATCAAGTATTATTC-3’) and TT8-xho1(5’-
ATTATCGATTAGATTAGTATCATGTATTATGAC-3’), digested by Cla1, Xho1 
and were introduced in HY109 vector between 2x35S promoter and glucocorticoid 
coding gene. Plant transformation was performed as described earlier (Bechtold and 
Pelletier, 1998). Twelve independent transformed lines were tested for expression 
levels of BAN and DFR, known direct targets of TT8 with and without dex treatment. 
Three lines that showed maximum up-regulation of known target genes were selected 
for analysing the phenotypes resulting from induced overexpression of TT8.  For 
further studies, we selected inducible TT8:GR overexpression line that showed 
maximum up-regulation of BAN and DFR on dex treatment. 
Seeds were surface sterilized using 30% Clorox with 7 minute incubation, 
followed by 6 times washing with autoclaved water and transferred to MS (Duchefa 
Biochemie) agar plate [1x MS media, 20 g/liter sucrose, and 6 g/liter phytoagar (pH 
5.7)] for 4 days before placing them in growth chamber at 22°C for 16 h light/8 h dark 
cycle. For inducible lines, transgenic seeds were sown directly on MS agar plates with 
30µM dex (stock solution prepared in ethanol) or equivalent amount of ethanol for 
mock treatment. Photon flux density was set at 50 µmol 2 min 1 s. Seedlings were 




5.2.2. Metabolome profiling 
5.2.2.1. Metabolite extraction  
Metabolite extraction for non-targeted metabolic profiling was performed as 
described in the protocol (Rai et al., 2013). Briefly, whole plants were snap frozen by 
liquid N2 and homogenized using mortar and pestle. 100mg of homogenized samples 
were transferred to a 1.5ml eppendrof tube and 0.5ml of ice cold 80% methanol was 
added immediately, centrifuged twice at 4°C, 13,500 rpm for 20 min and the 
supernatant collected were used to analyse through directly to mass spectrometry. 
Metabolite extracts for four biological replicates of each line, with each replicate 
injected thrice as technical replicates were used in Q-TOF, while Orbitrap had three 
biological replicates of each line, with three replicates. The sample run were not 
randomized, however, the entire extraction and analysis was performed in one batch. 
5.2.2.2. LCMS analysis 
We used two MS platforms to broaden coverage of ionized metabolites from 
samples. In the first platform, Agilent 1290 UHPLC system was used in-line with 
Agilent QTOF 6540. Six microliters of each metabolite extract sample was 
chromatographed on a Zorbax Eclipse Plus-C18 column (10cm length, 2.1 cm 
diameter, 1.8 µm particle size) with column temperature fixed at 50°C. Flow rate was 
maintained at 0.3 ml/min in an 18 min run with a gradient mobile phase: A) 0.1% FA 
in water; B) 0.1% FA in ACN (t = 0–0.5 min, B = 10%; t = 0.5–12 min, B = 100%; t = 
12–15 min, B = 100%; t = 15–15.1 min, B = 10%; t = 15.1–18 min, B = 10%). The 
eluent was introduced directly into the mass spectrometer by electrospray, and during 
the whole period of injection samples were maintained at 4°C. Untargeted mass 
profiling was performed with Agilent Q-TOF 6540 using ESI probe in positive mode 
of ionization. Parameter for MS were: drying gas temperature- 350ºC with 10L/min 
(nitrogen) flow rate, sheath gas temperature -400ºC with 12L/min (nitrogen) flow rate, 




acquisition rate- 4 spectra/s, mass range- 50-1200 m/z. The system was controlled by 
Mass-Hunter Data Acquisition Software (Agilent Technologies, Santa Clara, CA, 
USA).  
In the second platform, we used Acquity UHPLC system (Waters) in-line with 
LTQ-Orbitrap Velos (Thermo Fisher Scientific). Acquity UPLC BEH C18 column 
(10cm length, 2.1cm diameter, 1.7 µm particle size) was used with column temperature 
fixed at 50°C, injection volume was10 µl with sample vials maintained at 7°C. Solvents 
used were the same as in first approach with solvent flow rate of 0.4ml/min and a linear 
gradient of 13 min. The following gradient was used: 5% B for 0.5 min, 5–100% B in 
9 min, holding at 100% B for 2 min and re-equilibration at 5% B for 2 min. MS profiling 
was performed in positive mode using in-line LTQ-Orbitrap Velos equipped with a 
heated electrospray probe (H-ESI II). The system was controlled by Xcalibur 2.2 
(Thermo Fisher Scientific). ESI and MS parameters used for Orbitrap were: spray 
voltage 5.0 kV, sheath gas and auxiliary nitrogen pressures 50 and 10 arbitrary units, 
respectively, capillary and heater temperatures 300 and 350 ̊C, respectively, tube lens 
voltages 110 V. The resolution was set at 60,000 for full MS scan (50-1200 m/z) with 
acquisition rate of 3 scan/s. Data were acquired in profile mode with external 
calibration. 
Data-dependent MS/MS was performed using Agilent Q-TOF 6540 with ESI 
probe in positive mode of ionization. UHPLC system with column was setup in-line 
with mass spectrometer, with an 18 min long separation method same as described 
above for untargeted metabolic profiling. Parameters used were: drying gas 
temperature at 350ºC with 10L/min (nitrogen) flow rate, sheath gas temperature at 
400ºC with 12L/min (nitrogen) flow rate, capillary voltage at 4000V, nozzle voltage 
1500V, skimmer voltage 65.0V, fragmentor voltage 150V and octopole RFPeak 
voltage 750V. Parameters for precursor selections were - fixed collision energy at 
50eV, max precursors per cycle at 10, threshold (absolute) at 100cps, active exclusion 




Data acquisition was performed in centroid mode at the resolution of 30,000 with MS 
scan rate set at 8 spectra/s and MS/MS scan rate set at 2 spectra/s. 
5.2.3. Metabolomics data analysis 
  Raw data files from both Q-TOF (.d files) and Orbitrap (.RAW files) were 
converted into mzXML format using msconvert of the ProteoWizard suite (Kessner et 
al., 2008). Using parameters defined for Q-TOF (method = ‘centWave’, ppm = 30, 
peakwidth = c(10,60), prefilter = c(0,0); peak grouping: bw = 5, minfrac = 0.3, mzwid 
= 0.025; retention time correction algorithm: ‘obiwarp’) and  Orbitrap (method = 
‘centWave’, ppm = 2.5, peakwidth = c(10,60), prefilter = c(3,5000); peak grouping: 
bw = 5, minfrac = 0.3, mzwid = 0.015; retention time correction algorithm: ‘obiwarp’) 
a total of 8,734 (QTOF), 5,969 (Orbitap) features were extracted using XCMS 
package(Patti et al., 2012; Smith et al., 2006)  (version 1.38)  in R software (R Core 
Team, 2014). Exploratory data analysis was performed using R and datPAV. 
Metabolite profiles were analysed using XCMS and m/z values of putative metabolites 
were checked again using Agilent’s Mass Hunter Software. TICs for metabolite 
profiles obtained through Q-TOF showed a distinct divergence in the metabolite 
profiles for the biological replicate 1 for both tt8 and wild-type (Figure 5.1).  
Raw data was then log-transformed and quantile normalized. Similar to the 
TICs, for samples analysed in Q-TOF, we observed that biological replicate 1 from 
each genotype, tt8 and wild-type formed a separate cluster (Figure 5.1). We then 
analysed the remaining three biological replicates of Q-TOF to ensure that they were 
statistically robust.  All three biological replicates analysed using Orbitrap showed 
good reproducibility. This was visualized by performing Principal Coordinates 
Analysis (PCoA with Bray-Curtis dissimilarity) in PRIMER6 (Figure 5.2) on the 
replicates of Q-TOF and Orbitrap. Figure 5.2A shows the outlier biological replicate 1 
of both tt8 and wild-type in Q-TOF. After removing the outlier from Q-TOF samples, 




between wild-type and tt8 to be over 47% in Q-TOF (Figure 5.2B) and 23% in Orbitrap 
(Figure 5.2C) . We concur that any non-biological source of variation could have 
influenced this separation, thus, for further analysis, biological replicate 1 from both 
sets in Q-TOF were removed. As the remaining 3 biological replicates for each 
condition in Q-TOF showed strong analytical similarity, multivariate analysis was then 
performed on a total of 36 samples (3 biological replicates, 3 technical replicates for 
each genotype) from each MS. It is important to note that the analysis in the MS 
platforms were experimental replicates, meaning that the replicates used in each 
platform were from different batches of plants. Thus, biological replicate 1 of Q-TOF 
was not related to biological replicate 1 of Orbitrap. Furthermore, samples from Q-TOF 
could be used even after removing the outlier, only because these samples still had 
remaining three biological replicates in genotype, thus, they provided the required 
statistical robustness. Therefore, when designing such experiments, it is always useful 
to have a minimum of four biological replicates as even if one replicate is an outlier, 
the analysis can still be performed using the remaining three. Batch effect correction 
procedure described in Chapter 3, was not required in this scenario as all replicates 
were run in a single batch. 
Mann-Whitney test with p-values adjusted (p-value < 0.05) using Benjamini-
Hochberg false discovery rates was performed on the two groups yielding 1,259 and 
611 differential features with p-value < 0.05 and fold change >2 on the Q-TOF and 
Orbitrap, respectively. 
5.2.4. Metabolite identification 
A total of 101 differential features were then recursively mapped (with mass 
tolerance < 5 and 10 ppm) onto KEGG Arabidopsis database (2014 version) (Kanehisa 
and Goto, 2000; Kanehisa et al., 2014)  using PCDL manager (Agilent). Putative 
metabolites were predicted for each m/z feature following the same strategy described 




given m/z was minimum was selected to represent that feature. A list of all m/z features 
with their retention time, predicted metabolites and the ppm error is provided in Dataset 
3. Of these, 46 metabolites were validated using data-dependent MS/MS-based 
fragmentation, with the fragmentation pattern matched against metabolites in the 
MassBank database (Horai et al., 2010). 
5.2.5. Microarray-based expression profiling and analysis.  
Total RNA was extracted using Omega plant RNA extraction kit (Omega BIO-
TEK) following manufacturer’s protocol. RNA was purified using an RNeasy 
purification kit (Qiagen). Total RNA was sent to Genomax technologies, Singapore for 
microarray analysis including RNA quality control using Bioanalyser (Agilent), 
reverse transcription and labelling, single color hybridization onto Agilent Arabidopsis 
4×44k Array and preliminary data analysis. The experiments were performed for two 
biological replicates each for Ws and tt8 lines, with two technical replicates (of each 
biological replicate) of each line being hybridized on single slide. Analysis was 
performed using Genespring 12.0 (Agilent) software. 
All probes were normalized using percentile shift to 75% and were baseline 
corrected to the median. Data were filtered by taking 20th to 100th percentile of signal 
value followed by filtering data based on coefficient of variance with < 20% as cut off. 
Similar to the differences in metabolic profiles of Ws and tt8 lines, their respective 
gene expression profiles also exhibited a clear difference (Figure 5.3). Filtered data 
were used for statistical analysis to identify differentially expressed genes using 
unpaired t-test with asymptotic p-value computation with Benjamini-Hochberg-based 
FDR (False discovery Rate) correction. 1,284 differentially expressed genes were 
















Figure 5.1. Raw Total Ion Chromatograms showing four biological replicates with 
each having 3 analytical replicates of (A) tt8 (B) wild-type. The TICs of the 
biological replicate 1 of both tt8 and wild-type show distinct profiles compared 
to the other replicates. 












































Figure 5.2A. Exploratory data analysis depicting similarity in metabolic profiles 
within biological replicates and differences between genotypes in Q-TOF. The first 
row shows the hierarchical clustering between samples and the second row ordination 


































Figure 5.2B. Exploratory data analysis depicting similarity in metabolic profiles 
within biological replicates and differences between genotypes in Q-TOF after 
































Figure 5.2C. Exploratory data analysis depicting similarity in metabolic profiles 


































Figure 5.3. PCA using princomp function in R, shows similar trends between technical 
and biological replicates of wild-type and tt8. 
 
Gene Set Enrichment Analysis (GSEA) enrichment analysis was performed 
using the web-based tool PlantGSEA (Yi et al., 2013). Subpathway enrichment was 
performed on differential genes and metabolites in R using iSubpathwayMiner package 
(Li et al., 2013). Microarray data has been uploaded onto the GEO database [under 
embargo until publication]. All p-values mentioned in study are FDR corrected.   
5.2.6. Promoter regulatory network 
Differential  genes were analysed using network-guided guilt-by-association 
approach in AraNet (Vandepoele et al., 2009)  to identify target gene group (TGG).  
Among the 1,284 differential genes, those that have minimal set of information in The 
Arabidopsis Information Resource (TAIR, https://www.arabidopsis.org/) were further 
selected. This removed genes (306 genes) which did not contain any annotation in 
Arabidopsis or even functional/sequence similarity to other organisms.  
Amadeus (Linhart et al., 2008) platform was used for de novo motif discovery, 
we scanned for enriched motifs in the 968 differential genes with six different 
combinations, defined as: Promoter length: 1500, 1000 and 500 bps upstream of 
transcription start site, and, Motif length: 8-mer’s and 10-mer’s motifs. An adjacency 




the maximum motif similarity between the 23 CAZY genes and other differential genes 
to be 19 motifs. Using an approach similar to (Vandepoele et al., 2009), we tested 
different constraints, such as, genes sharing at least 95%, 90%, 75% and 50% of the 
maximum motif similarity, these gene clusters contained 15 (sharing 18 motifs), 27 
(sharing 17 motifs), 170 (sharing 14 motifs) and 596 (sharing 10 motifs) genes, 
respectively. To limit false positives but still have the potential to uncover new 
interactions, genes were selected based on a highly stringent condition i.e., those 
sharing a minimum of 14 motifs (at least 75% motif similarity). The promoter 
regulatory network was constructed using this list in Cytoscape (Shannon et al., 2003). 
PScan (Zambelli et al., 2009) was then used to identify enriched plant promoter motifs 
in 170 genes from the glycosylation regulatory network. 
5.2.7. Growth assays for stress tolerance 
For stress tolerance assays, Arabidopsis seeds were sown onto MS agar plate 
[1x MS media, 20 g/litre sucrose, and 6 g/litre phytoagar (pH 5.7)] with or without 
different stress conditions [Salt stress (100mM, 150mM, 200mM), Methyl jasmonate 
(MeJA) (50µM, 100µM, 150µM), Mannitol (250mM, 500mM), Deoxynivalenol 
(DON) (5ppm, 10ppm, 20ppm) and Abscisic (ABA) (1µM, 5µM, 10µM)], stratified 
for 4 days, and then incubated at 22 ̊C for 1 week. Ws and tt8 lines were sown directly 
on MS agar plates with or without salt, mannitol, ABA, MeJA and DON. TT8:GR seeds 
were sown on MS agar plates with all selected stress conditions in addition with 30 µM 
dex or equivalent volume of ethanol for TT8 induction or mock treatment, respectively. 
MeJA is a part of innate immune response for biotic stress(Navarro et al., 2008). DON 
is a fungal toxin that is inactivated by glycosylation to impart resistance against 
Fusarium graminearum (Poppenberger et al., 2003), and was used as a representative 
of biotic stress. For germination test under different stress conditions, 28 seeds for each 




measured. The germination of seeds was scored as positive when the tip of the radical 
had fully penetrated the seed coat. 
5.2.8. ChIP assay and Quantitative real time PCR 
ChIP assay using plant materials (0.8g) from six-day-old seedlings of TT8:GR 
lines, with or without dex treatment were performed as described previously 
(Kaufmann et al., 2009) with minor modifications. Promoters of target genes were 
scanned for putative motifs and primers were designed to cover entire promoter. 
Quantitative real-time PCR was performed in triplicates using Bio-Rad CFX384 real 
time PCR system (Bio-Rad) using Maxima SYBR Green qPCR mix (Thermo Fisher 
Scientific). The comparative Ct method (Ct) for relative quantification of gene 
expression was used for calculating the fold change using TUB2 as endogenous 
control.  
Above experiments were performed by colleagues from Metabolite Biology 
Lab, NUS - Dr. Amit Rai, Megha and Lim Boon Kiat. I performed systems level 
analysis of genomics, transcriptomics and metabolomics datasets and developed and 
implemented the integrative omics approach mainly using scripts in R and 
computational tools described in Section 5.2 (Materials and methods). I generated 
Figures 5.1 to 5.12, except for parts of Figure 5.11.  For Figure 5.11, images of 
Arabidopsis plants were produced by Dr. Amit Rai. 
5.3. Results and discussion 
5.3.1. Integrative omics approach to identify direct targets and the regulatory 
network mediated by a putative glycosylation regulator 
This integrative omics strategy (Figure 5.4) uses three complementary 
biological data measurements, namely, metabolomics, transcriptomics and 
transcriptome dependent in-silico genomics. Using non-targeted mass spectrometry-
based metabolomics, we aimed to capture a comprehensive portion of the Arabidopsis 




MS/MS approach to determine glycosylated and non-glycosylated metabolites (shaded 
grey on the left in Figure 5.4). For determining gene expression levels, we performed 
microarray to identify differential genes in tt8 w.r.t its wild-type control. PlantGSEA 
tool was used to identify enriched functional categories. A metabolite set enrichment 
analysis using iSubpathwayMiner was performed.  
Overrepresentation approaches (ORA) such as Fisher’s exact test or a 
hypergeometric test, are usually performed to understand the significance of entities, 
such as metabolites and genes that have been mapped onto pathways. These tests 
compare the number of differential entities that have been mapped onto a pathway, 
against the probability of such mappings occurring purely by chance. A pathway is then 
deemed to be enriched (usually in the form of p-values, such as those seen in Section 
4.3.2.1), if the number of entities that have been mapped onto it is significantly different 
from those expected by chance alone.  
A number of such methods, including ORA and GSEA are widely used for 
identifying pathways whose entities have significant changes in their levels. However, 
the predictive power generated by such methods are limited, as they focus only on 
genes or metabolites and do not factor in simultaneous changes to levels of both of 
genes and metabolites. Furthermore, standard correlation-based methods are unable to 
distinguish between direct and indirect associations when comparing gene and 
metabolite abundances (due to confounding variables such as batch effects). Thus, an 
integrative pathway analysis strategy that can utilize the combined power of both genes 
and metabolites provides an excellent solution to interpret the underlying biological 
phenomena.  
IMPaLA (Kamburov et al., 2011) and iSubpathwayMiner (Li et al., 2013) are 
two such tools that provide the option to use both gene and metabolite information for 
identifying significant pathways. The enrichment statistics for metabolic pathways in 
IMPaLA is generated by multiplying the p-values for genes and metabolites (obtained 




genes and metabolites separately. However, IMPaLA does not consider the topology 
or the presence of hub-nodes in its analysis. These are taken into account in 
iSubpathwayMiner, which analyses the structure of the metabolic pathway.  
If a biological entity has significant changes to its levels, then it might also 
induce corresponding changes to the levels of neighbouring entities in the metabolic 
pathway. This scenario is factored into the enrichment analysis in iSubpathwayMiner 
as it integrates information from genes, metabolites, and their relative positions in the 
sub pathway along with their metabolic cascade regions (Li et al., 2013). Furthermore, 
in a large metabolic pathway, only core part of the pathway, depending on the 
biological phenomena, might have an effect. Thus, iSubpathwayMiner performs 
integrative sub pathway enrichment analysis that can result in a higher predictive power 
for understanding metabolic responses. Specifically, iSubpathwayMiner analyses 
lenient distance similarities of key nodes within the metabolic pathway structure to 
identify important metabolic cascade sub-pathway regions. The enrichment scores for 
such analyses are then generated using a hypergeometric test. Furthermore, 
iSubpathwayMiner also enables direct import of the Arabidopsis metabolic network 
from KEGG into R. Therefore, in order to fully utilize the (i) strength of the combined 
gene and metabolite analysis, (ii) statistical power generated by analysing enriched sub-
pathways, (iii) most updated Arabidopsis metabolic network, we selected 
iSubpathwayMiner for performing integrative analysis. 
To determine the effect of TT8 loss on the metabolic network architecture we 
analysed genes and metabolites together in a sub-pathway enrichment analysis using 
𝑆𝑢𝑏𝑝𝑎𝑡ℎ𝑤𝑎𝑦𝐺𝑀 function in ‘iSubpathwayMiner’ package (Li et al., 2013) in R. The 
output from this analysis was then mapped onto AraCyc version 8.0 (Mueller et al., 
2003) pathways.  
Gene expression is affected by the combinatorial arrangement and sharing of 




Hence, the presence or absence of certain motifs plays a significant role in recruiting 
transcription factors and initiation of transcription, thereby affecting gene expression 
levels. The information encoded in these promoter sequences such as type and number 
of motifs can help understand genotype-phenotype relationships by providing a 
mechanistic interpretation of the genetic basis that govern metabolite regulation (Levo 
and Segal, 2014). Thus, we analysed the promoter sequences of differentially expressed 
genes. We selected only those genes that had  evidence (experimental or 
computational)-based on annotations in AraNet (Lee et al., 2010) to understand 
promoter relationships (shaded grey on the right in Figure 5.4). Furthermore, to identify 
conserved regions between differential genes, we performed de novo motif 
identification implemented using Amadeus (Linhart et al., 2008). This approach 
allowed us to identify motifs which had not yet been encoded to a transcription factor. 
Then, a constraint-based promoter regulatory network was developed based on shared 
enriched motifs between these genes. This subset of genes affected by TT8 loss formed 
the glycosylation regulatory network. The pathways associated with these genes were 
cross-referenced with the AraCyc metabolic pathways where the metabolites had 
earlier been mapped. This metabolic pathway level analysis helped us identify common 
targets affected by TT8. Taken together, by combining high-throughput metabolomics, 
genomics and transcriptomics data, we generated testable hypothesis on the role of TT8 
in Arabidopsis. The hypothesis was then validated using TT8 loss-of-function and 







Figure 5.4. Integrative omics approach to identify direct targets of a flavonoid 
glycosylation regulator. Differential metabolites and genes were identified by 
comparing the metabolic and transcriptome profiles of tt8 and wild-type. Glycosylated 
metabolites were identified using a targeted MS/MS approach. Promoter networks 
analysis was performed using differential genes. Enriched metabolic sub-networks in 
KEGG Arabidopsis metabolic network were identified by the combination of 
differential metabolite and genes 
 
5.3.2. TT8 loss affects glycosylation of flavonoids and nucleotides 
To determine the effects of TT8 loss on the metabolome, we performed 
untargeted metabolic profiling.  As glycosylation is dynamic during the early growth 
stages, we chose to perform the experiments using 6-day old seedling metabolite 
extracts from tt8 and wild-type (Ws background).  Two high resolution mass 
spectrometry platforms were used to improve the coverage of differential metabolites. 
Figure 5.5 illustrates the metabolites detected using the two mass spectrometers on a 




The x-axis represent the retention time, while the y-axis represents the mass-
by-charge ratio of the putative metabolites detected using database searches. From this 
figure, we observed that analytical methods were complementary rather than redundant 
as it covers unique regions of the metabolome. For example, the Q-TOF-based mass 
spectrometer (shaded green in Figure 5.5) covers the entire elution time, whereas 
Orbitrap which had a shorter run time (shaded red in Figure 5.5) was enriched towards 
the initial parts of the chromatography run. The differences in the types of metabolites 
being measured in the two MS arise mainly due to the differences in the 
chromatographic run (see Section 5.2.3). While Orbitrap had a LC run time for 15 mins, 
Q-TOF was run for 18 mins. Furthermore, there was also differences in the column 
make. These differences, plus the fact that Orbitrap slightly favours metabolites at 
lower mass range, eluting first, compared to Q-TOF, resulted in both the MS capturing 
different m/z ranges. Importantly, from Figure 5.2 we also know that both the mass 
spectrometers captured significant biological differences between wild-type and 
mutant. Thus, by using two mass spectrometers, we were able to obtain comprehensive 
coverage of the changes in the Arabidopsis metabolome as a result of TT8 loss. 
Figure 5.5. Comprehensive coverage of the perturbed metabolome. Two mass 
spectrometers were used for profiling complementary regions of the Arabidopsis 
metabolome. The points indicate the detected metabolite’s location based on mass (y 
axis) and retention time (x axis). 
From the differential metabolite analysis, we observed that flavonoids 
including flavonols, flavanones and anthocyanins were the largest class of metabolites 
affected by the loss of TT8 (Table 5.1).  Similar to previous reports, quercetin and 
kaempferol aglycones were up-regulated in TT8 loss-of-function line (Nesi et al., 2000; 

















Pelletier et al., 1999). Our comprehensive metabolomics approach enabled the 
detection of thirteen additional flavonoid aglycones, whose glycosylated forms have 
been not yet been shown to be affected in tt8 (Table 5.1). Interestingly, TT8 loss had 
differential effects on the glycosylation of aglycones mainly based upon the metabolite 
class. For example in Table 5.1A, the first group of metabolites had both aglycones and 
their corresponding glycosylated forms being affected in tt8, whereas, only the 
glycosylated forms were affected in the second group. 
Another interesting observation, is that the trends in the glycosylated 
metabolites were mainly dependent on the nature of the attached sugar moiety. For 
example, most of the glucoside conjugated quercetin and kaempferol were down-
regulated, while the rhamnoside conjugated forms were mostly up-regulated in tt8. 
We also observed a significant number of nucleotides and their glycosylated 
forms being affected in tt8 (Table 5.1B). The sugar conjugated nucleotides numbering 
around 13 out of 20 were mostly down-regulated whereas only 3 out of 10 aglycone 
nucleotides were down-regulated. Taken together, we observed that sugar conjugated 

















Table 5.1. Metabolites affected in tt8. Relative log2-fold levels of differential putative 
glycosylated metabolites and their aglycones belonging to (A) flavonoids, and (B) 
nucleotides in both TT8 loss and induced overexpression lines are shown. * indicates 






Aglycone Glycone    tt8     TT8:GR 
  cyanidin*   2.4 -2.2 
 cyanidin 3,5-diglucoside* -2.4 2.9 
 cyanidin 3-O-beta-D-glucoside* -3 2 
 cyanidin 3-O-sophoroside* -2.4 1.3 
kaempferol*  9.6 -1.4 
 kaempferol 3-sophorotrioside* -5.2 3.1 
 kaempferol 3-O-glucoside* -4.6 2.1 
 kaempferol 7-O-glucoside* -4.2 1.8 
 kaempferol 3,7-O-diglucoside* -8.8 2 
 kaempferol 3-O-glucosyl-(1-2)-glucoside* 1.6 -1.1 
 kaempferol 3-O-glucosylgalactoside* 7 -2.3 
 kaempferol 3-O-gentiobioside-7-O-rhamnoside* 2.7 -2.3 
 kaempferol 3-rhamnoside* 2.8 -1.5 
 kaempferol 3-rhamnoside-7-rhamnoside* 6.9 1.4 
quercetin*  9.5 -6.3 
 quercetin 3,7-O-diglucoside* -3.8 2.6 
 quercetin 3-O-[xylosyl-(1-2)-glucoside]* -7.8 3.1 
 quercetin 3-O-glucoside* -9.7 8.8 
 quercetin 3-O-glucosyl-(1-2)-glucoside* 0.8 -2.1 
 quercetin 3-O-rhamnoside* 9 -2 
 quercetin 3-O-rhamnoside-7-O-glucoside* -8.8 2.3 
 quercetin 3-rhamnoside-7-rhamnoside* 9.9 -3.2 
luteolin*  12.9 -1.3 
 luteolin 7-O-glucoside* -10 0.8 
vitexin*  15.2 N.D 
 vitexin 2-O-D-glucoside* -8.6 N.D 
isovitexin*  -1.9 2.1 
 isovitexin 2''-O-beta-D-glucoside* -0.8 -1.9 
salicylate  -4.6 1.8 
 salicylate -D-glucose ester 7.5 -2.2 
 salicylate 2-O-D-glucoside -0.5 -1.1 
apigenin  3.4 -1.7 
 apigenin 7-O-beta-glucoside* -9.5 N.D 
 apigenin 7-O-neohesperidoside* -1.7 N.D 
 genistein 7-O-glucoside* -0.8 2.1 
 hesperetin 7-O-glucoside* -7.6 3.3 
 pelargonidin-3,5-diglucoside* 5 -3.8 
 naringenin 7-O-glucoside* 8.6 -2.5 
 bracteatin 6-O-glucoside* 0.7 -1.3 
 coniferaldehyde glucoside -1.3 1.4 
 dihydroconiferyl alcohol glucoside 7.14 14.1 
eriodictyol  8.3 -0.3 
2',4,4',6'-
tetrahydroxychalcone 
 8.3 -0.3 
4-coumarate  -2.3 8.8 
caffeoylshikimate  8.1 -3 
camalexin  -6.4 13 
chorismate  -6.5 10.4 
dihydroconiferyl alcohol  1.1 -2.7 







Aglycone Glycone tt8 TT8:GR 




 UDP-4-dehydro-6-deoxy-D-glucose* 2.8 -1.9 
 UDP-D-apiose -7.7 1.2 
 UDP-D-glucose -6.6 1.8 
 UDP-D-glucuronate -6.9 3.1 
 UDP-D-xylo-4-keto-hexuronate -11.8 3.3 
 UDP-D-xylose -7.7 3.9 
 UDP-galactose -6.6 2.3 
 UDP-L-arabinofuranose* 8.5 -3.1 
 UDP-L-arabinose -7.7 3.5 
 UDP-N-acetyl-D-glucosamine -12 N.D 
UMP  1.7 N.D 
UTP  -10.8 3.4 
dUMP  6.6 -1.7 
dUTP  8.5 -2.1 
dTDP  6.4 -3.3 
dTTP  -3 3.1 
 dTDP-alpha-L-rhamnose 2.8 N.D 
 dTDP-D-glucose -15.9 2.3 
 TDP-rhamnose -6.4 4 
 dTDP-4-acetamido-4,6-dideoxy-D-galactose 2.7 -2.3 
 dTDP-4-dehydro-6-deoxy-D-glucose -9.2 7.5 
dGTP*  -3.9 1.1 
 GDP-D-glucose* -1.7 1.3 
 GDP-L-fucose* -15.9 2.3 
 CDP-4-dehydro-3,6-dideoxy-D-glucose 9 -1.7 
 CDP-4-dehydro-6-deoxy-D-glucose 7.5 -2.3 
dCTP  N.D -2.7 
dGMP  N.D    6.3 
   
5.3.3. TT8 loss affects genes associated with sugar metabolism and 
glycosylation 
Microarray-based gene expression profiling was performed using tt8 and wild-
type seedlings to determine the effects of TT8 loss at transcript levels. As expected, the 
levels of TT8 were down-regulated in the mutant compared to the wild-type. Consistent 
with previous reports, targets of TT8 such as BAN and DFR were down-regulated by 
1.3- and 1.67-fold, respectively, while homologs of TT8 namely, EGL3 and GL3, were 
up-regulated by 1.45- and 2.3-fold, respectively. The up-regulation of homologs 




Several biosynthetic genes from phenylpropanoid and flavonoid pathway 
showed down-regulation in their gene expression trends compared to wild-type. 
Similar results were also seen at their corresponding metabolite levels. As we observed 
a number of metabolites being glycosylated, we focused on the enzymes mediating 
glycosylation processes, specifically CAZy. Expectedly, 34 genes from the CAZy 
category were differentially expressed by more than 2-fold (Figure 5.6). We also 
observed around 10% of the total CAZy genes in Arabidopsis being significantly 
affected by more than 1.5-fold. The expression levels for CAZy genes associated with 
glycosylation of specific metabolites showed similar trends. For example, UGT78D1, 
regulates the glycosylation of aglycone forms of kaempferol by adding rhamnosides 
(Jones et al., 2003) was up-regulated by over 6.5-fold, showing the same trend as that 
of rhamnoside conjugated forms of kaempferol in tt8 (Table 5.1A). Similarly, 
UGT88A1, which glucosylates quercetin was down-regulated by 2.5-fold (Figure 5.6), 
and so were the levels of three forms of quercetin glucosides in tt8 (Table 5.1A). These 
two genes are also associated with several sugar conjugation processes. 
To identify coordinated response of genes and metabolites in enriched sub 
pathways in the KEGG Arabidopsis metabolite network, we mapped differential genes 
and metabolites onto their respective KEGG identifiers and used iSubpathwayMiner in 
R. The most enriched process was inositol phosphate metabolism which is related to 
signalling in defence responses in Arabidopsis. However, the above analysis is limited 
by the fact that KEGG maps does not provide exhaustive coverage of the glycosylated 
forms. Using our targeted MS/MS analysis we observed that a number of metabolites 
from the flavonoid pathway being glycosylated. Upon incorporating results from 
MS/MS analysis, flavonoid or nucleotide glycosylation networks had the maximum 
number of affected entities based mainly upon the number of differential metabolites 
(glycosylated and non-glycosylated) in those pathways (Table 5.1A). Thus, sub-
networks associated with flavonoid metabolism were the most enriched sub-network 




metabolism (Figure 5.8 and Supplementary Dataset 3). Sugar metabolism networks of 
fructose, mannose and pyruvate pathways were enriched together with glycolysis and 
TCA cycle (Supplementary Dataset 3). Branches of TCA cycle that lead to amino acid 
pathways such as arginine, proline, and cysteine and methionine metabolism were also 
enriched. 
Sugar associated pathways, such as pentose phosphate pathways, and amino 
acid pathways, such as alanine and proline metabolism contribute precursors to the 
components of nucleotide network, namely purine and pyrimidines. Sub-networks with 
these pathway inputs were significantly enriched, suggesting indirect influence of 
enriched sugar metabolism network on nucleotide metabolism. These results suggest 
that TT8 loss affects nucleotide and flavonoid sugar conjugation process at both gene 
and metabolite levels 
In addition to the sugar and nucleotide metabolic sub-network, a number of 
sugar transporters and sucrose synthases were also affected in tt8. Sugar transporters 
SUC6 and SUC7, sucrose synthases SUS2, SUS3 and SUS5 along with sugar binding 
proteins STP6 were down–regulated by more than 1.5-fold. Taken together, gene 
expression analysis shows disruption of sugar conjugation machinery in tt8 with 
members of sugar metabolism and glycosylation machinery such as sucrose synthases, 
sugar binding proteins, sugar transporters, glycosyltransferases and hydrolases being 























































































































Figure 5.6. Differentially expressed CAZy genes. Heatmap on the left showing 
relative CAZy gene expression levels computed as z-scores using heatmap2 
function in R. In the above plot, the each column represents two biological replicates 
each of tt8 and its wild-type. Each column is an average of two technical replicates.  
Each row represents the relative abundance of genes. In the matrix on the right, each 
column represents a pathway from AraCyc. The presence of a gene in that pathway is 






5.3.4. Abiotic-biotic stress response together with jasmonate and 
brassinosteroid biosynthesis network is enriched in tt8 
GSEA revealed 14 biological processes encompassing around 30% of the 
differential genes to be significantly enriched. Interestingly, abiotic and biotic stress 
response, hormone response, metabolic pathways and developmental functions were 
the major categories that were enriched (Figure 5.7).  From Figure 5.7, we observed 
that genes associated with biotic stress response showed overall up-regulation 
(relatively higher proportion of red in the figure), while abiotic stress categories 
showed a mixed trend, with hormone response and biosynthesis processes being 
effectively up-regulated in TT8 loss.  
Furthermore, from our sub-network enrichment analysis, we observed 
jasmonate sub-networks to be significantly enriched (p-value < 0.01) at both gene and 
metabolite levels. Interestingly, the sugar or amino conjugated forms of jasmonates, 
were not affected in tt8. Expression levels of genes from jasmonic acid biosynthesis 
pathways, such as, AOC1, AOC2, AOC3, LOX2, LOX3, HPL1, OPCL1, OPR3 and 
ST2A were all up-regulated by more than 2-fold in tt8, this was the same trend 
witnessed in their metabolic intermediates (Table 5.2). Genes associated with jasmonic 
acid responses, such as, key regulators - JAZ1 to JAZ12 (Thines et al., 2007), JMT, and 
CEJ1 and expect JAZ3 and JAR1, were all up-regulated in tt8. Additionally, JAR1 
regulates jasmonic acid-dependent processes, whereas CEJ1 expression is co-regulated 
by jasmonic acid.  
Previous reports (Chico et al., 2008), state that increase in jasmonic acid 
biosynthesis leads to up-regulation of MYC2, a bHLH transcription factor, which has 
an important role in jasmonate signalling pathways. This was also observed in our study 
with MYC2 being up-regulated by 2.3-fold in response to increased jasmonic acid 
biosynthesis in tt8. TT8 loss not only affected jasmonic acid biosynthesis, but also 




omics analysis also revealed enrichment of fatty acid biosynthesis and lipid pathways 
(Supplementary Dataset 3),  which is further supported by recent biochemical evidence 
that shows that TT8 exudes inhibitory effects fatty acid biosynthesis (Chen et al., 2014).  
Another major phytohormone pathway affected by tt8 is brassinosteroid 
biosynthesis. Brassinosteroid sub-networks showed significant enrichment at the 
metabolite levels. Furthermore, the key genes of this pathway, namely BR6OX1 and 
AT4G27440 were down-regulated by more than 2-fold. Biosynthesis of brassinolide 
from campesterol in Arabidopsis occurs through two routes, one through (6α)-
hydroxycampestanol and second through 6-deoxycathasterone (Figure 5.8). Although, 
both branches for brassinolide biosynthesis are active in wild-type (Noguchi et al., 
2000), TT8 loss resulted in a switch, with (6α)-hydroxycampestanol branch being up-
regulated while 6-deoxycathasterone being down-regulated, thus suggesting a 
preferred route of brassinolide biosynthesis in tt8 (Figure 5.8). 
SERK4 (AT2G13790), SERK5 (AT2G13800) which are part of the 
brassinosteroid signalling cascade were up-regulated by over 2-fold, while FLS2 was 
down-regulated by 1.5-fold change. These results suggest that the signalling 
mechanisms in brassinosteroid pathway were not majorly affected. However, there 
were significant changes observed in the genes and metabolites belonging to 
brassinosteroid biosynthesis pathway. 
These results clearly indicate that TT8 loss affects two major phytohormone 
biosynthesis pathways in Arabidopsis. Furthermore, these pathways are also known to 
play an important role in stress response.  
Figure 5.7. Gene Set Enrichment Analysis. Top 33 enriched GO categories (p-value < 
0.05) with the number of differential genes affected in each category is shown here. 
Within each of the enriched GO category, the number of overexpressed and down-
regulated genes are indicated in red and green colour, respectively.
No of genes enriched
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cellular nitrogen compound biosynthetic process
S-glycoside metabolic process
flavonoid biosynthetic process
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Table 5.2. Metabolites belonging to phytohormone pathways affected in tt8. * indicates 
metabolite was confirmed using MS/MS. 
Aglycone Glycone tt8 TT8:GR 
Jasmonic acid biosynthesis 
volicitin *  -11.7 N.D 
12-OPDA  -6.1 3.4 
jasmonic acid  9.1 -1.8 
7-Isomethyljasmonate  8.5 -3.2 
17-hydroxylinolenic acid  8.9 -3.3 
2(R)-HOT  11.3 -2.5 
2(R)-HPOT  11.5 -2.6 
methyl jasmonate  5.6 -3.7 
OPC4-trans-2-enoyl-CoA  2.1 -1.1 
OPC6-trans-2-enoyl-CoA  -6.5 -2 




 7.1 1.8 
Brassinosteroid biosynthesis 
campest-4-en-3-one *  -5.9 6.1 
22 alpha-hydroxy-campest-4-
en-3-one 
 2.2 -0.3 
26-hydroxycastasterone  8.2 -5.4 
brassinolide *  1.3 -1.9 
castasterone *  8.6 -1.1 
6 alpha-hydroxy-castasterone  -11.5 2.9 
6-deoxocastasterone  -5.3 9.4 
6-deoxotyphasterol  -6.5 6.9 












































































































































































































Figure 5.8. The top 3 enriched pathways (redrawn based on AraCyc and KEGG), 
namely biosynthesis of flavonoids and their conjugation, jasmonic acid and brassi-
nosteroids and their associated differential metabolites and genes are shown. TT8 
leads to increase in both metabolite and gene levels in jasmonic acid pathways, 





5.3.5. TT8 regulatory network links genes associated with carbohydrate active 
enzymes to innate immunity 
We analysed the promoter sequences of differentially expressed genes to 
determine whether these genes shared common enriched motifs. Transcription Factor 
Binding Sites (TFBS) by controlling the timing and location of transcriptional activity, 
play an important role in regulating gene expression levels (Leister et al., 2011; Meier 
et al., 2008; Vandepoele et al., 2009; Vidal et al., 2013). Thus, genes sharing motifs 
might be under common regulatory mechanisms. We used a network-guided guilt-by-
association approach to uncover relationships at a regulome level and analysed 
enriched 8-mer and 10-mer de novo promoter motifs (Linhart et al., 2008) to obtain 
shared motifs between differentially expressed genes. As described in the previous 
sections, glycosylation of flavonoids and nucleotides and CAZy associated genes were 
significantly affected in tt8. Furthermore, we also witnessed TT8 having significant 
effects on processes associated with stress response and hormone biosynthesis (Figure 
5.7). Therefore, in order to identify whether these genes share common regulatory 
mechanisms, we constrained the promoter network to show only relationships between 
genes that were connected with CAZy genes.  
We then developed an undirected network with nodes representing genes and 
edges representing the shared motifs (Figure 5.9). The width of the edges is 
proportional to the number of shared motifs between any two genes (nodes), with high 
similarity indicated by thicker edges. This network represents the genes in the TT8-
glycosylation regulome. This glycosylation regulome consists of 18 CAZy genes that 
connect mainly with genes associated with stress response (13 genes) and 
phytohormone biosynthesis (13 genes). CAZy genes also share motifs with genes 
involved in sugar metabolism such as transporters (5 genes) and transferases, 




biosynthesis and response, such as the cytochrome P450 genes (Figure 5.9) also shared 
motifs with jasmonate and CAZy genes. 
Genes from the TT8-glycosylation regulome analysed using PScan (Zambelli 
et al., 2009) tool revealed bZIP-related binding sites, EmBP-1, MYB, and Squamosa, 
TFBS over-represented (Table 5.3). Interestingly, recent reports have suggested these 
TFBS to be enriched in the presence of regulators such as JAZ and a number of stress 
associated CAZy genes and sugar-related pathways (Kang et al., 2010; Kazan and 
Manners, 2012; Qi et al., 2011). These relationships suggest the possibility of a 
common regulatory mechanisms among CAZy genes and between CAZy and jasmonic 
acid-associated genes. The results from transcriptome and metabolite profiling also 
support the novel relationships identified in the network, such as those between CAZy 
and jasmonic acid biosynthesis associated genes. Taken together, our results suggest 
that glycosylation of metabolites and processes associated with stress response might 

















Table 5.3. Enriched plant transcription factors of the TT8-glycosylation regulome. The 
co-regulated gene sets were assessed for the occurrence of 21 known plant transcription 
factor binding sites. 
 
Transcription factor binding site  500bp  1000bp  
Jaspar 
EmBP-1  1.00E-04 2.00E-05 
HAT5  0.001 0.0001 
squamosa  0.002 0.015 
ATHB-5  0.016 0.001 
PEND  0.018 0.003 
bZIP910  0.021 0.164 
AGL3  0.023 0.001 
   
Jaspar-Fam 
MADS  4.00E-12 7.00E-07 
Homeobox  1.00E-11 2.00E-11 








   
Transfac 
P$PIF3_02  8.00E-06 2.00E-05 
P$PIF3_01  1.00E-04 3.00E-06 
P$AGL3_01  3.00E-03 0.007 
P$AGL3_02  0.01 0.007 
P$SBF1_01  0.029 7.00E-05 
P$ATHB5_01  0.04 0.001 
P$DOF1_01  0.769 0.007 
P$ATHB1_01  0.157 3.00E-04 
P$PBF_01  0.173 0.009 
TT8
CAZy
Stress response Phytohormone associated
genes
Transporters






Figure 5.9. Promoter network showing 
CAZy genes that share motif similarity with 
stress response and phytohormone-
associated genes. Differential genes formed 
the nodes, while the edge width indicates the 

































































































































































5.3.6. TT8 reprograms hormone biosynthesis and sugar conjugations by 
physically binding to their promoters 
Direct associations of TT8 with genes associated with jasmonic acid and 
brassinosteroid biosynthesis, glycosylation of metabolites and stress response 
pathways were tested using ChIP-PCR and RT-PCR in inducible overexpression lines. 
Representative genes from each process in the promoter network were selected and 
their expression levels were analysed in overexpression and mutant lines using RT-
PCR-based relative quantification.  
Interestingly a number of CAZy genes showed reciprocal expression trends in 
TT8 loss and induced overexpression lines, suggesting direct association of the 
expression of these genes with TT8 activity (Figure 5.10A). Hydrolases which were 
down-regulated in dex-induced overexpression lines were up-regulated in tt8. 
Conversely, transferases and sugar transporters, down-regulated in TT8 loss-of-
function lines were up-regulated in dex-induced overexpression lines. TT8 also showed 
direct binding to the promoters of the CAZy genes, UGT84A1, UGT85A3 and 
UGT88A1 in dex-induced lines (Figure 5.10A). In TT8 loss-of-function lines, twelve 
jasmonic acid-associated genes were up-regulated, while the same set of genes were 
down-regulated in the dex-inducible system (Figure 5.10B). TT8 also showed direct 
binding to the promoters of six jasmonic acid biosynthesis genes, namely AOC2, 
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Gene expression ChIP enrichment
Figure 5.10. Expression trends of genes which shared promoter motifs in tt8 and 
induced overexpression lines. Dark grey bar represents relative gene expression 
levels in tt8/Ws, whereas light indicates TT8:GR dex/TT8:GR mock. (A) Genes 






 The key gene from brassinosteroid biosynthesis pathway, BR6ox1 was up-
regulated in tt8 and down-regulated in dex-induced overexpression lines. Genes 
associated with stress response also showed reversal in gene expression trends in 
mutant and overexpression lines (Figure 5.10C). Interestingly, the overall gene and 
metabolite expression trends in dex-induced overexpression lines were similar to tt8 
but showed exact inverse trends. These results taken together show that TT8 is a 
potential master regulator that directly binds to and reprograms genes associated with 
stress-related hormone biosynthesis, sugar conjugation processes and indirectly 
regulates stress-associated genes in Arabidopsis thaliana. 
5.3.7. TT8 overexpression enhances stress tolerance 
The results from gene expression and metabolomics analyses showing that TT8 
controls stress response and hormone biosynthesis overwhelmingly suggest a 
regulatory role for TT8 in mediating plant innate immunity. Thus, we tested tt8 and its 
dex-induced overexpression lines with salt, mannitol and ABA treatments for abiotic 
stress conditions and for biotic stress, we used MeJA and DON. Response to these 
stress conditions was analysed by counting the number of germinated seeds and 
recording images of 6-day-old seedlings. The germination percentage of seeds was 
calculated to provide a quantitative measure of the stress response.  
We observed a large reduction in the germination rates for all treatments in tt8 
when compared to its wild-type (Figure 5.11A). Remarkably, dex-induced TT8:GR 
showed nearly 20-30% improvement in germination rates compared to its wild-type 
(Figure 5.11B). The germination rates of dex-induced TT8:GR compared with its wild-
type in stress-free conditions were similar. Therefore, the increased germination rates 
witnessed in TT8:GR lines were not induced by dex, but rather are a result of increased 
TT8. The effect of stress treatments to tt8 were most pronounced in salt, mannitol and 
DON (we observed effects on germination between days 1 to 3), with tt8 showing 




Effects of MeJa and ABA were observed between days two or three and 
culminated in nearly 25% lower germination rates compared to wild-type after one 
week. Under severe salt stress (200 mM NaCl), tt8 germinated as late as five days after 
sowing. These results establish that TT8 plays a direct role in tolerance towards 
multiple abiotic and biotic stresses tested here.  
Figure 5.11. Effect of selected stress conditions on (A) TT8 loss of function, and (B) 
mock/dex treated induced TT8 overexpression lines. TT8 overexpression lines show 






In this study, we provide computational and biochemical evidence to establish 
the role of TT8 as a key regulator of glycosylation of metabolites. We have also shown 
for the first time, the role of TT8 in mediating,  
(i) Coordinated regulation of glycosylation of both primary and secondary 
metabolites through a common mechanism. The utilization of a common 
mechanism to regulate both primary and secondary metabolites suggests 
that glycosylation processes that generate diverse metabolites require 
wide range of cellular resources to be regulated in a coordinated manner.  
(ii) Direct relationship between metabolite conjugation and stress hormone 
biosynthesis through coordinated regulation via direct binding to the 
promoters or indirectly affecting expression levels.  
(iii) Plant stress response against multiple biotic and abiotic stress factors by 
directly or indirectly regulating the gene expression levels of eight 
stress-associated genes. These genes have important roles in enabling 
the plants to survive salt and drought stress (Liu et al., 2013; Mir et al., 
2013; Seo et al., 2008).  
Interestingly, TT8 overexpression improves stress tolerance, while its loss 
renders the plant to be more sensitive to abiotic and biotic stresses. Recent reports had 
suggested that TT8 might play a role in stress response based on increase TT8 levels 
witnessed in roots in response to salt and osmotic stress (Jiang et al., 2009).  Based on 
TT8’s roles in coordination of glycosylation of metabolites and stress response 
processes, we have now established TT8 as a key regulator of plant stress response. 
Finally, we propose a model highlighting the role of TT8 in co-ordinately regulating 




























































Figure 5.12. Model depicting the role of TT8 in regulating glycosylation of metabolites 
and mediating plant innate immunity. Glycosylation of nucleotides and flavonoids are 
positively regulated by TT8, while jasmonic acid biosynthesis is negatively regulated. 
Expression level of several genes associated with stress response are also regulated by 





The model shows that TT8 directly binds to the promoters of genes associated 
with glycosylation of metabolites (such as UGT84A1, UGT85A3 and UGT88A1) and 
hormone biosynthesis (LOX2, AOC2, AOC3, HPL1, ST2 and OPCL1).  
Furthermore, the expression levels of members of sugar conjugation machinery 
(highlighted in blue in Figure 5.12) are also affected by TT8. Thus the regulatory 
control exhibited through TT8-mediated processes results in increased metabolite 
diversity. Finally, several genes associated with stress response are either up- or down- 
regulated as a result of TT8 activity.  
Taken together, these results highlight the importance of processes that 
generate metabolite diversity and reveal the underlying complex mechanistic 




6. Overall conclusions and future perspectives 
 
 
 “Fill the brain with high thoughts, highest ideals, 
place them day and night before you, and  
out of that will come great work.” 
...Swami Vivekananda, Indian philosopher 
 
Deriving meaningful biological information from complex systems requires 
robust statistical methods. It is clear from these studies that metabolomics approaches 
can provide valuable insights into cellular responses by linking genotype to 
phenotypes. Furthermore, we also show that integrating datasets with complementary 
information about the biological system can generate strong testable biological 
hypothesis, which can further be validated.  
The major conclusions from the three studies are: 
(i) Large-scale experiments are prone to unwanted non-biological sources of 
variation that confound the outcome. If these variations are not corrected, they 
lead to erroneous biological interpretations. Furthermore, off-the-shelf 
solutions do not work for complex experimental designs, thus, requiring tailor-
made statistical solutions to investigate possible batch effects using 
exploratory data analysis. This study also highlights the importance of storing 
all possible meta-information that can be used for investigating unwanted 
variations. Finally, the statistical methods in this study can also be used for 
others types of omics datasets. 
(ii) While direct induced perturbations can be used in model organisms to 
understand the metabolic processes, natural varying species that contain 
genetically intractable systems can be studied using a non-targeted 
metabolomics approach. As the first study of natural variation in the microalga- 




between habitat and metabolic diversity. This diversity is greater compared to 
the metabolic divergence at species level between Chlorella and Parachlorella 
strains. Physiological and environmental factors therefore outweigh genetic 
influence on metabolic phenotypes. Furthermore, we showed that by 
associating growth and physiochemical parameters with metabolic profiles, we 
can derive biomarkers and associated metabolic pathways. Such associations 
can be used for predicting and optimizing the behaviour of non-model systems 
and help in bioprospecting of natural products in naturally varying systems.  
(iii) We show that organisms respond to perturbations by modulating their gene 
expression levels, thus, exuding regulatory controls involving coordinated 
gene-metabolite changes that reprogram the Arabidopsis metabolite network. 
By utilizing the combined power derived by integrating genomic relationships 
and gene expression outcomes with metabolite profiling, we were able to 
uncover TT8’s role in increasing metabolite diversity and in regulating stress 
response and phytohormone biosynthesis. This systems level understanding of 
the regulatory control in reprogramming of perturbed metabolic networks 
could only be detected using both transcriptome and metabolome 
measurements, thus highlighting the utility of a multi-omics approach. 
Furthermore, we show that plant stress responses are highly dependent on 
biochemical processes that generate metabolic diversity. 
The approaches developed in this study integrate experimental design, 
environmental factors and direct measurements of metabolic network components (i.e., 
enzyme and metabolite levels) to assess multiple sources of influence on metabolic 
phenotypes. These are then analysed using statistical methods to provide valuable 
biological interpretations. Taken together, the current research work contributes 
important results that have the potential to be developed into useful applications for 





Future perspectives from these results include:  
 We will be including recommendations for the minimal meta-data structure 
based on the metabolomics data standards initiative (Fernie et al., 2011; 
Steinbeck et al., 2012) for reporting and analysing batch-specific variations. 
To facilitate open access research, we are also planning to provide open access 
to R scripts upon publication of the paper.   
 Secondly, we have identified efficient strains for biofuel production based on 
the results of metabolomics data that was generated from a survey of naturally 
varying oleaginous microalgae in Malaysia. Currently we are working on a 
small-scale batch culture of the same strains in collaboration with Prof. Phang 
Siew Moi (University of Malaya). Furthermore, as a part of metabolic 
engineering strategies, multi-omics approaches used in Arabidopsis can be 
extended to top-performing Chlorella for enhancing the naturally existing 
biological design principles leading to efficient biofuel production.  
  We identified important components and mechanisms that affect bioactive 
properties of flavonoids, hormones, stress response, and generate increased 
metabolite diversity in Arabidopsis. Additionally, by establishing TT8, which 
has homologs in crop plants, as a key integrator of biochemical processes that 
lead to increased diversity of secondary metabolites and increase plant stress 
response, we have uncovered untapped potential for the application of TT8 in 
agriculture and pharmaceutical industries. We are now at an advanced stage in 
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Appendix 1: datPAV- A web-based exploratory data analysis 
tool 
This tool was developed to provide user-friendly informatics programs for 
analysis of large omics data sets. The input data is a standard two dimensional matrix 
with rows and columns. This tool explores organization of the data, detect errors and 
supports basic statistical analyses whose results can be visualized using a suite of 
programs. The functions are placed as individual modules as well as in a customizable 
workflow.  
Statistical techniques in datPAV help to determine the distribution of data, 
establish correlations to explore experimental consistency or instrument reliability, 
perform fold-change analysis and fit a relation between variables using linear 
regression techniques. My contribution to the development of datPAV is the 
implementation of statistical data analysis (Table A1) modules written in PERL and 
integration with the R statistical environment. 
  
Process/Analyse data 
With further options to select columns and
set parameters for selected processing 
option 
Mean centering (auto scale) Subtract column mean and divide by column σ 
Pareto scaling Divide by column standard deviation (σ) 
Column normalization Divides each value by its column maximum 
Global normalization Divides each value by the dataset maximum 
Distribution Computes % distribution for 10 intervals for each 
column 
Filter(moving average) Useful for time series data 
Variable correlation Depicts dependency between every pair of attributes 
Noise correction Helps in filtering the predefined noise in the data 
Fold change (between 
columns) 
Log2 transformation of ratio between two columns 
t-test P-value calculation between columns 
Auto correlation Depicts similarity between observations as a function 
of time 
Cross correlation Depicts dependency between every pair of attributes 
as a  measure of time 
Table A1. Statistical tools in datPAV
  
Zhang, W.C., Shyh-Chang, N., Yang, H., Rai, A., Umashankar, S., Ma, S., Soh, B.S., 
Sun, L.L., Tai, B.C., Nga, M.E., et al. (2012). Glycine decarboxylase activity drives 
non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148, 259-272. 
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Appendix 2: Metabolic reprogramming in Cancer 
Lung cancer is the leading cause of cancer-related mortality in both men and 
women worldwide with over 1 million deaths each year, and a 5-year survival below 
15%. Non-small cell lung cancer accounts for approximately 85% of all lung cancers. 
Our collaborator Dr. Bing Lim (Genome Institute of Sciences) identified the metabolic 
enzyme glycine decarboxylase (GLDC) as critical for tumour initiating cells (TIC). 
However the effect of GLDC in initiating metabolic reprogramming of cancer cells was 
not known.  
We performed non-targeted metabolomics on perturbed (overexpression or 
knock down) cells from human lung cancer cell line (A549), mouse embryonic 
fibroblasts (3T3), and normal human adult lung fibroblasts (HLF) using LC-MS to 
identify the global perturbations in the metabolome. Using the statistical techniques 
discussed in this thesis, I performed metabolomics data analysis which lead to the 
identification of glycine, serine and threonine metabolism, glycolysis and pyrimidine 
pathways as being significantly perturbed.  These were then verified using targeted 
metabolomics approach (Tandem MS/MS and Multiple Reaction Monitoring analysis). 
Taken together, our metabolomics approach helped us determine that GLDC 
over expression induces dramatic changes in glycolysis and glycine/serine metabolism 
which then lead to changes in pyrimidine metabolism to regulate cancer cell 
proliferation (Zhang et al., 2012). In human patients, GLDC overexpression is 
significantly associated with higher mortality from lung cancer, and aberrant GLDC 
expression is observed in multiple cancer types. Our findings helped establish a novel 
link between glycine metabolism and tumorigenesis, and may provide novel targets for 
advancing anti-cancer therapy.  
